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ABSTRACT 
Porcine circovirus type 2 (PCV2) impacts global swine production, is economically 
important, and is associated with multiple disease entities that include multisystemic disease, 
wasting, pneumonia, diarrhea and reproductive failure. Transmission of PCV2 within or 
between swine populations is not well understood. We characterized semen shedding of 
PCV2a and PCV2b in Landrace boars and found that PCV2 viremia precedes semen 
shedding, clinical signs are absent, and peak PCV2 semen shedding occurs between 10-20 
days post-infection. PCV2 can be continuously shed in semen for at least 90 days. We 
determined that PCV2 shed in semen is infectious when used in a swine bioassay model, but 
dam or fetal infection after artificial insemination with PCV2 positive extended semen does 
not necessarily occur. However, when naïve dams were artificially inseminated with PCV2-
spiked semen, dam viremia and fetal infection occurred. Naïve dams inseminated with spiked 
semen did not show clinical signs of infection after PCV2 exposure, but increased numbers 
of mummified and stillborn fetuses were observed. Stillborn fetuses exhibited gross lesions 
of heart failure and myocardial tissue was determined to be the best sample for diagnosing in 
utero PCV2 infection. Using the PCV2-spiked semen model, we compared dam immunity 
associated with PCV2 vaccination to immunity associated with a previous infection to induce 
protection against subsequent PCV2-challenge. PCV2 antibodies induced by a homologous 
strain of PCV2 protected against in utero infection; however, 63% of the piglets from 
vaccinated dams were PCV2 viremic at birth suggesting that commercial vaccines may not 
prevent fetal infection. We also verified that PCV2 vaccination of dams is not protective 
against fetal infection following oro-nasal challenge during gestation, and affirmed that 
immunocompetent in utero fetuses are able to clear PCV2 infection prior to parturition.   
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CHAPTER 1.  GENERAL INTRODUCTION 
 
Introduction 
Porcine circoviruses (PCV) are non-enveloped, single-stranded, circular DNA viruses 
of approximately 1.7kb classified in the Circoviridae family, genus Circovirus (Todd et al., 
2005). There are two known PCV species, porcine circovirus type 1 (PCV1) and porcine 
circovirus type 2 (PCV2). PCV1 was first described in 1974 as a non-cytopathic contaminate 
of a porcine kidney cell line, PK-15 (Tischer et al., 1974). Experimental studies later 
determined that PCV1 was non-pathogenic in swine (Tischer et al., 1986; Allan et al., 1995).  
PCV2 is pathogenic in swine and associated with multiple disease entities which 
include pneumonia, diarrhea, wasting, multisystemic disease, and reproductive failure. 
Within the current PCV2 nomenclature, there are three recognized genotypes: PCV2a, 
PCV2b, and PCV2c (Opriessnig et al., 2007; Dupont et al., 2008). Those in the PCV2a 
genotype group have 1,768 base-pairs and both PCV2b and PCV2c have 1,767 base-pairs. 
PCV2c has recently been identified in archived serum samples from Denmark collected in 
the 1980’s and shows 95% and 91-93.6% nucleotide homology with PCV2b and PCV2a, 
respectively (Dupont et al., 2008).   
Porcine circovirus associated disease (PCVAD) was first recognized in conventional 
pigs of high health status located in Western Canada in the early 1990’s (Harding et al., 
1997). PCV2 is now ubiquitous, most swine herds are seropositive, and the clinical 
expression of PCV2 infection is recognized globally (Allan et al., 2000).  PCV2 infection 
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most commonly occurs in the growing phase of production, though only a small percentage 
of infected pigs develop clinical PCVAD. 
In 2005-2006, PCVAD spread rapidly throughout North American swine production 
regions resulting in severe systemic disease in growing pigs characterized by high morbidity 
and mortality with decreased growth efficiencies. Molecular characterization of the PCV2 
isolates from these outbreaks identified PCV2b, a genotype that had not been previously 
reported in North America (Cheung et al., 2007; Gagnon et al., 2007). The identification of 
this subtype and the apparent rapid spread of clinical PCVAD raised many questions on virus 
transmission.  
Transmission of PCV2 in or between swine populations is not well understood; 
however, the main route of infection is thought to be fecal-oral (Segalés et al., 2005a). 
Detection of PCV2 DNA has been reported in secretions and excretions including feces, 
urine, saliva, ocular fluid, nasal secretions, colostrum, and semen of infected pigs (Larochelle 
et al., 2000; Krakowka et al., 2000; Bolin et al., 2001; Shibata et al., 2003; Shibata et al., 
2006). We focused our research on semen transmission because of the heavy use of artificial 
insemination in modern swine production and because viral contamination of semen is 
known to be an important route of introduction of other diseases such as porcine reproductive 
and respiratory syndrome virus (PRRSV) into swine herds. Artificial insemination (AI) has 
become standard practice by most large production systems in North America. Semen is 
transported over great distances, sometimes between countries for genetic improvement, and 
therefore semen-associated PCV2 transmission is a potential reason for the rapid 
dissemination of PCVAD in North America.  
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PCV2 has been detected in semen by virus isolation, nested polymerase chain 
reaction (PCR) and quantitative real-time PCR (Kim et al., 2001; Pal et al., 2008). 
Experimental inoculation of  naïve boars with PCV2 resulted in presence of PCV2 DNA in 
semen as early as 5 days post inoculation (DPI) and intermittently thereafter up to DPI 47 as 
determined by nested PCR (nPCR) (Larochelle et al., 2000). In the field, the presence of 
PCV2 DNA in semen can be detected up to 27.3 weeks; boars less than 12 months of age and 
Landrace or Duroc breeds have been found to shed more PCV2 DNA in semen. Sperm 
morphology was not affected by PCV2 infection (McIntosh et al., 2006b). The amount of 
PCV2 shed in semen over time was unknown with no reports comparing shedding patterns of 
PCV2a and PCV2b in semen. Therefore, the primary objectives in our first experiments were 
to evaluate the amount of PCV2a and PCV2b in semen of Landrace boars over a 90 day time 
period and correlate the incidence and amount of PCV2 DNA in semen with PCV2 DNA 
present in serum and blood swab samples. Reported information involving boar infection 
with PRRSV has shown that PRRSV RNA can be more readily detected in serum when 
compared to detection in semen samples in experimentally challenged boars early in the 
disease phase (Reicks et al., 2006a). Moreover, there was agreement between PRRSV PCR 
results on blood swab samples and serum samples during the first 6 days post-challenge in 
boars (Reicks et al., 2006b). Our primary goal was to examine the potential risks associated 
with PCV2a and PCV2b infection of mature boars, and to determine the most appropriate 
diagnostic sample for testing boars to assess shedding.  
 The prevalence of PCV2 semen shedding in boar studs is variable and depends on the 
age of boars within the operation. In North America, PCV2 DNA was detected in semen 
samples from 13 of 43 Canadian boars (30 of 903 semen samples) (McIntosh et al., 2006b). 
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In four boar studs in the United States, 25.4% (61/240) of tested boar semen samples 
contained PCV2 DNA (Reicks et al., 2007). In other geographical locations, PCV2 DNA was 
detected in 47% (28/60) and 27% (26/98) of semen samples obtained from 30 and 49 Korean 
swine herds, respectively (Kim et al., 2001; Kim et al., 2003b), 18% (86/472) of semen 
samples tested from Austrian and German boars (Schmoll et al., 2008), and 22% (67/304) of 
semen samples collected from four Brazilian farms (Ciacci-Zanella et al., 2007). However, 
the significance of detecting PCV2 DNA in semen is largely unknown.  
Determining if semen-associated PCV2 is infectious is difficult to do by cell culture 
because semen alone is often linked with cell culture cytotoxicity (Medveczky et al., 1981; 
Schultz et al., 1982; Weiblen et al., 1992) and it is a non-cytopathic virus (Tischer et al., 
1987; Allan et al., 2000). Kim et al. (2001) evaluated 60 raw semen samples from 30 
different Korean farms using virus isolation. PCV2 nucleic acid was detected by in situ 
hybridization in 6.7 % (4/60) of raw semen inoculated on PK-15 cells. Cell culture 
supernatants also contained PCV2 DNA as detected by PCR (Kim et al., 2001). The main 
goals of our second experiment were to determine if PCV2 shed in semen is infectious in a 
swine bioassay model and to determine if naïve dams can  become infected following AI 
with PCV2 contaminated extended semen. Semen collected from boars experimentally-
inoculated with PCV2a or with PCV2b was used in this experiment. The intended outcome 
of these studies was to determine if monitoring boar studs for PCV2 shedding is needed to 
reduce transmission of PCV2 between herds.  
 In pregnant dams, PCV2 infection is associated with reproductive failure. Clinical 
signs of PCV2-associated reproductive failure are thought to depend upon timing of 
infection. PCV2 infection can manifest at all stages of pregnancy (early embryonic death, 
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mummified fetuses, abortion, and reduced litter size). PCV2-associated reproductive failure 
is more frequently observed in newly populated swine farms or associated with gilts entering 
an existing operation (West et al., 1999; O'Connor et al., 2001; Josephson et al., 2001). 
Clinical signs of disease associated with PCV2 infection in the dam are typically unapparent. 
On rare occasions, lethargy, pyrexia, and anorexia have been reported (Park et al., 2005). Our 
second study proved that semen-associated PCV2 is infectious in a bioassay model. 
However, when the same semen was extended and used for AI, infection was not established 
in naïve gilts indicating a potential dose or route effect. This led us to the objectives for our 
third experiment which were to determine if semen spiked with PCV2 has the ability to cause 
infection in naïve mature female swine and if delivery of PCV2 via AI causes reproductive 
failure or fetal infection. 
Globally, most swine herds are PCV2 seropositive with few known naïve 
populations. To combat PCVAD, several commercial killed PCV2 vaccines based on the 
PCV2a genotype were recently introduced to the swine industry. However, an approved 
vaccine for use in breeding age animals to protect against PCV2-associated reproductive 
failure is not currently available in the United States. PCV2 vaccination in growing pigs has 
been shown to induce neutralizing antibodies (Opriessnig et al., 2008a), to significantly 
reduce PCV2 shedding in feces (Fort et al., 2008), and to decrease PCV2-associated 
morbidity and mortality in the field (Kixmoller et al., 2008). Vaccination has also been 
reported to block detectable viremia following heterologous challenge (PCV2b) (Fort et al., 
2008). The objectives of the fourth study were to determine if the use of PCV2 vaccination 
against PCV2 or prior natural infection of the dam with PCV2 is sufficient to prevent fetal 
infection when dams are artificially inseminated with PCV2-spiked semen.   
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 The consequence of PCV2 infection in the pregnant dam is viremia that results in 
opportunity for PCV2 to cross the placenta and culminate in fetal infection and replication. In 
affected litters, stillborn and mummified fetuses can have gross lesions that include dilated 
cardiomyopathy, pulmonary edema, hepatomegaly, and ascites (West et al., 1999). The most 
consistent microscopic lesion in fetal tissue is myocardial degeneration, necrosis, fibrosis, 
and nonsuppurative myocarditis because of an apparent tropism for fetal myocardiocytes 
(Sanchez, Jr. et al., 2001). The tropism of PCV2 for fetal myocardiocytes diminishes with 
gestational age. In the later stages of gestation, increased levels of PCV2 can be detected in 
lymphoid organs similar to growing pigs (Sanchez, Jr. et al., 2003). There is little 
information about the safety and efficacy of vaccination of pregnant dams in the literature. 
However, there are reports of sow vaccination reducing pre-wean mortality and increasing 
numbers of live-born piglets (decreased stillborn and mummified fetuses). In these reports, 
vaccinations were given during gestation (Hérin et al., 2007; Joisel et al., 2007b; Ebbesen et 
al., 2008). Our fifth study evaluated the effect of PCV2 vaccination of the dam following 
intranasal PCV2 challenge. The aim of this study was to determine if PCV2 vaccination of 
the dam is effective in preventing fetal PCV2 infection. 
 
Dissertation Organization 
 This dissertation is prepared in an alternate manuscript format. The dissertation is 
composed of eight chapters and includes a general introduction, a literature review, five 
separate scientific manuscripts, and a general conclusion. References cited in the general 
introduction, literature review, and the general conclusion chapters are listed at the end of the 
dissertation. Four manuscripts have been published and one manuscript has been accepted in 
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refereed scientific journals. The Ph.D. candidate, Darin Michael Madson is the primary 
author of the manuscripts and is the principal investigator for the experimental work 
described.  
 The first manuscript describes the characterization of shedding patterns of PCV2a and 
PCV2b in mature experimentally inoculated boars. This manuscript was published in the 
Journal of Veterinary Diagnostic Investigation. The second manuscript describes the 
infectivity of semen-associated PCV2 DNA in a swine bioassay model and in naïve gilts. 
This manuscript was published in Veterinary Research. The third manuscript describes the 
experimental reproduction of PCV2-associated reproductive failure using PCV2-spiked 
semen for artificial insemination. This manuscript has been published in Veterinary 
Pathology. The fourth manuscript describes the effect of natural or vaccine induced PCV2 
immunity on fetal infection after artificial insemination with PCV2-spiked semen. This 
manuscript has been accepted in Theriogenology. The fifth manuscript describes the effect of 
PCV2 vaccination of the pregnant dam on PCV2 replication in utero. This manuscript has 
been published in Clinical and Vaccine Immunology.    
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CHAPTER 2.  LITERATURE REVEIW 
 
Historical background 
Porcine circovirus (PCV) was first discovered as a contaminant of a permanent 
porcine kidney cell line (PK-15 [ATCC-CCL33]), and described as a small, spherical, non-
cytopathic virus similar in morphology to picornavirus (Tischer et al., 1974). PCV is an 
icosahedral, non-enveloped, circular, single-stranded DNA (ssDNA) virus with a diameter of 
17nm (Tischer et al., 1982).  
In 1991, a novel disease characterized by progressive weight loss, dyspnea, and 
icterus was described in post-wean, specific-pathogen-free (SPF) pigs in Western Canada 
(Harding et al., 1997; Clark, 1997). The disease was called post-weaning multisystemic 
wasting syndrome (PMWS) and soon was recognized in Europe, Spain and the United States 
(LeCann et al., 1997; Segales et al., 1997; Allan et al., 1998b). PCV antigen and DNA were 
readily detected in multiple tissues of pigs exhibiting clinical wasting (Ellis et al., 1998). 
Genetic comparison analysis of PCV isolates from diseased pigs found the PCV to be 
distinctly different from the previous non-pathogenic PCV isolates (Hamel et al., 1998; 
Meehan et al., 1998; Morozov et al., 1998; Allan et al., 1998a; Allan et al., 1999). Porcine 
circovirus type 1 (PCV1) is now acknowledged as the non-pathogenic PCV strain, and 
porcine circovirus type 2 (PCV2) isolates are considered pathogenic in swine. PCV1 does 
replicate in swine corresponding to serum antibody detection within populations (Dulac et 
al., 1989; Allan et al., 1994; Edwards et al., 1994), but reports of experimental PCV1 
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infection have failed to result in clinical disease or associated pathology (Tischer et al., 1986; 
Allan et al., 1995).  
The clinical manifestation of PCV2-associated PMWS was first reported in the early 
1990’s; however, the presence of PCV2 antibody dates back to 1969 in Belgium (Sanchez et 
al., 2001) while PCV2 DNA and antigen were identified in archived formalin fixed paraffin 
wax-embedded tissues collected in 1970 in the United Kingdom (UK) (Grierson et al., 2004). 
PCV2 was present in swine populations in Ireland as far back as 1973 (Walker et al., 2000), 
Canada and Spain in 1985 (Magar et al., 2000b; Rodríguez-Arrioja et al., 2003), and in Japan 
in 1989 (Mori et al., 2000). PCV2 is now considered ubiquitous in swine populations 
throughout the world with few isolated PCV2 negative herds (Allan et al., 2000; Segalés et 
al., 2005a). 
 
Etiology 
PCV2 is one of the smallest known viruses to infect animals and classified in the 
family Circoviridae (Todd et al., 2005). Circoviridae encompasses three genera: Circovirus, 
Gyrovirus, and Anellovirus. Members of the genus Circovirus include: PCV2, PCV1, beak 
and feather disease virus (BFDV), canary circovirus (CaCV) goose circovirus (GoCV), and 
pigeon circovirus (PiCV). Proposed members of Circovirus are duck circovirus (DuCV), 
finch circovirus (FiCV), and gull circovirus (GuCV) (Todd et al., 2005). Both Gyrovirus and 
Anellovirus include only one member; chicken anemia virus (CAV) and torque teno virus 
(TTV), respectively (Biagini, 2004; Todd et al., 2005). Comparison analysis of replication 
strategies employed by members of Circovirus are similar to other small, circular, ssDNA 
plant geminiviruses and nanoviruses (Niagro et al., 1998; Bassami et al., 1998; Gibbs et al., 
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1999; Cheung, 2006). Furthermore, it has been shown that Escherichia coli can support 
replication of porcine and plant circular ssDNA viruses, suggesting a common prokaryotic 
origin (Cheung, 2006). 
The DNA genome sequence homology between PCV1 and PCV2 varies between 68-
76% (Hamel et al., 1998; Meehan et al., 1998; Morozov et al., 1998). Within PCV1 and 
PCV2 isolates, there is 97-99% and 93-99% genome homology, respectively (Fenaux et al., 
2000; de Boisseson C. et al., 2004; Olvera et al., 2007). PCV1 genomic DNA length ranges 
from 1,758-1,760 base-pairs (bp) and PCV2 contains either 1,767 or 1,768 bp (Fenaux et al., 
2000; Mankertz et al., 2000; Dupont et al., 2008). PCV2 isolates are clustered into groups 
based on DNA bp lengths. PCV2a (North American like, genotype 2) and PCV2b (European 
like, genotype 1) isolates have 1,768 and 1,767 bp, respectively (Olvera et al., 2007; Cheung 
et al., 2007). The complete genomic analysis of 148 PCV2a or PCV2b isolates present within 
the National Center for Biotechnology Information (NCBI) nucleotide data base in 2005 
showed that PCV2a and PCV2b isolates differ in nucleotide homology by about 5% with 
more variation in the Capsid (Cap) gene as compared to the Replication (Rep) gene (Olvera 
et al., 2007). The difference in the Capsid gene nucleotide sequence between PCV2a and 
PCV2b is approximately 10% (Cheung et al., 2007). 
Recent field data suggests that as many as 25% of growing pigs may be infected with 
both PCV2a and PCV2b simultaneously (Hesse et al., 2008). Dual infection of PCV2a and 
PCV2b can result in viral recombination. Recombination has been shown to occur in the Rep 
gene sequence, the flanking Rep gene sequence, or in the Cap gene sequence (Olvera et al., 
2007; Ma et al., 2007; Hesse et al., 2008; Cheung, 2009).   
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Evaluation of archived serum samples from Denmark recently identified a third 
PCV2 genotype, PCV2c (genotype 3). Positive samples were collected from non-clinical pigs 
in 1980, 1987 and 1990.  The PCV2c isolates are more closely related in nucleotide 
homology with PCV2b (95%) than PCV2a (91-93.6%) (Dupont et al., 2008). In addition, 
after evaluating Swedish field cases pre- and post-PMWS, PCV2c was identified in swine 
tissues from 1993. This particular PCV2c isolate remained stable (99.1% nucleotide 
homology) on the farm of origin for 11 years (Timmusk et al., 2008).  
 
Replication 
The closed circular ambisense ssDNA of the PCV viral genome uses host cell DNA 
polymerase during the S phase of cellular replication to form a circular double stranded DNA 
(dsDNA) intermediate (Todd et al., 2005). The dsDNA intermediate is the template for 
rolling-circle replication that is initiated at a conserved 111 bp hairpin loop (Mankertz et al., 
1997). The conformation of the hairpin loop, origin of replication, is more important than the 
exact nucleotide (nt) sequence conformation (Steinfeldt et al., 2001). An embedded 
octanucleotide sequence (AGTATTAC) in the hairpin loop is essential for viral replication 
(Cheung, 2004).     
Six opening reading frames (ORFs) have been described for PCV (Mankertz et al., 
1997); however, only ORF1 and ORF2 are known to encode essential proteins and ORF3 has 
only recently been identified to transcribe a protein that is perceived to be associated with 
host cell apoptosis (Liu et al., 2005; Liu et al., 2006). ORF1 is required for host cell 
replication, is highly conserved, and transcribes the full-length Rep protein (Mankertz et al., 
1998a; Sun et al., 2007). Intron splicing of the full-length Rep results in a truncated Rep 
12 
 
protein (Rep’), and both Rep and Rep’ are essential for replication (Mankertz et al., 2001; 
Cheung, 2003a). ORF2 encodes a 702 nt Cap protein (Mankertz et al., 1998b; Nawagitgul et 
al., 2000).  
Rep protein, derived from ORF1, is more conserved across PCV1 and PCV2 as 
compared to ORF2-associated Cap. Cap protein homology between different PCV1 isolates 
is 94%, while PCV2 isolates share 90% Cap protein homology (Fenaux et al., 2000). A total 
of nine RNAs have been identified during PCV2 replication in PK-15 cells (Cap, Rep, Rep’ 
Rep3a, Rep3b, Rep3c, NS515, NS672 and NSO) (Cheung, 2003b), but all are not essential 
for viral replication (Cheung, 2003a).   
PCV2 antigen or DNA can be found in multiple tissues and cell types (Darwich et al., 
2004; Segalés et al., 2005a; Opriessnig et al., 2007), but the primary location of PCV2 
replication is largely unknown. PCV2 can often be found in antigen presenting cells in tissue-
associated lesions (Chae, 2005), but viral replication within dendritic cells does not occur, 
nor does it affect antigen presentation (Vincent et al., 2003; McCullough et al., 2009). 
Previously, in vitro replication of PCV2 was shown in PK-15 cells, pulmonary alveolar 
macrophages, and fetal myocardiocytes. Rep protein could be detected in the nucleus after 12 
hrs in PK-15 cells and in a lower percentage both pulmonary alveolar macrophages and fetal 
myocardiocytes at 48 hrs. Replication difference in virus isolates were seen, but production 
of PCV2 virions only occurred in the PK-15 cell line (Meerts et al., 2005a). Replication of 
PCV2 in peripheral blood mononuclear cells has also been reported. PCV2 replication, as 
determined by Cap mRNA, was demonstrated in stimulated cultures of both B- and T-cells 
over time (Yu et al., 2007b). Replication was decreased 100-fold in monocyte/macrophage-
enriched peripheral blood mononuclear cell cultures compared to enriched-T lymphocytes 
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and monocyte/macrophage-depleted cultures (Yu et al., 2007b). PCV2 uptake, infection, and 
replication were recently evaluated  by determining levels of Rep and Cap protein in 
fibrocytes, gut epithelial cells, aortic endothelial cells and endothelial (PEDSV.15) cell lines 
(Steiner et al., 2008). The aforementioned cell lines secreted viral PCV2 progeny by day 7 
post infection, and approximately 90% of PEDSV.15 cells were positive for PCV2. PCV2 
infection did not negatively impact cell viability in any of the cell lines, apoptosis was not a 
feature of infection, nor was proliferation of cell lines diminished. Results attest to field cases 
wherein PCV2 antigen was demonstrated in gut epithelium and arterial endothelial cells 
(Jensen et al., 2006; Opriessnig et al., 2006c). Furthermore, 97% of dendritic cells took 
PCV2 into their cytoplasm, yet replication did not occur (Steiner et al., 2008).   
Cap mRNA was detected in lung tissues 3 days post intranasal PCV2 challenge in 4.5 
week old conventional pigs (Yu et al., 2007a). By day 7 post challenge, PCV2 Cap mRNA 
was detected in multiple lymph nodes, kidney, liver, lung, spleen and tonsil with increased 
mRNA present in tracheobronchial lymph node compared to all other tissues. Similar levels 
of Cap-associated mRNA were measured across all tissues at 14 days post infection, but only 
tracheobronchial lymph node, lung and tonsil were positive at 21 days post challenge (Yu et 
al., 2007a). In vivo results confirmed in vitro studies that indicate PCV2 can replicate in 
multiple tissues and cells (Steiner et al., 2008). 
 
Horizontal transmission, shedding and viral persistence 
 Horizontal transmission through contaminated feces is the suspected major route of 
PCV2 infection (Segalés et al., 2005a), but nasal-oral and urine-oral routes have also been 
proposed (Magar et al., 2000a; Bolin et al., 2001; Segalés et al., 2005b). The role of fomites, 
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insects or other animal species in PCV2 transmission between domesticated swine 
populations is largely unknown. The presence of PCV2 DNA or antibody production has 
been demonstrated in multiple strains of mice (Kiupel et al., 2001; Quintana et al., 2002; 
Kiupel et al., 2005; Csagola et al., 2008; Opriessnig et al., 2009b), rabbits (Sorden et al., 
1999; Quintana et al., 2002) and wild boars (feral swine) (Ellis et al., 2003; Csagola et al., 
2006; Sofia et al., 2008). 
Pig-to-pig transmission within and between pens was demonstrated by Andraud et al. 
(2008). Intranasally-infected pigs were housed in the same pen or in the adjacent pen 
(separation distance of 10 cm) to negative sentinel pigs. Inoculated pigs were viremic within 
the first week of infection. PCV2 viremia was first detected in sentinel pigs housed in the 
same pen on day 17 and in pigs housed in an adjacent pen 21 days after the control pigs were 
inoculated (Andraud et al., 2008). By 28 days, most sentinel pigs housed with inoculated pigs 
were infected with PCV2; however, only about 25% of the pigs in adjacent pens were 
infected after 42 days. An eight day latency period was reported by Andraud et al. (2009) for 
inoculated pigs to transmit PCV2 to pigs within the same pen. Contact pigs within the same 
pen had a mean disease generation time (time to first viremia) of 18.4 days (Andraud et al., 
2009).  
 Spray-dried plasma protein in swine nursery diets has been speculated as a potential 
source of PCV2 transmission. Even though the production of spray-dried plasma protein 
requires heating, PCV2 shows extreme thermal resistance with infectivity still present after 
dry heat treatment at 120 °C for 30 minutes (Welch et al., 2006; O'Dea et al., 2008). Three-
to-four week old pigs were fed an ad libidum diet containing an 8% fraction of spray-dried 
plasma for 45 days. The plasma protein contained 2.47 x 105 PCV2 genomic copies per ml 
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when reconstituted in sterile saline. None of the pigs in the study developed PCV2 viremia or 
anti-PCV2 antibodies (Pujols et al., 2008).  
Oral consumption of PCV2 contaminated tissues can result in transmission of 
infectious virus. PCV2 PCR positive and virus isolation negative, skeletal muscle and bone 
marrow were fed to pigs for 3 consecutive days. PCV2 viremia was detected in all pigs at 7 
days post consumption, and PCV2 antigen was detected at necropsy (28 days) in lymph 
nodes, spleen, tonsil and ileum confirming oral transmission of PCV2 (Opriessnig et al., 
2009d).  
 Post PCV2 infection, PCV2 DNA is detected in multiple secretions and excretions. In 
gnotobiotic pigs, Krakowka et al. (2000) identified PCV2 DNA in feces, ocular and nasal 
secretions from singularly infected PCV2 pigs and porcine parvovirus (PPV) co-infected pigs 
35 days post challenge. PCV2 viremia was first demonstrated at 14 days post challenge and 
was present until termination of the study at 35 days (Krakowka et al., 2000). Colostrum-
deprived, PCV2 infected piglets (intranasal inoculation) shed PCV2 DNA in feces, nasal, 
oropharyngeal and tonsillar secretions as early as one day post inoculation (Shibata et al., 
2003; Caprioli et al., 2006; Allan et al., 2007). PCV2 DNA was also detected in urine (Bolin 
et al., 2001). Serum viremia, nasal, oropharyngeal and fecal shedding of PCV2 DNA have 
been reported to last at least 70 days in colostrum-deprived pigs (Shibata et al., 2003).  
 The amount of PCV2 DNA shedding in tonsil, nasal, fecal and urine samples was 
compared to serum viremia from clinical and subclinical field pigs (Segalés et al., 2005b). 
PCV2 DNA was identified in a high proportion of animals (60-91.9%), but shedding did not 
necessarily correlate with PCV2 viremia or severity of clinical disease. Pigs older than 1.5 
months of age had higher amounts of PCV2 in serum and more severe clinical disease 
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(Segalés et al., 2005b). A longitudinal analysis of PCV2 viremia in one-to-eleven week-old 
pigs from Spain and Denmark found a significant correlation with the amount of PCV2 
viremia and viral shedding in nasal and rectal swabs. The authors reported that nasal and 
rectal swabs were suitable indicators of PCV2 shedding in growing pigs (Grau-Roma et al., 
2008). PCV2 DNA can also be detected in semen, colostrum and milk of sexually mature 
pigs post infection (Larochelle et al., 2000; Shibata et al., 2006; McIntosh et al., 2006b; Ha et 
al., 2009).  
The mechanism for PCV2 persistence in pigs has not been elucidated. There are 
indications that  genetic differences (Lopéz-Soria et al., 2004; Sibila et al., 2005; Opriessnig 
et al., 2006a; Opriessnig et al., 2009c), vaccination (Hoogland et al., 2006; Opriessnig et al., 
2006b), and differences in PCV2 isolate virulence (Opriessnig et al., 2006e; Opriessnig et al., 
2008b) and coinfections (Rodríguez-Arrioja et al., 1999; Pallarés et al., 2002; Pogranichniy 
et al., 2002; Rose et al., 2003; Dorr et al., 2007) may be associated with PCV2 persistence. 
However, most pigs are thought to be able to clear PCV2 infection (Quintana et al., 2001). In 
experimentally inoculated pigs, PCV2 DNA was detected in tissues 125 days after 
inoculation, and infectivity was confirmed by virus isolation (Bolin et al., 2001). Length of 
PCV2 viremia in inoculated pigs has been reported up to 15 weeks (Madson et al., 2009c). In 
the field, PCV2 DNA was detected in serum samples for 22 weeks (Rodríguez-Arrioja et al., 
2002) and virus shedding was present for 27.3 weeks (McIntosh et al., 2006b).   
 
PCV2-associated disease (PCVAD); the growing pig 
PCV2 is globally distributed and most herds are seropositive for anti-PCV2 
antibodies. PCV2 infection occurs as maternally derived antibodies wane in post-weaned 
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pigs (7-15 weeks of age) and results in either subclinical infection or clinical disease. Clinical 
disease associated with PCV2 infection can have multiple manifestations which include the 
following: PMWS, respiratory disease, enteritis, porcine dermatitis and nephropathy 
syndrome (PDNS), myocarditis/vasculitis, and exudative dermatitis (Chae, 2004; Chae, 
2005). In Europe, porcine circovirus disease (PCVD) is used to describe the multiple and 
systemic clinical entities (Allan et al., 2002a; Segalés et al., 2005a). PCVAD is more 
common terminology used in North America to summarize the different clinical 
manifestations associated with PCV2 infection. PCVAD includes both subclinical and 
clinical disease (Opriessnig et al., 2007). 
A. Subclinical disease 
PCV2 can be detected in normal, healthy pigs without signs of disease (Allan et al., 
2000; Calsamiglia et al., 2002). Subclinical PCV2 infection can reduce growth performance, 
can cause increased susceptibility to other swine-associated pathogens, or result in decreased 
efficacy of commonly administered swine vaccines (Opriessnig et al., 2007). Quantification 
of PCV2 DNA in serum and tissue has been proposed as a means of differentiating 
subclinical from clinically affected animals. Subclinically infected PCV2 pigs typically have 
lower amounts of DNA in serum and tissue; animals with  ≥107 genomic copies per ml/serum 
or in 500ng tissue are typically clinically infected (Brunborg et al., 2004; Olvera et al., 2004). 
Stage of viral infection has been correlated with the amount of PCV2 DNA in samples 
(Quintana et al., 2001).  
In general, approximately 108 PCV2 genomic copies per 25 micrograms are needed to 
demonstrate PCV2 by IHC or ISH in tissue. Anti-PCV2 antibody titers do not correlate with 
clinical disease (Sibila et al., 2004), but often clinically affected pigs have lower titers 
18 
 
(Ladekjær-Mikkelsen et al., 2002; Rovira et al., 2002; Hasslung et al., 2005). Experimental 
evidence suggests that the failure to produce neutralizing antibodies is associated with 
manifestation of clinical disease (Meerts et al., 2005b; Meerts et al., 2006; Fort et al., 2007). 
Researchers from Spain reported that neutralizing antibody titers are inversely correlated 
with the amount of PCV2 DNA in serum after evaluating 63 subclinical or clinically affected 
pigs (Fort et al., 2007).   
Segalés et al. (2004) measured the amount of two acute phase proteins, heptoglobulin 
(HPT) and pig-major acute protein (pig-MAP), in 60 subclinical or clinically affected pigs. 
Both HPT and pig-MAP were significantly increased in clinically affected pigs compared to 
subclinical pigs, but there were no differences in PCV2 negative versus subclinically infected 
pigs at 3, 7, 12, and 28 weeks of age (Segalés et al., 2004a).   
B. Post-weaning multisystemic wasting syndrome (PMWS) 
PMWS is a multifactorial systemic disease and clinically manifests at 25-150 days of 
age with most cases occurring between 7 and 15 weeks (Kim et al., 2002; Harding, 2004). 
Six fundamental clinical signs were emphasized by Harding (2004) and include wasting, 
dyspnea, lymphadenopathy, diarrhea, pallor and jaundice. Coughing, pyrexia, gastric 
ulceration, and meningitis have also been reported, but are sporadic. Not all clinical signs 
have to be present in an individual pig, but all six fundamental signs can generally be 
observed among the population of pigs in affected herds over time (Harding, 2004). Herd 
morbidity in PMWS herds is variable with 4-30% of the pigs affected. Mortality rates are 
often high (20%) with occasional reports of greater than 50% death loss within a group 
(Segalés et al., 2005a). A herd diagnosis of PMWS can be made when mortality rates are 
greater than the historical mean plus 1.66 times the standard deviation (Segalés, 2006). 
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  The most consistent necropsy finding in PMWS pigs is generalized lymph node 
enlargement. Other macroscopic lesions can include mottled-tan, non-collapsing lungs 
(Opriessnig et al., 2009c) and thymic atrophy (Ladekjær-Mikkelsen et al., 2002; Darwich et 
al., 2003). Chronic PMWS-affected pigs can display normal to atrophied lymph nodes 
(Segalés et al., 2004b). PMWS pigs are frequently coinfected with other common bacterial 
and viral pathogens, and coinfection often complicates gross findings. A North American 
survey of PMWS cases submitted to the Iowa State University Veterinary Diagnostic 
Laboratory (Ames, IA) found that only 2% of the cases were infected with PCV2 alone. 
PRRSV was identified in 52% and Mycoplasma hyopneumoniae in 36% of PMWS-affected 
pigs (Pallarés et al., 2002). A similar study conducted in Korea (Kim et al., 2002) 
demonstrated that 85% of PMWS pigs were dually infected; Haemophilus parasuis (32.3%) 
and PRRSV (29.3%) were the most common coinfections.  
Microscopic lesions in PMWS-affected pigs are consistently found in lymphoid 
tissues and characterized by loss (depletion) of lymphocytes and replacement by 
histiocytic/granulomatous inflammation. Lymphoid depletion can be associated with 
paracortical or follicular regions with the latter being more prevalent (Rosell et al., 1999). 
Multinucleated giant cells (Langhans-type), epitheloid macrophages and macrophage-
associated intracytoplasmic, botyroid-like, basophilic inclusions are also commonly seen in 
lymphoid tissues (lymph node, tonsil, and spleen) (Chae, 2004; Segalés et al., 2004b). Focal 
parenchymal coagulative and apoptotic necrosis in lymphoid tissues has also been described 
(Rodríguez-Arrioja et al., 1999; Kim et al., 2005). The reported frequency of lymphoid 
lesions in 396 PMWS-affected Spanish pigs was 89.1% for lymphoid depletion, 77% for 
histiocytic inflammation, 34.6% contained intracytoplasmic inclusion bodies, 28.5% had 
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multinucleated giant cells, and coagulative necrosis was seen in 9.9%  of the pigs (Segalés et 
al., 2004b). Microscopic lesions in non-lymphoid tissues are composed of 
lymphomacrophagic inflammation and include interstitial pneumonia, hepatitis, interstitial 
nephritis and enteritis/colitis.  
Clinical signs, macroscopic and microscopic lesions associated with PCV2 infection 
are suggestive, but not definitive for a PMWS diagnosis in an individual or group of pigs. A 
definition for diagnosing PMWS was established by Sorden (2000). Based on this definition, 
animals must meet three criteria: (1) clinical signs of wasting, weight loss or failure to thrive 
that may or may not include respiratory distress and icterus, (2) microscopic lesions of 
lymphoid depletion and granulomatous inflammation, and (3) the presence of PCV2 antigen 
or nucleic acid associated with microscopic lesions (Sorden, 2000). Not all PMWS-affected 
pigs will have equal distribution of microscopic lymphoid lesions. Other authors have 
proposed that PMWS can be diagnosed if moderate-to-abundant PCV2 antigen or nucleic 
acid is present with hallmarked microscopic lesions in more than one lymphoid tissue or in 
one lymphoid tissue and at least one other major organ system (Opriessnig et al., 2007).  
C. PCV2-associated respiratory disease 
PCV2-associated respiratory disease can often overlap with PMWS or be a 
contributing factor in porcine respiratory disease complex (PRDC). In the first cases of 
PMWS, lymphomacrophagic interstitial pneumonia was a common microscopic lesion (Ellis 
et al., 1998). Interstitial pneumonia can be reproduced experimentally with PCV2 infection 
alone (Magar et al., 2000a; Bolin et al., 2001; Opriessnig et al., 2009c). Other hallmark 
microscopic lung lesions of PCV2 include type II pneumocyte hypertrophy and hyperplasia, 
peribronchiolar fibrosis, and associated lymphoid hyperplasia (Chae, 2005).  
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Proliferative and necrotizing pneumonia (PNP) is another microscopic lesion that has 
been linked to PCV2 infection (Chae, 2005). Histologically, PNP is characterized by 
necrotizing and/or proliferative bronchiolar epithelium, type II pneumocyte hyperplasia and 
hypertrophy, interstitial pneumonia with peribronchiolar lymphohistiocytic cuffing, rare 
syncytial cells, alveolar hyaline membranes and necrotic cellular debris, and flooding of 
alveolar lumina by proteinic fluid (Morin et al., 1990). PNP lesions are similar to what is 
seen with swine influenza virus (SIV) or porcine respiratory coronavirus infection, but field 
cases of PNP rarely detect SIV (Drolet et al., 2003). Previously, Drolet et al. (2003) 
suggested that PRRSV was the cause of PNP because 92% of examined lung tissues (55/60) 
contained PRRSV RNA. A different investigation of 74 PNP cases demonstrated PCV2 
nucleic acid in 85.1% of cases. PCV2 was the sole agent indentified in 39.1% of those cases 
while PRRSV was only solely detected in 4.1% (Grau-Roma et al., 2007). Recent reports 
have demonstrated bronchiolar-epithelial PCV2 induced inclusion bodies and PCV2 was 
identified as the sole agent in PNP microscopic lesions (Szeredi et al., 2008; Huang et al., 
2008).   
   The diagnosis of PCV2-associated respiratory disease should meet the following 
criteria: (1) lymphomacrophagic interstitial pneumonia with or without peribronchiolar 
fibrosis and lymphoid hyperplasia, (2) presence of PCV2 DNA or antigen within the lesions, 
and (3) the absence of hallmark PMWS lesions in lymphoid tissues (Chae, 2005). 
D. PCV2-associated enteritis 
The suspected major route of PCV2 transmission is fecal-oral, suggesting that the 
alimentary mucosa, intestinal M-cells, and gut-associated lymphoid tissue (GALT; Peyer’s 
patches) are exposed to varying amounts of infectious virus. Peyer’s patches can exhibit 
22 
 
hallmark microscopic lesions of lymphoid depletion and granulomatous inflammation in both 
PCV2-associated enteritis and PMWS-affected pigs. The diagnosis of PCV2-associated 
enteritis is appropriate when (1) there is clinical diarrhea, (2) the hallmark microscopic 
lesions are present in Peyer’s patches but not in other lymphoid tissues, and (3) PCV2 DNA 
or antigen can be demonstrated within the lesions (Chae, 2005).  
PCV2-associated enteritis may occur anytime in the grow-finish phase, and can be 
associated with the small or large intestine. Experimental reproduction of PCV2-associated 
enteritis has been accomplished after oral gavage (Opriessnig et al., 2008c). Affected 
intestinal segments are sometimes thickened and necrotic resembling gross lesions of 
Lawsonia intracellularis infection and can be misdiagnosed as such (Jensen et al., 2006). 
Microscopically, PCV2-associated enteritis has been described as having variable amounts of 
macrophages infiltrating the mucosa with PCV2 antigen present in crypt epithelium, the 
lamina propria, and submucosa. Villous atrophy and fusion along with multinucleated giant 
cells within the lamina propria have also been reported (Carrasco et al., 2000; Núñez et al., 
2003; Kim et al., 2004b; Zlotowski et al., 2008).  
E. Porcine dermatitis and nephropathy syndrome (PDNS) 
PDNS is a distinctive, acute clinical entity of growing swine that was first recognized 
in 1993 (Smith et al., 1993; White et al., 1993) and is now globally distributed (Chae, 2005). 
Affected pigs have circular to coalescing, red to purple macules or raised papules and 
plaques, occasionally with black centers, that originate on the skin of the hind legs and 
perineal region. Skin lesions progress to affect the ventral abdomen, front limbs and ears, and 
last for 2-4 weeks (Thibault et al., 1998; Segalés et al., 1998; Drolet et al., 1999; Johnstone et 
al., 2008). Lesions may become exudative, crust-over, and eventually regress leaving dermal 
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scars. PDNS-affected pigs are generally afebrile, alert, and may recover without treatment. 
Bilateral swollen kidneys with widely disseminated cortical petechial hemorrhages are 
common features of the syndrome, and pigs generally have increased serum blood urea 
nitrogen (BUN) and creatinine concentrations (Segalés et al., 1998). Increased mortality is 
seen in affected pigs older than three months of age, the syndrome is sporadic, and herd-
outbreak mortality can range from 0.25 to > 20% (Elbers et al., 2000; Gresham et al., 2000; 
Wellenberg et al., 2004).    
The hallmark microscopic lesion in PDNS-affected pigs is necrotizing vasculitis and 
glomerulonephritis. Small to medium sized dermal and subcutaneous arterioles are cuffed by 
neutrophils, macrophages, lymphocytes, and plasma cells that are sometimes present within 
vascular walls. Arterioles are lined by plump endothelial cells, occasionally occluded by 
fibrin thrombi and walls can display multifocal hyalinization. The corresponding dermis is 
necrotic and hemorrhagic (Segalés et al., 1998; Johnstone et al., 2008). Kidney sections are 
characterized by distension of urinary spaces by fibrin intermixed with necrotic cellular 
debris and hemorrhage, periglomerular and interstitial mononuclear cell infiltration, and 
distension of renal tubules that contain cellular and proteinaceous casts. Perirenal lymph 
nodes are sometimes depleted and hemorrhagic.  
Skin and glomerular lesions are characteristic of a type III hypersensitivity reaction 
with deposition of antigen-antibody complexes (immune complexes). Immune complexes 
have been demonstrated in glomerular tufts (Thibault et al., 1998).  
Multiple viral and bacterial pathogens have been implicated in PDNS and include: 
PCV2 (Rosell et al., 2000), PRRSV (Thibault et al., 1998; Choi et al., 2001), Torque 
tenovirus (TTV) (Krakowka et al., 2008), Pasteurella multocida, Streptococcus suis type I 
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and type II, Actinobacillus pleuropneumoniae, Escherichia coli, Proteus sp., Haemophilus 
parasuis, Bordetella bronchiseptica, Arcanobacterium pyogenes, Staphylococcus aureus, 
Serratia sp., Acinetobacter sp., and Salmonella sp. (Thomson et al., 2001; Thomson et al., 
2002). Olvera et al. (2004) demonstrated that 11 of 12 PDNS pigs were PCV2 viremic at 
necropsy suggesting PCV2 as the etiologic agent. PDNS pigs have lower serum PCV2 DNA 
levels than PMWS pigs (Olvera et al., 2004) and usually PDNS follows herd outbreaks of 
PMWS (Gresham et al., 2000). Some authors suggested differences between PCV2 isolates 
as a potential cause for the development of PDNS (Meehan et al., 2001; Choi et al., 2002a).  
However, phylogenic analysis of 233 PCV2 isolates from healthy-, PMWS- and PDNS- pigs 
showed that both PCV2a and PCV2b isolates can be isolated from each group (An et al., 
2007). To date, PDNS has not been reproduced with PCV2 infection, but similar lesions were 
reported in a single gnotobiotic piglet coinfected with PRRSV and TTV (Krakowka et al., 
2008). 
 
PCV2-associated reproductive failure 
Reproductive failure in swine can manifest as failure of implantation resulting in 
irregular return to estrus, failure of pregnancy progressing to term due to expulsion of all 
embryos or fetuses (abortion), or reduced litter size due to increased numbers of non-viable 
piglets at parturition (Almond et al., 2006). PCV2-associated reproductive failure has been 
linked to abortion and associated with increased rates of mummified, macerated, stillborn and 
weak-born piglets (West et al., 1999; O'Connor et al., 2001). Early embryonic death has also 
been linked to PCV2 infection (Kim et al., 2004c; Mateusen et al., 2007). However, the 
clinical presentation of abortion, mummified fetuses and stillbirths in swine operations must 
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be distinguished from other infectious agents including PRRSV, PPV, pseudorabies virus, 
porcine enterovirus and others.   
A. Clinical presentation 
PCV2-associated reproductive failure was first described in the late 1990’s in Canada 
(West et al., 1999). The clinical presentation included late-term abortions, pseudopregnancy, 
and increased incidence of mummified and stillborn fetuses (up to 75% of term litters) at 
parturition in a new 450 head swine farm composed of first parity dams. Farrowing rates 
decreased below 60% with the greatest proportion of pregnancy loss occurring after 13 
weeks of gestation. Clinical signs associated with disease were not observed in any of the 
gilts (West et al., 1999).  
Following the initial description by West et al. (1999), multiple case reports 
implicated PCV2 as the cause of reproductive failure. In one report, reproductive failure was 
characterized by increased mummified fetuses, stillborns, and preweaning mortality in a 
3,000 head operation composed of gilts comingled from multiple sources. Individual litters 
were described as having few live-born and stillborn piglets, and increased numbers of 
mummified fetuses ranging in crown-to-rump length from 6-26 cm (O'Connor et al., 2001).    
The most consistent clinical presentation of PCV2-associated reproductive failure is 
increased stillborns and mummified fetuses at parturition. Clinical signs of PCV2 infection in 
the dam are typically absent or unapparent; however, a low percentage of females may abort 
due to systemic illness. Pyrexia and anorexia are frequently observed in aborting dams 
(Cariolet et al., 2002; Park et al., 2005). Delayed farrowing (>118 days of gestation) 
(Ladekjær-Mikkelsen et al., 2001) or pseudopregnancy (Josephson et al., 2001) can be 
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additional clinical features with PCV2-associated reproductive failure. Table 1 summarizes 
the clinical presentation of PCV2-associated reproductive in affected dams. 
 
Table 1. Gestational PCV2 infection in the dam. 
Stage of gestation Clinical presentation Reference 
Early 
(1-35 days) 
Embryonic death 
Irregular returns 
Pseudopregnancy 
Small litter sizes 
Kim et al., 2004 
Mateusen et al., 2007 
Josephson et al., 2001 
West et al., 1999 
Mid 
(35-70 days) 
Mummified fetuses 
Abortion 
Kim et al., 2004 
Kim et al., 2004 
Late 
(70-115 days) 
Mummified fetuses 
Stillborns 
Weak-born piglets 
Delayed farrowing 
Normal litters 
Abortion 
Johnson et al., 2002 
O'Connor et al., 2001 
Nielsen et al., 2004 
Ladekjær-Mikkelsen et al., 2001 
Madson et al., 2009a 
Cariolet et al., 2002 
  
Coughing, diarrhea or wasting has not been reported in dams with increased non-
viable piglets at parturition. Developing replacements gilts in off-site locations can display 
clinical signs of PCV2 infection. A recent herd outbreak of PCV2-associated reproductive 
documented that a small percentage of gilts in a developer unit that supplied the farm with 
gilts displayed clinical signs of pneumonia, diarrhea, and systemic wasting (Pittman, 2008). 
A different report noted that 31 of 94 replacement gilts developed necrotizing dermatitis with 
enlarged kidneys similar to PDNS upon entry into a sow farm (Mauch, 2004). 
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Because of the ubiquitous nature of the virus, most replacement gilts and sows have 
been previously exposed to PCV2 prior to breeding, and are therefore at least partially 
protected from clinical signs of disease and PCV2-associated reproductive failure (Madson et 
al., 2009a). PCV2-associated reproductive failure outbreaks are typically reported in gilt-
start-ups or new farms and likely related to seronegative populations (West et al., 1999; 
O'Connor et al., 2001; Ladekjær-Mikkelsen et al., 2001; Josephson et al., 2001; Sanford, 
2002; Mauch, 2004; Mikami et al., 2005; Brunborg et al., 2007; Pittman, 2008; Høgedal et 
al., 2008). The spread of PCV2 in a naïve population can, however, result in few clinical 
signs and only a portion of affected dams may develop abnormal litter characteristics 
(Ladekjær-Mikkelsen et al., 2001).  
PCV2-associated reproductive failure has been reported in seropositive dams (Janke, 
2000; Nielsen et al., 2004). Increased numbers of non-viable piglets were reported at 
parturition. The affected herd was well established with no new animal introductions for 
many years. Both gilts and multiparous sows were affected. The reason for the PCV2 
circulation, or re-circulation, was not determined, but three months after the initial 
presentation the production in the herd was back to normal (Janke, 2000). Spontaneous 
resolution to normal appearing litters after PCV2-associated reproductive failure has been 
document in other case herds (Josephson et al., 2001).   
B. Prevalence of PCV2 associated reproductive failure 
 PCV2-associated reproductive failure was described eight years following the initial 
account of PMWS in Canada (Harding et al., 1997). The failure to detect PCV2-associated 
reproductive failure prior to 1999 was likely due to lack of testing assays for detection of 
PCV2 (Allan et al., 2000). Dam clinical signs can be unapparent, abortion is not a common 
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feature and not all fetuses are infected in utero; thus, PCV2-associated reproductive failure 
was possibly often misdiagnosed because of similarities to PPV-associated reproductive 
failure.  
 Multiple retrospective studies evaluated the prevalence of PCV2 within fetal tissues. 
Archived paraffin-embedded fetal tissues from reproductive failure cases submitted to the 
Western College of Veterinary Medicine Diagnostic Laboratory (Saskatoon, Saskatchewan, 
Canada) between 1995-1998 were tested for the presence of PCV2 antigen and DNA by IHC 
and PCR (Bogdan et al., 2001). The sensitivity of the PCV2 PCR used in the study was found 
not to be inhibited by formalin fixation or storage time. Of the 36 reproductive cases 
evaluated, 69% (25/36) were abortions and the remaining 11cases included at least one non-
viable piglet (stillborn or mummified fetus). Tissues from the respective cases were tested for 
PCV2 DNA and antigen included lung (77%), liver (61%), kidney (47%), thymus (27%), 
heart (16%), spleen (13.8%), intestine (11%), brain (11%), and skeletal muscle (5%). The 
presence of PCV2 DNA or antigen was not confirmed in any sample (Bogdan et al., 2001). 
This suggests that PCV2-associated reproductive failure in Canada is infrequently diagnosed 
and was not an important cause of reproductive failure prior to the initial report by West et al 
(1999). 
 A retrospective analysis of 350 aborted and stillborn fetuses from 321 different swine 
farms across five Korean provinces was conducted by Kim et al. (2004) for the presence of 
PCV2 DNA, antigen, or viable virus. Fetal samples were further classified based on the stage 
of gestation as early (1 to 30 days), mid (30 to 70 days), or late gestation (70 to 114) aborted 
or stillborn fetuses. Using fetal tissue homogenates composed of heart, liver, lung, spleen, 
thymus and lymph node, 35 of the 350 (10%) fetuses or stillborns were determined to be 
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positive for PCV2. PCV2 positive fetuses were noted in all stages of gestation with the 
highest frequency found in late gestation (12/35 aborted fetuses). In addition, 11 fetuses or 
stillborns were found to be dually infected with PPV (9/11) or PRRSV (2/11) (Kim et al., 
2004c).  
 A different research group analyzed 293 late gestational aborted fetuses or stillborn 
piglets from 100 diagnostic case submissions obtained from 15 Spanish provinces over a 10 
month period in 2002 (Maldonado et al., 2005). Pooled fetal samples (heart, thymus, lung, 
spleen, liver and kidney) were tested by PCR. PCV2 DNA was detected in only one case 
submission (Maldonado et al., 2005). A similar study assessed 195 fetal tissue cases from 
125 different Spanish herds between 1999 and 2001. PCV2 DNA was detected in only one of 
125 fetuses (Segalés et al., 2002). Results of both studies indicate that PCV2 is a minor cause 
of reproductive failure in Spain.    
 Ritzmann et al. (2005) evaluated 210 fetuses, stillborns, and weak-born piglets from 
87 different German swine herds for the presence of PCV2 DNA. PCV2 was found in 
homogenized lung and lymph node tissues from 57/210 fetuses (27.1%). PCV2 DNA was 
demonstrated in 9.1% (1/11) of mummified fetuses, in 27.6% (8/29) of aborted fetuses less 
than 100 days of gestation, in 16.6% (9/54) of aborted fetuses greater than 100 days of 
gestation, in 25.7% (9/35) of stillborn piglets, and in 37% (30/81) of weak-born piglets 
(Ritzmann et al., 2005).  
 Prevalence of PCV2 fetal infection in Brazil was evaluated by examining one 
hundred twenty-one aborted fetuses or stillborn piglets for associated microscopic lesions 
with the presence of PCV2 DNA or antigen (IHC). PCV2-associated fetal infection was 
demonstrated in 7/121 (5.8%) fetuses or piglets in which all had histological lesions of 
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myocarditis, PCV2 antigen in assorted tissues, and were positive for PCV2 DNA in lung 
tissue (Pescador, 2007). 
 Farnham et al. (2003) tested fetal serum from stillborn piglets on three farms in 
Minnesota (United States) with a history of greater than 10% non-viable fetuses at farrowing 
for more than six months duration. Serum samples from a total of 171 fetuses were tested for 
anti-PCV2 antibodies and PCV2 DNA. Anti-PCV2 antibodies were demonstrated in 16.4% 
(28/171) of samples and 7.6% (13/171) were positive for both PCV DNA and anti-PCV2 
antibodies (Farnham et al., 2003).  
 In the Czech Republic, Zizlavsky et al. (2008) examined aborted fetuses and stillborn 
piglets over a three year period (2005-2007). PCR data from fetal tissue samples showed a 
gradual increase in the diagnosis of PCV2 fetal infection (2005= 20 cases, 2006 = 41 cases, 
and 2007 = 64 cases) while PPV and PRRSV were decreasingly diagnosed (Zizlavsky et al., 
2008).   
C. Coinfections 
 PCV2 in utero fetal infection can result in reproductive failure by itself (West et al., 
1999; Pittman, 2008). However, multiple field reports and retrospective studies have 
identified other pathogens in combination with PCV2-associated reproductive failure. Other 
pathogens recognized in fetal tissues include PPV (O'Connor et al., 2001; Kim et al., 2004c; 
Ritzmann et al., 2005; Pescador, 2007), PRRSV (O'Connor et al., 2001; Farnham et al., 2003; 
Kim et al., 2004c; Ritzmann et al., 2005; Pescador, 2007), PCV1 (Pescador, 2007), and 
Escherichia coli (Pescador, 2007). The significance of coinfections is unknown.  
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D. Anti-PCV2 antibody status and reproductive failure 
The majority of PCV2-associated reproductive cases are perceived to occur in naïve 
dams after first exposure to PCV2. However, PCV2-associated reproductive failure has been 
reported in seropositive herds across multiple parities and has been experimentally 
reproduced in anti-PCV2 antibody positive sows (Janke, 2000; Nielsen et al., 2004). In the 
report by Nielsen et al. (2004), anti-PCV2 antibody positive sows were experimentally 
inoculated intranasally with PCV2 in late gestation. One challenged sow delivered a 
mummified fetus and three weak-born piglets that were positive for PCV2 DNA by PCR. At 
necropsy, the weak-born piglets had interstitial pneumonia with interlobular pulmonary 
edema, thymic atrophy and cardiomegaly. None of the other challenged dams displayed signs 
of disease and all delivered healthy, PCV2 PCR negative piglets at parturition (Nielsen et al., 
2004).  
Sixty-days after oro-nasally inoculating naïve, non-pregnant sows with PCV2, Rose 
et al. (2007) inseminated two sows with spiked semen containing the homologous PCV2 
isolate. PCV2 viremia was not measured at insemination, but both sows were seropositive at 
35 days post oro-nasal inoculation. Both sows delivered PCV2 positive mummified fetuses 
varying in crown-to-rump length from 5 to 33 cm (Rose et al., 2007). Conversely, Madson et 
al. (2009) found different results following oro-nasal challenge in three PCV2 naïve dams 
120 days prior to artificial insemination with PCV2 spiked semen containing 5 ml of PCV2. 
Dams were not PCV2 viremic at insemination. Post-insemination viremia was detected in 
two of the three sows, but reproductive failure and PCV2 fetal infection were not observed 
(Madson et al., 2009a). This suggests that dam-associated homologous anti-PCV2 antibodies 
are at least partially protective for the development of PCV2-associated reproductive failure.    
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PCV2 isolates associated with reproductive failure  
Genetic comparison of PCV2 isolates obtained from reproductive failure cases and 
other clinical manifestation (PDNS and PCVAD) cases have suggested that genetic 
composition is likely the reason for the reproductive manifestation (Meehan et al., 2001; 
Farnham et al., 2003). In one report, comparison was done between the following four PCV2 
isolates: two Canadian PCV2a isolates associated with reproductive failure on separate 
farms, a PDNS (PCV2b) isolate from the United Kingdom, and a Canadian PMWS isolate 
(PCV2a; Stoon isolate). ORF1 was essentially the same across all four isolates. 
Characterization of the ORF2 region showed that the reproductive failure associated PCV2 
isolates were 99% (nucleic acid sequence) and 97% (protein sequence) identical when 
compared to the PMWS PCV2 isolate. When compared to the PDNS PCV2 isolate, the two 
reproductive failure associated PCV2 isolates were 96% (nucleic acid homology) and 92% 
(protein homology) identical (Meehan et al., 2001).  
In a similar comparison study, the ORF2 sequence homology of two PCV2-associated 
reproductive failure isolates from Minnesota were characterized and compared to 13 other 
PCV2 GenBank accession isolates from Canada, France, China, Taiwan, and the United 
Kingdom. The Minnesota PCV2 isolates were from two different farms experiencing greater 
than 10% stillborns and mummified fetuses for more than six months. Sequence homology 
between the two Minnesota PCV2 isolates was 98%. When compared with two different 
reproductive PCV2 isolates (Meehan et al., 2001), one PDNS PCV2 isolate (Meehan et al., 
2001), one PCV2 isolate from a bovine lung, and ten PMWS-associated PCV2 isolates 
(Hamel et al., 1998; Meehan et al., 1998; Ouardani et al., 1999) it was found that overall, the 
two Minnesota reproductive associated PCV2 isolates varied in nucleotide homology from 
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90.6-98.7% when compared to the other 13 PCV2 isolates (ten isolates were PCV2a and 
three were PCV2b). The Minnesota PCV2 isolates were closely related to the other PCV2a 
isolates, including the Canadian reproductive PCV2 isolates characterized by Meehan et al. 
(2001). This further suggested that reproductive failure PCV2 isolates differ from isolates 
recovered from other clinical manifestations (Farnham et al., 2003).   
 
Table 2. PCV2 isolates associated with or perceived to be linked with in utero infection. 
 
In vitro replication kinetics of PCV2 reproductive failure isolates were evaluated and 
compared to PCV2 isolates recovered from growing pigs to further determine the 
significance and potential differences (Meerts et al., 2005a). The two reproductive PCV2 
isolates were as previously described (Meehan et al., 2001). Replication kinetics were 
contrasted against the PDNS PCV2 isolate (Meehan et al., 2001) and five PCV2 isolates from 
GenBank 
accession 
 Location  Original isolation  Genotype 
Reproductive 
manifestation  Reference 
AJ293867  Canada  Reproductive  PCV2a  Yes  West et al., 1999  Sanchez et al., 2001 
AJ293868  Canada  Reproductive  PCV2a  Yes  O'Connor et al., 2001 
AJ293869  UK  PDNS  PCV2b  Yes  Lefebvre et al., 2008 
AY129154  U.S.  Reproductive  PCV2a  Yes  Farnham et al., 2003 
AY129155  U.S.  Reproductive  PCV2a  Yes  Farnham et al., 2003 
AF055394  France  PMWS  PCV2b  Yes  Lefebvre et al., 2008 
AF147751  U.S.  PMWS  PCV2a  Yes  Johnson et al., 2002 Yoon et al., 2004 
EU340258  U.S.  PMWS  PCV2b  Yes  Madson et al., 2009b 
AF264042  U.S.  PMWS  PCV2a  Unknown  Madson et al., 2009b 
AY099499  U.S.  Congenital tremors  PCV2a  Unknown  Choi et al., 2002 
AY099500  U.S.  Congenital tremors  PCV2a  Unknown  Choi et al., 2002 
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PMWS affected pigs (Ellis et al., 1998; Meehan et al., 2001; Meerts et al., 2004). A greater 
amount of PCV2 capsid protein was detected in the cytoplasm of PK-15 cells when 
inoculated with the reproductive failure associated PCV2 stains as compared to the other 
isolates; however, the production of new virus particles was slightly diminished when 
compared to the reference PMWS-associated PCV2 isolate. The reproductive failure PCV2 
isolates were able to infect a greater number of fetal myocardiocytes and pulmonary 
macrophages over a 72 hrs time period (Meerts et al., 2005a).  
PCV2 fetal infection in pregnant sows has been experimentally reproduced using 
PCV2 isolates recovered from field cases of reproductive failures (Nielsen et al., 2004; Park 
et al., 2005; Lefebvre et al., 2008). Furthermore, PCV2-associated reproductive failure has 
also been reproduced in naïve sows artificially inseminated with semen contaminated with a 
PCV2b isolate obtained from a PMWS outbreak (Madson et al., 2009c). A recent study 
reported on the outcome of in utero inoculation of fetuses with different PCV2 isolates at 55 
days of gestation. PCV2 isolates were obtained from a reproductive failure case (PCV2a), a 
PDNS case (PCV2b), and two isolates were from PMWS affected pigs (one PCV2a and one 
PCV2b). The reproductive failure PCV2 isolate, the PDNS PCV2 isolate and the PMWS 
PCV2a isolate were previously compared by Meehan et al. (2001). Twenty-one days post 
fetal inoculation, sows were euthanized. Gross lesions of PCV2 fetal infection and high 
PCV2 titers in tissues were noted across all PCV2 isolates used in the experimental study 
(Lefebvre et al., 2008). Similarly, PCV2 replication was observed after placement of a 
PCV2a PMWS isolate into fetal fluids by laparotomy or ultrasound guided trans-abdominal 
inoculation (Johnson et al., 2002; Yoon et al., 2004). With the information known to date 
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(summarized in Fig. 1 and Table 2), it appears that ORF2 differences between PCV2 isolates 
cannot predict the associated clinical manifestations of the virus. 
 
 
 
 
 
 
 
Figure 1. ORF2 nucleotide sequence based dendogram of PCV2 isolates associated with or 
perceived to be linked with in utero infection. PCV2c was included as a reference. 
 
Impact of PCV2 on oocytes and embryos 
Viral pathogens have been shown to be able to attach to the zona pellucida of 
developing swine oocytes and embryos (Singh et al., 1987; Bielanski et al., 2004b). Tissues 
and serum from 55 seropositive 6-month-old conventional gilts were obtained at slaughter. 
PCV2 DNA was demonstrated by nested PCR (nPCR) in follicular fluid of 12/55 gilts (22%), 
oviductal cells in 31/55 gilts (56%), uterine washes for 20/55 gilts (36%), and in oocytes of 
6/55 gilts (11%). Eighty-four percent (46/55) of the gilts were PCV2 viremic at slaughter, but 
PCV2 DNA was also detected in uterine washes and oviductal cells of non-viremic gilts. The 
reproductive tract environment may be a potential source of PCV2 contamination for a subset 
of oocytes prior to fertilization (Bielanski et al., 2004a).  
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Embryo transfer is a growing field for genetic improvement. Decontamination 
protocols were tested on oocytes and embryos that were exposed to PCV2 in an attempt to 
provide clean specimens that may be used for embryo transfer (Bielanski et al., 2004b; 
Bureau et al., 2005). Similar protocols involving trypsin, hyaluronidase, DNase and RNase 
were used. Bielanski et al. (2004b) was unable to identify a protocol sufficient to remove 
PCV2 DNA contamination; however, Bureau et al. (2005) showed that 0.1% hyaluronidase 
treatment removed PCV2 DNA along with the DNA of other swine viruses.  
Fluorescent particles with a diameter of 20 nm and 26 nm can cross the zona 
pellucida and reach the embryo while 200 nm particles are deposited on the outer surface 
(Mateusen et al., 2004). Previously, PPV with an approximate diameter of 20 nm was 
demonstrated to pass through an intact zona pellucida after 48 hrs of incubation (Bane et al., 
1990). Virions of PCV2 are slightly smaller than PPV with an approximate diameter of 17 
nm (Todd et al., 2005). When swine morulae with intact or absent zona pellucida (6 day old 
embryos), early blastocysts (7 day old embryos), and late blastocysts (8 days old embryos) 
were exposed to PCV2 for 48 hrs, only zona pellucida free morulae and blastocysts became 
infected with PCV2 (Mateusen et al., 2004). Based on the relative size of PCV2, it could 
penetrate the zona pellucida; however, due to unknown factors this was not detected.  
Incubation of zona pellucida free morulae and early blastocysts with PCV2 for 48 
hours had no significant effect on development when compared to intact zona pellucida 
embryos during the incubation period (Mateusen et al., 2004). In contrast, PCV2 incubation 
of hatched blastocysts (7 day old embryos) for one hour resulted in increased numbers of 
non-viable embryos 21 days later. Embryonic development still occurred in some PCV2 
exposed embryos (Mateusen et al., 2007).  
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Fetal PCV2 infection 
 Experimental PCV2 fetal infection has been documented after exposing the dam to 
PCV2 via oro-nasal infection or by artificial insemination with spiked semen (Nielsen et al., 
2004; Park et al., 2005; Madson et al., 2008a; Madson et al., 2009c). PCV2 viremia in adult 
animals may last for multiple weeks (Madson et al., 2009c). During dam viremia, PCV2 
crosses the placenta as free virus or cell-associated virus (Pensaert et al., 2004). Fetal 
infection and death can occur at different stages of gestation resulting in variably sized 
mummified fetuses (crown-to-rump length) and stillborns at parturition (O'Connor et al., 
2001; Ladekjær-Mikkelsen et al., 2001; Josephson et al., 2001; Cariolet et al., 2002; Pittman, 
2008; Madson et al., 2009c). Timing of PCV2 fetal infection will also result in differences in 
gross lesions and distribution of PCV2 (Sanchez, Jr. et al., 2001; Johnson et al., 2002; 
Sanchez, Jr. et al., 2003; Sanchez, Jr. et al., 2004). After fetal infection, PCV2 is capable of 
spreading to other fetuses (Yoon et al., 2004; Madson et al., 2009c). Furthermore, Kim et al. 
(2004) detected PCV2 in early aborted fetuses less than 30 days of gestation by PCR 
implicating PCV2-associated early embryonic fetal death (Kim et al., 2004c).  
A. PCV2 fetal replication and distribution 
 After fetal infection is established, PCV2 can be detected in multiple tissues. In one 
experimental study, Sanchez et al. (2001) infected in utero fetuses at 57, 75, and 92 days of 
gestation by injecting PCV2 into the amniotic fluid. All fetuses were retrieved 21 days later. 
Gross lesions of edema, hepatomegaly and congestion were observed in fetuses inoculated at 
57 days, but not in fetuses inoculated at 75 or 92 days of gestation. Inoculation at 57 days of 
gestation resulted in significantly higher amounts of PCV2 in tissue with systemic organ 
distribution including heart, lung, spleen, kidney, lymph nodes, and brain (Sanchez, Jr. et al., 
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2001). Myocardium and liver contained the highest amount of infectious virus. PCV2 
inoculation at 75 and 90 days of gestation resulted in a more narrow range of organ infection 
which included myocardium and to a lesser degree lymphoid tissue (spleen and lymph node), 
lung and liver (Sanchez, Jr. et al., 2001). The distribution of PCV2 antigen was similar to 
what had been reported in field cases of PCV2-associated reproductive failure (West et al., 
1999; O'Connor et al., 2001) indicating that the myocardium is likely the preferred site of 
fetal PCV2 replication (Sanchez, Jr. et al., 2003). PCV2 DNA or antigen has also been 
detected in sera (Sanchez, Jr. et al., 2001; Farnham et al., 2003; Madson et al., 2009c), 
thymus (Park et al., 2005), tonsil (Park et al., 2005; Madson et al., 2009c), thoracic fluid 
(Sanchez, Jr. et al., 2001; Yoon et al., 2004), small intestines (Johnson et al., 2002), colon 
(Pescador, 2007), and ear notch skin (Madson et al., 2009c) of in utero PCV2 infected 
fetuses.  
 Myocardial PCV2 replication diminishes with increased fetal age. This associated 
shift is related to myocardial development (Sanchez, Jr. et al., 2003). As fetuses near full 
development or are infected shortly after birth, PCV2 replication appears to take place in 
cells of the monocyte-macrophage lineage (Sanchez, Jr. et al., 2003; Sanchez, Jr. et al., 
2004). 
B. Fetal gross lesions and clinical signs associated with PCV2 infection 
 Following PCV2 infection, dams may abort due to systemic illness and fetal gross 
lesions can be unapparent (Cariolet et al., 2002; Park et al., 2005). More common is 
subclinical dam PCV2 infection with increased non-viable fetuses (mummified and stillborn) 
at parturition. Mummified fetuses can vary in crown-to-rump length with smallest fetuses 
around 6-7 cm (O'Connor et al., 2001; Madson et al., 2009c). Live-born or weak-born piglets 
39 
 
can also be delivered and display ill-thrift (West et al., 1999; O'Connor et al., 2001; Cariolet 
et al., 2002; Nielsen et al., 2004; Mikami et al., 2005; Park et al., 2005; Madson et al., 
2009c). PCV2 fetal infection can occur prior to fetal bone mineralization (Kim et al., 2004c) 
which results in early embryonic death with fetal readsorption, low litter sizes, or possibly 
irregular returns to estrus of the dam.  
Fetal gross lesions are not always present following in utero PCV2 infection (Madson 
et al., 2009a; Madson et al., 2009b). Frequently, the only indication of in utero infection is 
increased numbers of stillborn and mummified fetuses at parturition. When present, gross 
lesions can be observed in live-born pigs, stillborn piglets or late term mummified fetuses 
and are generally associated with myocardial failure. The lesions include dilated 
cardiomyopathy with regions of pallor, pulmonary edema, hepatomegaly with an accentuated 
lobular pattern (congestion), hydrothorax, ascites, and subcutaneous edema (West et al., 
1999; O'Connor et al., 2001; Cariolet et al., 2002; Park et al., 2005; Brunborg et al., 2007; 
Madson et al., 2009c). Other infrequent observed gross lesions include lymphadenopathy 
(Johnson et al., 2002; Lefebvre et al., 2008), thymic atrophy (Nielsen et al., 2004; Madson et 
al., 2009c), perirenal edema (Madson et al., 2009c), mesocolonic edema (Pescador, 2007; 
Madson et al., 2009c), and cerebral and splenic petechiation (Brunborg et al., 2007; Lefebvre 
et al., 2008; Madson et al., 2009c).  
In utero PCV2 infection has been previously linked with congenital tremors in new 
born piglets in the United States. PCV2 DNA and antigen were demonstrated in the brain and 
spinal cord of piglets less than two days of age with congenital tremors. The piglets were 
born to gilts; however, no other gross lesions or clinical characteristics of PCV2-associated 
reproductive failure were noted in affected herds (Stevenson et al., 2001). The PCV2 isolates 
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obtained from affected piglets were characterized as PCV2a isolates and shared 99% 
nucleotide homology (Table 2). The congenital tremor isolates were compared with known 
PMWS isolates and 99% genetic homology was reported (Choi et al., 2002b). In other 
countries, a PCV2 association with congenital tremor has not been confirmed following 
examination of 95 piglet cases (Kennedy et al., 2003; Ha et al., 2005; Brunborg et al., 2007). 
A clear association of congenital tremors has been previously documented with multiple 
swine viruses (Harding et al., 1966; Harding et al., 1973; Mare et al., 1974), but there is no 
substantial evidence of PCV2 in utero infection leading to congenital tremors.       
C. Fetal microscopic lesions associated with PCV2 infection 
 Microscopic lesions associated with PCV2 in fetuses are most consistently present in 
the myocardium of mummified, stillborn, and live-born piglets (West et al., 1999; O'Connor 
et al., 2001; Madson et al., 2009c). Myocardiocytes are often degenerative, necrotic, or lost 
and replaced by variable amounts of fibrous connective tissue and mineralization with 
infiltration of inflammatory cells composed of lymphocytes, plasma cells, macrophages, and 
lesser multinucleated giant cells. Occasionally, botyroid intranuclear inclusion bodies within 
cardiomyocytes are present (O'Connor et al., 2001; Pescador, 2007; Madson et al., 2009c). 
Other microscopic changes may include mild multifocal non-suppurative interstitial 
pneumonia (Kim et al., 2004c; Park et al., 2005; Pescador, 2007), bronchopneumonia (Yoon 
et al., 2004; Brunborg et al., 2007), hepatic congestion with hepatocellular loss (West et al., 
1999), non-suppurative hepatitis with periacinar necrosis (Brunborg et al., 2007), lymph node 
and splenic lymphocyte depletion with occasional multinucleated giant cells (Mikami et al., 
2005; Brunborg et al., 2007; Madson et al., 2009c), or lymph node follicular hyperplasia 
(Brunborg et al., 2007).  
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D. Diagnosis of in utero fetal PCV2 infection 
  PCV2 infection should be suspected in cases with increased numbers of non-viable 
piglets at parturition or in cases of abortion; however, several other infectious and non-
infectious causes of reproductive failure in swine can be associated with similar clinical 
presentations (Almond et al., 2006). The diagnostic success rate can depend on the timing of 
PCV2 infection, length of viremia in the dam, the number of fetuses infected, and number of 
fetuses sampled. Pregnant dams infrequently show clinical signs of infection, are usually 
seropositive, and can be PCV2 viremic or non-viremic at farrowing (Madson et al., 2008a). 
Therefore, interpreting fetal infection based on sow diagnostics is extremely difficult and 
should be avoided. Interpretation of sow serology is frequently complicated by the ubiquitous 
nature of PCV2 and viremia does not always correlate with fetal infection (Madson et al., 
2009a). 
 In utero PCV2 exposure may result in all fetuses becoming infected (Madson et al., 
2009c). Alternatively, as little as one piglet in a litter of 10 clinical normal appearing piglets 
may have an active infection at birth following gestational viremia in dams (Madson et al., 
2009b). Fetuses can also clear active PCV2 infection prior to farrowing if primary infection 
occurs in the post immunocompetent phase (approximately 70 days of gestation) (Madson et 
al., 2009b).  
 Following experimental trans-uterine inoculation of fetuses, Sanchez et al. (2001) was 
able to isolate PCV2 from multiple major organs including heart, lung, liver, spleen, brain, 
lymph node pools, serum, and body fluids and found that successful isolation was age 
dependent. PCV2 was isolated from myocardium of all fetuses 21 days after in utero 
inoculation at 57, 75, 92 days of gestation (Sanchez, Jr. et al., 2001). Other authors have also 
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isolated PCV2 from fetuses at farrowing that were experimentally infected in late gestation 
(86, 92, and 93 days of gestation) via laparotomies (Johnson et al., 2002). All fetuses from 
three sows were intramuscularly inoculated. PCV2 infection was confirmed in 12/12, 10/15, 
and 4/9 fetuses from the respected litters. Positive PCV2 isolation was confirmed in 11 
spleens, 10 lymph nodes, 6 livers, 6 lungs, and 3 intestinal samples from 34 tested fetuses. 
PCV2 was not isolated from any of the 34 kidney samples (Johnson et al., 2002).  
The distribution of PCV2 in expelled fetuses was assessed by Park et al. (2005) 
following experimental intranasal dam inoculation at 93-95 days of gestation. Sixty-five 
stillborn and 10 live-born piglets were examined by IHC and ISH. PCV2 antigen or DNA 
were demonstrated in 10/75 lungs, 61/75 thymuses, 8/75 livers, 69/75 tonsils, 70/75 spleens, 
and 72/75 lymph node samples. IHC and ISH techniques were compared and were very 
similar across all tissues tested (Park et al., 2005). Myocardium was not assessed, but results 
confirm that lymphoid tissues are a good diagnostic sample if PCV2 infection occurred 
during late gestation.  
PCV2-associated reproductive failure was experimentally reproduced by Madson et 
al. (2009) following artificial insemination of naïve dams with PCV2-spiked extended 
semen. Three of three dams gave birth to numerous non-viable pigs ranging in crown-to-
rump length from 7 to 27 cm. PCV2 antigen was detected by IHC in myocardium of all 27 
non-viable fetuses and 7 of 8 live-born piglets. PCV2 antigen was also detected in tonsil 
(8/15), lung (4/21), and ear notch samples (2/21) (Madson et al., 2009c).   
In field cases of PCV2-associated reproductive failure, Brunborg et al. (2007) 
detected PCV2 DNA in heart, liver, kidney, spleen, lymph node, and brain tissues of non-
viable fetuses (mummified and stillborn) and live-born pigs at farrowing using quantitative 
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real-time PCR. The amount of PCV2 DNA in examined tissues ranged from 107 to 1012 
genomic copies per 500 ng of DNA in non-viable fetuses. Myocardial and liver samples 
contained the highest amounts of DNA. The amount of PCV2 DNA in live-born piglets was 
lower and ranged from 102 to 1010 genomic copies per 500 ng DNA. Myocardium, liver, and 
splenic tissues were positive for PCV2 DNA in all live-born piglets (Brunborg et al., 2007).   
Multiple diagnostics assays have been used for the detection of PCV2 in fetal 
samples. Similar to PCVAD in growing pigs, it is beneficial to find PCV2 DNA or antigen 
associated with affected fetal tissue. IHC (Ellis et al., 1998; Sorden et al., 1999) and ISH 
(Kim et al., 2003a) are considered to be the gold standard for detection of PCV2 antigen or 
DNA in formalin fixed, paraffin embedded tissues from affected or suspected fetuses. The 
most consistent tissue for detection and diagnosis of in utero PCV2 infection is myocardium 
(Sanchez, Jr. et al., 2001; Brunborg et al., 2007; Madson et al., 2009c). Myocardium readily 
stains if PCV2 is present and the antigen can be seen in the cytoplasm as well as the nucleus 
of infected cells. PCV2 antigen or DNA can also be present in thymus, spleen, tonsil, and 
lung tissue with variation. 
Detection of PCV2 DNA in fetal tissues or presuckle sera by PCR (Ellis et al., 1999; 
Opriessnig et al., 2003) or virus isolation (Ellis et al., 1998; Kim et al., 2004a) is another 
method for diagnosing PCV2 in utero infection. Using a PCR method allows for the 
detection of small amounts of virus, and tissue pooling can alleviate problems with timing of 
in utero infection and the distribution of virus. Myocardium should always be a part of the 
tissue pool. PCV2 detection by PCR has been reported to be successful in fetal thoracic fluid 
following direct fetal inoculation (Yoon et al., 2004); however, the sensitivity of this sample 
is unknown and unproven. Virus isolation in general is more difficult and less sensitive.  
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In utero PCV2 infection can also be diagnosed by demonstrating anti-PCV2-
antibodies in fetal or live-born pre-suckle serum samples (Farnham et al., 2003; Madson et 
al., 2008a; Madson et al., 2009c). PCV2 antibodies in pre-suckle serum samples have been 
detected using a PCV2 recombinant capsid protein-based ELISA (Nawagitgul et al., 2002) 
from live-born piglets (Madson et al., 2009b). Other serology tests include indirect 
fluorescent antibody (IFA) (Pogranichniy et al., 2000a) and immunoperoxidase monolayer 
assay (IPMA) (Pogranichniy et al., 2000b). In an experimental sow challenge model, anti-
PCV2 antibodies were the only indication of fetal infection (Madson et al., 2009b). Anti-
PCV2 antibodies in fetal thoracic fluid were also detected by Ladekjær-Mikkelsen et al. 
(2001) using an IPMA technique.   
A definitive diagnosis of PCV2-associated reproductive failure is two-fold. Clinical 
abortion or increased numbers of non-viable fetuses at parturition should be observed and 
PCV2 DNA or antigen must be detected in tissues of affected fetuses. Detection of PCV2 
DNA or antibodies in pre-suckle serum or fetal thoracic fluid from fetuses only indicates in 
utero infection.  
E. In utero PCV2 infected live-born piglets 
 There appears to be a window of timing where in utero fetal infection can result in 
live-born piglets with no clinical signs (West et al., 1999; Ladekjær-Mikkelsen et al., 2001; 
Mikami et al., 2005; Brunborg et al., 2007; Madson et al., 2009c). It has been speculated that 
there may be differences in dam or litter susceptibility for development of PCVAD in 
growing pigs (Madec et al., 2000). The authors suggested that dams transferred infection, but 
in utero PCV2 infection was not determined in the epidemiological study (Madec et al., 
2000). Further examination of a possible litter effect and association with the development of 
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PMWS in growing pigs was conducted by Calsamiglia et al. (2007). Sow viremia and 
antibody titer at parturition were documented and litter mates were followed into the growing 
phase. Piglets derived from low PCV2 antibody titer or viremic sows had a higher morbidity 
and mortality rate associated with PMWS (Calsamiglia et al., 2007). This information 
confirms a litter effect and implies that in utero fetal infection may be a contributing factor in 
the development of PMWS. Further studies are needed to confirm that affected piglets in 
corresponding litters are truly infected in utero.   
 Other groups have experimentally investigated the role of in utero fetal infection with 
PCV2 and postnatal disease. In one report, Jung et al. (2006) infected PCV2 naïve sows oro-
nasally at 93 days of gestation and PCV2 positive live-born piglets were subsequently 
infected at three days of age with porcine epidemic diarrhea virus (PEDV). Piglets from sows 
exposed to PCV2 and challenged with PEDV at 3 days of age contained higher numbers of 
PEDV infected intestinal cells 24 hr post-challenge compared with piglets only infected with 
PEDV (Jung et al., 2006). Similarly, Ha et al. (2008) inoculated PCV2 naïve dams oro-
nasally in late gestation (3 weeks prior to expected farrowing) and consequently challenged 
PCV2 positive live-born piglets at 28 days of age with either PPV or immune stimulated with 
keyhole limpet hemocyanin mixed with incomplete Freund’s adjuvant (KLH/ICFA). All 
PCV2 in utero infected live-born pigs that were challenged or immune stimulated developed 
PMWS by 63 days of age (Ha et al., 2008). PMWS lesions were also observed in pigs post-
natal infected with PCV2 and PPV (Ha et al., 2008). Non-stimulated or coinfected PCV2 
positive live-born piglets in these prior studies did not developed PMWS (Jung et al., 2006; 
Ha et al., 2008). PCV2 in utero infection likely makes pigs more susceptible to coinfections 
with other pathogens and therefore may be associated with PMWS in the growing pig. 
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PCV2 and sow colostrum or milk 
 Sow colostrum and milk can contain PCV2 DNA post partum. The prevalence of 
PCV2 in sow milk was reported by Shibata et al. (2006) after investigating three Japanese 
swine herds. PCV2 DNA was found by PCR in 33/33 samples tested. PCV2 was isolated 
from 1/33 milk samples (Shibata et al., 2006). PCV2 DNA was demonstrated in colostrum 
samples obtained 24 hours after birth in PCV2 seronegative sows experimentally infected 
with PCV2 on day 93 of gestation.  Alternatively, day 2 and day 3 sow milk samples were 
negative by PCR, but PCV2 antigen in macrophage-like cells within ductal lumina was 
detected in mammary tissue 3 days post-partum (Park et al., 2009). Similarly, Madson et al. 
(2009) detected PCV2 DNA in colostral samples post-partum in sows that were challenged 
intra-uterine at estrus. The length of sow colostral PCV2 DNA shedding has been described 
to last for at least 27 days post-partum following oro-nasal challenge in late gestation (Ha et 
al., 2009).   
A. Colostrum and anti-PCV2 antibodies 
 It is well known that passively acquired, maternally derived colostral antibodies are 
important to protect neonates prior to full development of the immune system (Sangild, 
2003). In regards to PCV2, most swine herds are seropositive (Allan et al., 2000; Opriessnig 
et al., 2007), and thus dams are likely to confer PCV2 antibodies to offspring via colostrum. 
Dam antibody levels vary amongst individual dams within a herd (Opriessnig et al., 2004; 
Calsamiglia et al., 2007) or between herds (Opriessnig et al., 2004; Zhou et al., 2006), and 
piglet antibody uptake from the same dam can vary (Opriessnig et al., 2004; McKeown et al., 
2005). Passively acquired maternal antibodies in general protect the piglet from developing 
clinical disease associated with PCV2 (Harms et al., 2002; Allan et al., 2002b; Ostanello et 
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al., 2005; Calsamiglia et al., 2007), but do not protect against PCV2 infection (McKeown et 
al., 2005). However, one report found no significant protective effect of PCV2 passively 
derived antibodies on the development of PMWS (Hassing et al., 2003). PCV2 maternal 
antibody half-life in piglets is approximately 3 weeks (Opriessnig et al., 2004) and antibodies 
may last up to 18 weeks of age (Opriessnig et al., 2009c). 
 The titer of anti-PCV2 antibodies in colostrum has only recently been evaluated 
(Madson et al., 2009a; Madson et al., 2009b). Colostrum and serum at parturition from dams 
challenged at insemination have similar anti-PCV2-IgG antibody levels as determined by an 
ORF2 capsid protein based enzyme-linked immunosorbent assay. PCV2 vaccination of the 
dam confers colostral antibody levels similar to that induced by natural infection of the dam 
(Madson et al., 2009a).   
 
PCV2 infection in mature boars 
Artificial insemination (AI) is standard practice commonly implemented by most 
large swine production systems worldwide. In North America, reports estimate that nearly 
60% of the swine herds are practicing AI (Singleton, 2001). This percentage increased from 
the previous decade when estimates were around 5% (Flowers et al., 1993). Estimates in 
Western European countries approach 90% or greater (Madsen, 2005; Maes et al., 2008). The 
main advantage of AI is genetic improvement (Gerrits et al., 2005). Though AI has many 
benefits in swine production, introduction of boar semen to sow herds from outside sources 
(AI centers) has been implicated in disease transmission (Yaeger et al., 1993). A recent 
review summarizes swine viruses that can be detected in boar semen and includes PCV2 
(Guerin et al., 2005).  
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Mature boars infected with PCV2 generally lack clinical signs associated with disease 
(Larochelle et al., 2000; Madson et al., 2008b). Alternatively, Opriessnig et al. (2006) 
reported clinical disease in an 11-month-old PCV2 positive boar coinfected with 
Mycoplasma hyopneumoniae and Pasteurella multocida. The boar was euthanized for poor 
semen quality (Opriessnig et al., 2006d). Semen alternations (morphology, motility, or 
quality) are not a frequent feature associated with natural or experimental PCV2 infection 
(McIntosh et al., 2006b; Ciacci-Zanella et al., 2007; Madson et al., 2008b).  
 In the acute phase of infection, PCV2 DNA can be detected in serum and semen at 
two and five days post inoculation, respectively (Larochelle et al., 2000; Madson et al., 
2008b). Detection of PCV2 viremia commonly precedes the detection of semen-associated 
virus (Madson et al., 2008b), but semen shedding has been reported in the absence of viremia 
(Larochelle et al., 2000). PCV2 antibodies typically develop by two weeks post inoculation 
(Larochelle et al., 2000; Madson et al., 2008b). Following intranasal inoculation of four 
PCV2 negative boars, Larochelle et al. (2000) documented intermittent semen shedding of 
PCV2 DNA in a 47 day observation period. Intermittent semen shedding was confirmed by 
Grasland et al. (2008) after testing semen samples for 8 weeks in four inoculated boars. In 
contrast, Madson et al. (2008) found continuous semen shedding following intranasal and 
intramuscular inoculation in 12 Landrace boars following a 90 day observational period. 
Peak PCV2 shedding in semen occurs between nine and 20 days post inoculation and ranges 
from 105.1 (Madson et al., 2008b) to 106.0 (Grasland et al., 2008) log transformed PCV2 
genomic copies/ml. PCV2 PCR positive results in serum or blood swab are not correlated 
with semen PCR results, and therefore not predictive of the presence of PCV2 DNA in semen 
(Larochelle et al., 2000; Reicks et al., 2007; Madson et al., 2008b); however, there is 
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correlation and predictability of serum PCR in the acute stage of infection in naïve boars 
(Madson et al., 2008b). 
 Experimentally inoculated boars can be viremic for at least 90 days and blood swabs 
can be positive for at least 47 days after viremia was last detected (Madson et al., 2008b). 
Naturally infected boars can sporadically shed PCV2 DNA in semen for up to 27.3 weeks in 
a PCV2 positive boar stud (McIntosh et al., 2006b).  
 Sex organs and accessory sex glands of PCV2 infected boars can contain PCV2 DNA 
or antigen. In non-clinical and clinically diseased boars, PCV2 antigen and nucleic acid have 
been demonstrated by IHC and ISH in bulbourethral glands, testes, epididymis, prostate and 
seminal vesicles (Opriessnig et al., 2006d; Ciacci-Zanella et al., 2007; Gava et al., 2008; 
Ciacci-Zanella et al., 2008). Abundant IHC staining of PCV2 antigen was identified within 
interstitial macrophages and fibroblast-like cells of seminal vesicles in a clinically affected, 
naturally infected boar from a commercial boar stud (Opriessnig et al., 2006d). Detection of 
PCV2 by ISH was identified at a higher frequency in epididymis and bulbourethral gland 
sections compared to other accessory sex glands of naturally infected boars (Ciacci-Zanella 
et al., 2008). PCV2 DNA in testes, bulbourethral glands, epididymis, prostate and seminal 
vesicles has been demonstrated of by quantitative real-time PCR in experimentally infected 
boars. Similar amounts were detected between accessory sex glands (Madson et al., 2008b). 
PCV2 DNA was also detected in penile tissue of naturally infected boars (Gava et al., 2008). 
A. Artificial insemination and PCV2 epidemiology 
Multiple investigators have evaluated the risk of boar semen as a point source of 
PCV2 dissemination. A survey of 25 PCV2 seropositive Ontario swine farms using 
purchased semen or natural matings found no correlation with semen and the incidence of 
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PMWS in growing pigs (Cottrell et al., 1999). When PMWS started to spread in Sweden, an 
epidemiological assessment of affected herds concluded that dissemination via infected 
semen was not occurring (Wallgren et al., 2004). Similarly, Lawton et al. (2004) investigated  
the spread of PMWS in New Zealand swine herds and determined that imported boar semen 
could not explain the spatial distribution of affected farms (Lawton et al., 2004).  
In 2005-2006, North American swine populations saw an increase in PMWS 
associated with PCV2b isolates. One group investigated multiple PCV2b PMWS finishing 
sites in Kansas. The affected farms were sourced from two different sow herds which were 
supplied with semen from a single boar stud. Evaluation and PCV2 sequencing showed that 
boars within AI centers supplying semen were infected with PCV2a. No correlation with the 
boar stud and the downstream PWMS associated with PCV2b was reported (Horlen et al., 
2007).     
A more thorough risk analysis was conducted on 149 French swine farms to 
determine the association of boar semen and development of PMWS. The investigators 
evaluated 59 farrow-to-finish farms clinically affected with PMWS, 55 farms that had never 
experienced PMWS, and 35 farms that previously experienced PMWS and recovered. No 
correlation between the purchase of boar semen and the development of PMWS was 
demonstrated; however, an increased risk of PMWS in downstream growing pigs was 
positively correlated with on-farm semen collection (Rose et al., 2003). 
B. Infectivity of PCV2 in semen 
 Numerous bacteria and viruses can be present in boar semen and have been shown to 
be transmitted to breeding sows (Maes et al., 2008). Evaluation of 60 raw semen samples 
from 30 different Korean farms using virus isolation demonstrated that 6.7% (4/50) of the 
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raw semen samples inoculated on PK-15 cells were positive for PCV2 DNA by in-situ 
hybridization. Cell culture supernatants also contained PCV2 DNA as detected by PCR (Kim 
et al., 2001). In a separate study, virus isolation on 98 raw semen samples collected from 
one-year-old boars on 49 different Korean farms was attempted; seven of the 98 semen 
samples (7.1%) contained PCV2 that replicated in PK-15 cells (Kim et al., 2003b).  
Recently, Madson et al. (2009) using a swine bioassay model demonstrated 
infectivity of both PCV2a and PCV2b in semen from acutely infected boars when injected 
intraperitoneally into three-week-old PCV2 naïve pigs. When the same semen that contained 
PCV2a or PCV2b was extended and used for AI in PCV2 naïve gilts, transmission of PCV2 
did not occur to inseminated gilts or gilt progeny (Madson et al., 2009d). Other groups have 
also failed to infect PCV2 negative gilts or their offspring following AI with PCV2 
contaminated semen (Grasland et al., 2008). Semen extender used for AI has little effect on 
PCV2 viability in semen (Madson et al., 2009d). The lack of PCV2 transmission in the AI 
model using contaminated semen from PCV2 infected boars suggests that infectivity of 
PCV2 via AI is dose dependent (Madson et al., 2009d). PCV2-associated reproductive failure 
was experimentally reproduced in PCV2 naïve sows following AI with extended semen 
spiked with 5 ml of cell culture propagated PCV2 (104.2 TCID50 per ml) (Madson et al., 
2009c). Sows were viremic up to 15 weeks following AI, maintained pregnancy to term 
without clinical signs of disease and delivered large numbers of mummified fetuses. The 
reproducibility of in utero fetal infection was also demonstrated in seropositive sows using 
the PCV2-spiked semen model (Madson et al., 2009a). Seropositive sows were viremic for a 
short duration (1-2 weeks), had no clinical signs of disease, but delivered PCV2 viremic live-
born piglets in the absence of increased non-viable piglets.  
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In a different investigation, 20 PCV2 negative sows were inseminated with either 
PCV2 negative semen (n=10) or PCV2 positive semen (n=10) during estrus. At 30 days of 
gestation one sow in the positive semen group developed PCV2 viremia. Length of sow 
viremia, amount of PCV2 DNA in semen, and whether the semen was extended was not 
reported; nevertheless, the sow farrowed a normal litter of piglets (Gava et al., 2008).  
C. PCV2 semen testing  
 The significance of PCV2 detection in semen was largely unknown until recently 
when it was shown that PCV2 was infectious in a bioassay model (Madson et al., 2009d). 
Cell culture assays for PCV2 are difficult to conduct because semen is cytotoxic to cell 
culture lines by itself (Medveczky et al., 1981; Schultz et al., 1982; Weiblen et al., 1992) and 
because PCV2 is a non-cytopathic virus (Tischer et al., 1987; Allan et al., 2000). However, 
successful PCV2 virus isolation from raw semen samples has been reported by Kim et al. 
(2001, 2003). More sensitive PCR methodologies are routinely used to demonstrate PCV2 
DNA is in semen. Detection of PCV2 DNA in semen has been demonstrated by nested-PCR 
(Larochelle et al., 2000; Kim et al., 2001; Kim et al., 2003b; McIntosh et al., 2006b) and 
quantitative real-time PCR (Pal et al., 2008) for both naturally exposed and experimentally 
infected boars.   
 A multiplex nested-PCR was developed for the detection of both PCV1 and PCV2 in 
semen. Sixty raw semen samples were centrifuged and aliquoted into seminal plasma, non-
sperm cell fraction, and sperm head fraction. Twenty-eight semen samples (46.7%) were 
positive for PCV2 DNA. PCV2 DNA was detected in all 28 seminal plasma samples, but 
only 11 and four of the non-sperm cell and sperm head fractions were found to contain PCV2 
DNA, respectively (Kim et al., 2001). This same group also tested 98 semen fractions for the 
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presence of PCV1, PCV2, and PPV using a multiplex nested PCR reaction. Twenty-six of 98 
whole semen samples (26.5%) were found to contain PCV2 DNA. When whole positive 
semen was fractionated and tested; 26/26 seminal plasma fractions, 9/26 non-sperm cells 
fractions, and 3/26 sperm head fractions were positive for PCV2 DNA (Kim et al., 2003b).  
 More recently, Pal et al. (2008) using a quantitative real-time PCR with an internal 
positive control found semen cell fractions to contain more DNA than seminal fluid. 
Furthermore, quantitative analysis in raw semen was comparable to cell fraction samples for 
detection of PCV2 DNA (Pal et al., 2008).    
D. Prevalence of PCV2 in semen  
Presence of  PCV2 DNA in boar semen is variable and depends on age (McIntosh et 
al., 2006b; Reicks et al., 2007; Schmoll et al., 2008) and breed (McIntosh et al., 2006b). In 
one Canadian boar stud, semen PCV2 shedding was detected in 13 of 43 boars over a nine 
month period. The overall detection rate was 3.3% (30 of 903 semen samples). Duroc and 
Landrace boars and boars less than 12 months of age were found to shed more PCV2 DNA in 
semen. In 30 and 49 Korean boar centers, PCV2 DNA was detected in 28 of 60 (47 %) and 
26 of 98 (27 %) semen samples, respectively (Kim et al., 2001; Kim et al., 2003b). A 
different group found 18% (86/472) of semen samples from two German boars studs (22/96 
and 28/176), one Austrian boar stud (12/110), and on-farm boars from 30 Austrian herds 
(24/90) to be positive for PCV2 DNA. Additionally, it was confirmed that PCV2a and 
PCV2b can be present in semen within the same herd (Schmoll et al., 2008). Of 240 boars 
tested in four U.S. studs, 25.4% (61/240) of the semen samples contained PCV2 DNA. Sixty 
semen samples were tested per stud with individual studs having 23/60, 14/60, 14/60 and 
10/60 positive boars (Reicks et al., 2007). Similarly, 22% (67/304) of semen samples 
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collected from 4 Brazilian boar studs were positive for PCV2 DNA in semen (Ciacci-Zanella 
et al., 2007). In Sweden, none of the 78 tested boar semen samples exported to Norway were 
positive for PCV2 DNA (Wallgren et al., 2008). With age and breed differences aside, 
collectively, the literature supports that approximately 20% of individual boars within a stud 
are shedding PCV2 DNA in semen at any particular time point.   
 
Control of PCV2-associated disease 
Managing and controlling PCVAD in affected herds has evolved in recent years with 
the introduction of multiple commercial killed PCV2 vaccines. Prior to the availability of 
commercial PCV2 vaccines, good production practices with elimination of stressful pig-
associated events and coinfections were promoted for controlling disease (Madec et al., 
1999). Serotherapy was also implemented as a control measure for PMWS affected herds. 
The goal of serotherapy was to inject growing pigs with serum from immunized market 
weight animals that were previously infected or survived clinical disease in the growing 
phase. Initial field reports involving serotherapy were promising with reduction of morbidity 
and mortality (Ferreira et al., 2001; Waddilove et al., 2002). In a controlled study, 
serotherapy did not prevent infection, development of PCV2-associated lesions, or disease in 
challenged pigs intraperitoneally injected with acute or convalescent serum containing PCV2 
DNA or anti-PCV2 antibodies (Thomas et al., 2007). A live PCV1-2 chimeric vaccine did, 
however, protect against PCVAD and infection. From this information the authors concluded 
that serum therapy may potentiate PCVAD whereas the use of commercial killed vaccines 
was effective in minimizing disease (Thomas et al., 2007).   
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Preceding the availability of commercial PCV2 vaccines, Pogranichniy et al (2004) 
experimented with PCV2 inactivation by ultraviolet irradiation or binary ethylenimine to 
immunize CDCD pigs on day 0 and 14 (days of age). Pigs were immune stimulated with 
KLH/IFA on DPI 7 and 21 or infected with PRRSV on DPI 27. All pigs were challenged 
with PCV2 at 24 days of age. Vaccinated pigs continued to gain weight after PCV2 challenge 
with mortality rate reaching 20% in one group. In contrast, the mortality in the non-
vaccinated group reached 70% after PCV2 inoculation (Pogranichniy et al., 2004).  
The ORF2-associated capsid protein of PCV2 is immunogenic and infected pigs 
develop specific antibodies (Nawagitgul et al., 2002; Blanchard et al., 2003b). Secreted 
capsid protein has been proposed as the ideal antigen for PCV2 vaccination (Fan et al., 
2008). When compared to PCV2 DNA vaccination, vaccination with 2 doses of ORF2-
associated capsid protein expressed in a baculovirus-system was more effective and 
completely inhibited PCV2 replication following PCV2 challenge (Blanchard et al., 2003a). 
A chimeric clone (PCV1-2) was directly injected into the superficial inguinal lymph node of 
eight, 3-4 week-old pigs. Seroconversion to PCV2 capsid antigen, but not PCV1 was 
detected (Fenaux et al., 2003). Moreover, inoculated pigs also had less severe gross and 
microscopic lesions compared to eight PCV2 challenged pigs (Fenaux et al., 2003). In a 
follow-up experiment, 48 pigs were divided into four equal groups with the chimeric PCV1-2 
clone injected into groups 1-3. Forty-two days after injection, all pigs were challenged with 
wild-type PCV2. Injection of chimeric PCV1-2 blocked detectable PCV2 viremia, 
significantly reduced PCV2 genomic copies in lymph nodes (P < 0.0001), and decreased 
PCV2-associated lesions compared to controls (Fenaux et al., 2004). After 11 serial passages 
in PK-15 cells, the PCV1-2 chimeric clone did not mutate. When passaged in pigs, a tracker 
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mutation reverted back to its original sequence (V79F) and was stable thereafter indicating 
the PCV1-2 chimeric clone was genetically secure and a good vaccine candidate (Gillespie et 
al., 2008). Recombinant adenovirus- or Lactococcus lactis-expressed PCV2 capsid protein 
has also been demonstrated to induce PCV2 specific antibodies and protect against disease 
after injection or oral consumption (Wang et al., 2006; Wang et al., 2007; Wang et al., 2008).  
A. PCV2 vaccination in the growing pig 
At the present time there are three commercially available PCV2 vaccines. All are 
based on the PCV2a genotype and directed to combat PCVAD in growing pigs. The vaccines 
are licensed for administration during the nursery phase of production (3-4 weeks of age). 
Several recent studies have tested the efficacy of PCV2 vaccination in growing pigs. 
Seventy-two conventional pigs were divided into five groups. One-half of the pigs were 
vaccinated at 4 and 6 weeks of age with a two dose PCV2 vaccine (Circumvent®, 
Intervet/Schering Plough, Boxmeer, The Netherlands). Fifteen days after the second dose, 
four groups were challenged intranasally with one of four PCV2 isolates (two PCV2a and 
two PCV2b isolates). PCV2 vaccinated pigs developed IgG and serum neutralizing 
antibodies directed against PCV2 prior to inoculation. None of the vaccinated pigs developed 
viremia post inoculation, and vaccination significantly (P > 0.05) reduced nasal and fecal 
shedding of PCV2 (Fort et al., 2008). There was no difference between PCV2a and PCV2b 
inoculated pigs demonstrating the PCV2 vaccine was cross-protective. In a different 
experimental evaluation, Opriessnig et al. (2008) vaccinated three-week-old conventional 
pigs with 2 ml of Suvaxyn® PCV2 One Dose (Fort Dodge Animal Health, Inc) 
intramuscularly or intradermally (needless injection system) and later challenged pigs with 
PRRSV, PCV2, or both 28 days post PCV2 vaccination. Vaccinated pigs developed PCV2 
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specific IgG-, IgM- and serum neutralizing-antibodies between 2 and 4 weeks post-
vaccination. Differences between vaccination routes were not identified and vaccinated pigs 
had significantly less PCV2 associated lymphoid lesions compared with non-vaccinated 
challenge controls (Opriessnig et al., 2008a). 
Field studies have demonstrated the use of PCV2 vaccine increase growth parameters 
and economic benefits. A study involving 1,519 conventional pigs showed the use of a PCV2 
vaccine (Ingelvac®, CircoFLEX™, Boehringer Ingelheim, Vetmedica Inc) significantly 
reduced (P > 0.0001) viral serum load and duration of viremia. Vaccination also decreased 
mortality by 53% and reduced the number of coinfections when compared to non-vaccinates 
(Kixmoller et al., 2008). This vaccine (Ingelvac®, CircoFLEX™, Boehringer Ingelheim, 
Vetmedica Inc) did improve average daily gain and reduced time to market (Fachinger et al., 
2008). Similar reduction in clinical signs of disease, decreased mortality, and improved 
growth were observed in other field scenarios (Horlen et al., 2008; Bischoff et al., 2009). 
Maternally derived antibody titers at vaccination had no apparent reduction on vaccine 
efficacy (Kixmoller et al., 2008; Bischoff et al., 2009).      
B. PCV2 sow vaccination 
There is only one vaccine currently marketed for sows (Circovac®, Merial, Lyon, 
France); however, other vaccines have been used in sows (Opriessnig et al., 2009a). The two 
dose sow vaccine is labeled for use to induce passive immunization of piglets via dam 
colostrum. Dam vaccination is recommended to be done 2-4 weeks prefarrow and will induce 
PCV2 specific antibodies post vaccination in naïve gilts (Charreyre et al., 2005). A 
significant increase in production parameters involving multiple herds in different 
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geographical locations has been reported in Europe using Circovac® as a prefarrow 
vaccination. 
In Denmark, sow PCV2 vaccination increased the number live-born piglets, total born 
pigs, and litters/sow/year while decreasing sow mortality, stillborn fetuses, and dam non-
productive days in multiple herds (Schøning et al., 2008; Bech et al., 2008; Kunstmann et al., 
2008). Moreover, in over 100 French herds, Circovac® sow vaccination resulted in similar 
production benefits (Hérin et al., 2007; Delisle et al., 2008), which was also confirmed in 233 
(Joisel et al., 2007a; Joisel et al., 2007b) and 277 (Joisel et al., 2008) German sow farms.  
There are few experimental studies evaluating PCV2 vaccination followed by PCV2 
challenge in mature sows. Madson et al. (2009) vaccinated PCV2 naïve pregnant dams at 28 
days of gestation using a one-dose baculovirus-expressed PCV2 vaccine (Ingelvac®, 
CircoFLEX™, Boehringer Ingelheim, Vetmedica Inc) followed by oro-nasal PCV2 challenge 
at 56 days of gestation. Vaccinated dams developed neutralizing antibodies against PCV2 
prior to challenge and PCV2 viremia was not detected in these dams during gestation. 
However, PCV2 in utero infection was detected at parturition in 10% (5/50) of the piglets 
born to vaccinated sows (Madson et al., 2009b). Similarly, in utero  infection was observed 
in the spiked semen model when PCV2 naïve dams were vaccinated (Ingelvac®, 
CircoFLEX™, Boehringer Ingelheim, Vetmedica Inc) 8 weeks prior to artificial insemination 
(Madson et al., 2009a). 
C. PCV2 boar vaccination 
 Since the introduction of commercial PCV2 vaccines, two studies have evaluated 
vaccine efficacy in boars. In one report, the authors vaccinated 15 of 30 boars entering a boar 
stud isolation unit with a single dose PCV2 vaccine (Suvaxyn® PCV2 One Dose, Fort Dodge 
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Animal Health, Inc). All boars were seropositive for anti-PCV2 antibodies upon entry into 
the isolation facility and 23 of 30 were either PCV2 viremic (12/23) or shedding PCV2 DNA 
in feces (23/23) upon entry into the isolation facility. Vaccinated boars had a higher average 
ELISA sample-to-positive ratio of anti-PCV2 antibodies compared to non-vaccinates in the 
study, but significant differences were not found between groups for fecal shedding and 
PCV2 viremia during the 84 days of the study. Boar vaccination did not reduce semen 
shedding after entry into the stud on day 30 (Erlandson et al., 2007). The second boar vaccine 
study involved vaccination of 8/16 PCV2 naïve landrace boars at five months of age with a 
single-dose PCV2 vaccine (Ingelvac®, CircoFLEX™, Boehringer Ingelheim, Vetmedica 
Inc). All boars were inoculated with PCV2 35 days later. Post-challenge, vaccinated boars 
became viremic and were positive for PCV2 DNA in semen at 4, 7, 14, and 21 days. 
Compared to non-vaccinated boars, vaccinated boars had lower quantities of PCV2 DNA in 
serum and semen after 4 days post challenge (Reicks et al., 2008).   
 With limited information in the literature concerning boar vaccination, speculations 
on efficacy, timing, dose, number of vaccinations, or type of vaccine cannot be made at this 
time. Further research is needed to test whether PCV2 boar vaccination will reduce semen 
shedding.  
 
Economic Impact of PCV2 
PCV2 has been circulating in the global swine population at a subclinical level for 
multiple decades resulting in unknown economic losses to the industry. The recent advent of 
killed commercial PCV2 vaccines has highlighted the cost of viral infection, especially in 
clinically affected herds.  
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Prior to PCV2 vaccine availability, one U.S. herd experienced severe PCVAD in 12-
16 week pigs. The estimated cost of the clinical outbreak was $6.60 per animal in a 1,000 
head finisher when compared to the previous two years. Mortality, average daily gain, and 
feed efficiency were used to calculate the economic impact (Gillespie et al., 2006). It is likely 
that individual farms and production systems will vary based on the return on investment 
(ROI) after implementing PCV2 vaccine. Other or concurrent diseases, management, and 
marketing strategies will also contribute to ROI. In one report, mortality, average daily gain, 
lightweight finishing culls, carcass weight, and loin muscle depth were used to analyze the 
impact of PCV2 vaccination on 600 treated and 600 control pigs. A calculated ROI of $4.38 
was obtained in this particular assessment (King et al., 2008)  
Economical assessment of PCV2 circulation within a breeding herd has not been 
conducted to date. This is likely due to lack of PCV2 research in breeding herds and the lack 
of availability of an approved sow vaccine in the U.S. Preliminary data from Europe 
indicates economic benefit in vaccinating sows. Sows vaccinated with two doses of a killed 
vaccine (Circovac®, Merial, Lyon, France) had significantly higher numbers of weaned 
pigs/sow/year and more live-born pigs/litter.  Additionally, farrowing rate, return to estrus 
intervals, and total born pigs were improved as compared to periods prior to vaccination 
implementation (Vila et al., 2009). Future assessments are needed to fully understand the 
significance and the economic impact of PCV2 circulation within breeding herds.   
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Abstract 
Porcine circovirus type 2 (PCV2) is an economically important swine pathogen, and 
causes porcine circovirus-associated disease (PCVAD) in pigs worldwide. Currently two 
genotypes of PCV2 are circulating in U.S. swine herds, PCV2a and PCV2b. The objectives 
of the study were to (1) evaluate the amount of PCV2 DNA present in semen over time, (2) 
compare and correlate incidence and amount of PCV2 present in semen to that present in 
serum and blood swabs and (3) determine if there are differences in shedding patterns 
between PCV2a and PCV2b. Fifteen 7-month-old PCV2 naïve Landrace boars were 
randomly allocated to three treatment groups: Group 1 (n = 3) served as negative controls, 
and groups 2 (n = 6) and 3 (n = 6) were intranasally and intramuscularly inoculated with 
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PCV2a and PCV2b, respectively. Semen, serum, and blood swab samples were collected up 
to 90 days post inoculation (DPI) and necropsies were performed on DPI 23, 48 and 90. 
Larger quantities of both PCV2a- and PCV2b- DNA were detected earlier in serum and 
blood swab samples than in raw semen of experimentally inoculated boars. The incidence 
and duration of presence of PCV2 DNA in semen varied among boars; however, intermittent 
shedding was not observed. In all sex glands, PCV2 DNA was detected by PCR; however, 
PCV2 antigen was not detected by immunohistochemistry and PCV2 had no effect on sperm 
morphology. Differences in shedding patterns between PCV2a and PCV2b were not 
observed under the study conditions.  
 
Introduction 
 Porcine circovirus type 2 (PCV2) is a small, non-enveloped, closed circular single-
stranded DNA virus that has been associated with many disease entities including weight 
loss, pneumonia, diarrhea, and reproductive problems in swine.28 Porcine circovirus 
associated disease (PCVAD) was first reported in high health herds in Canada in 1991,12 and 
has since been reported in swine worldwide.41   
 Transmission of PCV2 in swine populations is not well understood; however, the 
main route of infection is thought to be fecal-oral.41 Detection of PCV2 DNA has been 
reported in secretions and excretions including feces, urine, saliva, ocular fluid, nasal 
secretions, colostrum, and semen of infected pigs.4,19,21,42,43 Recently,  there has been a 
marked increase in the incidence of PCVAD in North America and it is thought by some to 
be associated with introduction of a distinct cluster of PCV2, PCV2b.9,14 Although previous 
epidemiological investigations found no association with the use of artificial insemination 
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(AI) as a risk factor for PCVAD,6,22,37,46 AI has not been ruled out as a way to quickly 
disseminate PCV2 through populations. 
 PCV2 DNA in semen has been detected by nested17,18,21,23 and quantitative real-time 
PCR32 in both naturally and experimentally infected boars and typically is not associated 
with clinical disease in sexually mature boars. Previously, experimental inoculation of PCV2 
in naïve boars revealed that PCV2 DNA was detected by nested PCR (nPCR) as early as 5 
days post inoculation (DPI) and intermittently thereafter up to DPI 47.21 Furthermore, 
shedding of PCV2 DNA in semen was detected up to 27.3 weeks in naturally infected boars, 
younger boars (less than 12 months of age) were more likely to shed PCV2 DNA in semen, 
and PCV2 infection had no effect on sperm morphology.23 Previous reports have most 
consistently demonstrated PCV2 DNA in the non-sperm fractions of raw semen in naturally 
infected boars.17 In contrast, more recent reports have demonstrated that PCV2 DNA is found 
in higher concentrations in the sperm rich fraction when compared to seminal plasma 
fractions.32 In addition, when raw semen was compared to sperm rich fractions of 
experimentally inoculated boars, similar quantities of PCV2 DNA were detected by 
quantitative real-time PCR.32  
 Prevalence of porcine circovirus DNA in semen of naturally infected boars as 
detected by nPCR is variable.17,18,23 Previous reports indicate that PCV2 DNA was detected 
in 13 of 43 Canadian boars originating from a single boar stud with an overall detection rate 
of 3.3% (30 of 903 semen samples).23 In 30 Korean swine herds, PCV2 DNA was detected in 
28 of 60 (47 %) semen samples tested.17 The same group, detected PCV2 DNA in 26 of 98  
(27 %) semen samples obtained from 49 Korean swine herds.18  
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 PCV2 viral antigen detection by immunohistochemistry (IHC) has been documented 
in reproductive organs of naturally and experimentally infected boars. PCV2 antigen was 
present in infiltrating macrophages of the tunic albuginea, interstitial macrophages and 
germinal epithelial cells in the testes and in infiltrating macrophages of the epididymis in 4-
week-old piglets 3 weeks after experimental co-inoculation with PPV and PCV2.16 Natural 
PCV2 infection in a clinically affected mature boar was associated with the presence of 
abundant PCV2 antigen in the interstitium of seminal vesicles.26  
 The objectives of this study were to evaluate the amount of PCV2 present in semen 
over time, to correlate incidence and amount of PCV2 present in semen compared to 
incidence and amount present in serum and blood swab samples, and to determine if there are 
differences in semen shedding patterns between PCV2a versus PCV2b. This information is 
needed to formulate management decisions in boar studs and breeding herds.  
  
Material and Methods 
Animals and housing 
 Fifteen purebred, male, Landrace pigs were segregated early weaned from a single 
farm and brought to Iowa State University infectious disease isolation facility at 
approximately 3 weeks of age. The source farm was known to be free of porcine reproductive 
and respiratory syndrome virus (PRRSV) and swine influenza virus (SIV) by frequent 
serologic surveillance of the herd.  Animals were group housed until 6 months of age and 
then were individually penned. The pens were 2 × 2 m with solid 1.5 m high partitioning. 
Each room had a separate collection pen of similar dimension with a mounting apparatus for 
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semen collection. Boars were fed approximately 2.5 kg of a balanced corn-soybean base 
ration daily. 
Experimental design 
 At 7 months of age, boars were randomly allocated into three groups. Group 1 (n = 3) 
served as negative controls, and groups 2 (n = 6) and 3 (n = 6) boars were inoculated with 
PCV2a or PCV2b, respectively. Randomly selected boars from each group were euthanized 
at three different time points during the study by lethal overdose of intravenous pentobarbital. 
Necropsies were performed on one boar from group 1 and two boars from each of groups 2 
and 3 at DPI 23, DPI 48, and DPI 90. The experimental protocol was approved by the Iowa 
State University Institutional Animal Care and Use Committee. 
Inoculation 
 Group 2 boars were inoculated intranasally (3mL) and intramuscularly (2mL) with a 
stock of PCV2a isolate ISU 40895 with an infectious titer of 104.5 TCID50 per ml. The PCV2a 
isolate was originally obtained from a clinical PCVAD affected pig in a western Iowa herd in 
1998 and has been shown to cause PCVAD in previous experimental studies using growing 
pigs.25,29 Group 3 boars were inoculated intranasally (3mL) and intramuscularly (2mL) with a 
stock of PCV2b isolate NC 16845 with an infectious titer of 104.3 TCID50 per ml. The PCV2b 
isolate was acquired from a finishing pig affected with severe PCVAD in North Carolina in 
2006. Both PCV2a and PCV2b infectious virus stocks were generated similarly by 
transfecting PK-15 cells with respective PCV2a and PCV2b infectious DNA clones as 
described previously.8 The PCV2a and PCV2b isolates shared 95.7% nucleic acid homology. 
The virus inocula were stored at -80°C until experimental inoculation. 
66 
 
Sample Collection 
 Semen and serum samples were collected from all boars prior to PCV2 inoculation on 
DPI -3. Semen, serum, and blood swabs36 were collected on DPI 2, 4, 6, 9, 13, 16, 20, 23, 27 
and every week thereafter until DPI 90. In addition, serum samples were collected on DPI 1 
from all boars. For sample collection, individual animals were moved into the collection pen, 
and once mounted on the collection apparatus, gloved-hand semen collection was initiated 
using an insulated mug lined by a 2 liter disposable plastic bag with tear-away filter.a Post 
ejaculation, the filter portion of the collection bag containing the gel fraction was torn off and 
discarded. Bags containing raw semen were sealed and placed immediately into a thermal 
container and transported to the laboratory for processing. 
 Concurrently, during semen collection, serum and blood swabs were obtained while 
the boar was mounted on the collection apparatus. Whole blood was collected by 
venapuncture of an ear vein and collected into a 300 µL serum gel capillary tube.b Similarly, 
blood swabs were obtained using individual packaged sterile swabsc and placed into a sterile 
5mL polystyrene round-bottom tubed containing 0.5mL sterile saline.  After capillary tubes 
were centrifuged, the serum and blood swabs were stored at -80°C until tested. 
Semen sample processing  
 Collection bags containing raw semen samples were gently agitated by inverting the 
sealed bag to re-suspend spermatozoa equally after transportation. Raw semen was carefully 
allocated into a sterile 1.5mL centrifuge vial using a sterile 10mL graduated serology pipette 
and stored at -80°C until testing.  
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Semen morphology 
 For morphology analysis, well-mixed raw semen from each ejaculate was initially 
diluted at a rate of 1:10 to 1:20 with pre-warmed extender.e Subsequently, the diluted semen 
was mixed with an equal volume of buffered formal salinef for preservation. A full 
morphology differential was performed on each sample with wet mounts and a phase contrast 
microscope at 1,000× under oil.3,15,20   
Serology 
 Serum samples were tested for the presence of anti-PCV2 IgG antibodies using an 
ELISA based on PCV2 recombinant major capsid protein (ORF2) as previously described.24 
Samples with a sample-to-positive ratio equal or greater than 0.2 were considered positive. 
PCR 
 Serum, blood swab samples, and raw semen were tested for the presence and amount 
of PCV2 DNA by quantitative real-time PCR as previously described.30,32 An internal 
positive control composed of the PCV2 genome clone with 25 nucleotide substitution 
beginning at position 1582 (mutated PCV2) was added to the raw semen samples prior to 
DNA extraction for quality control as previously described.32 In addition, selected tissue 
samples from each boar (lymph node, testes, epididymis, bulbourethral gland, seminal 
vesicle, and prostate) collected at necropsy were also tested for PCV2 DNA. Briefly, DNA 
was extracted from 0.25g tissue using a commercially available isolation kitg following the 
manufactures protocol and recommendation. The PCR parameters used in this study were 
essentially the same as previously described.30 
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Necropsy   
 At necropsy, lungs were evaluated for the presence of pneumonia lesions (0-100% of 
the lung affected by lesions),11 lymph nodes were examined for evidence of enlargement, and 
additional gross observations in other organ systems were recorded.  Sections of all major 
organ systems were collected in 10% buffered formalin. Tissue sections collected included 
testes, epididymis, seminal vesicles, bulbourethral gland, prostate, penile tissue, four lung 
sections (cranial, middle, caudal and accessory lobes), liver, spleen, kidney, tonsil, ileum, 
colon, thymus, lymph nodes (tracheobronchial, mediastinal, mesenteric, iliac, superficial 
inguinal), myocardium, and urinary bladder.  
Microscopic evaluation and immunohistochemistry  
 Formalin-fixed tissue samples were routinely processed, stained with hematoxylin 
and eosin and evaluated in a blinded fashion by a veterinary pathologist. Microscopic lesions 
characteristic of PCV2-infection (depletion of germinal center lymphocytes and histiocytic 
replacement or infiltration) in lymphoid tissues (lymph nodes, thymus, tonsil, and spleen) 
were scored as previously described.29 IHC staining using rabbit polyclonal antisera for 
PCV2 antigen detection was performed on lymphoid tissues, testes, epididymis, seminal 
vesicles, bulbourethral gland, prostate, and penile tissue.45 The presence and amount of 
PCV2 antigen was scored as previously described.29 
Statistical analysis 
 Data was assessed for overall quality, including normality. Differences in amount of 
PCV2 DNA in serum, semen, and blood swab samples were analyzed using repeated 
measures analysis of variance (MANOVA) with DPI as fixed factor followed by non-
parametric Kruskal-Wallis one-way ANOVA. Data until DPI 48 were included for the 
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analysis. Differences in amount of PCV2 DNA in tissues (lymph node, testes, epididymis, 
seminal vesicles, bulbourethral gland, and prostate) and normal sperm morphology were 
assessed using non-parametric Kruskal-Wallis one-way ANOVA. Calculations were done 
using statistical software, SAS®.h Outliers were excluded from the analysis.  
 
Results 
Serology 
 All boars had passively acquired anti-PCV2 antibodies at weaning which decayed as 
expected. By 4 months of age all 15 boars were negative for anti-PCV2 antibodies. Group 1 
boars (negative controls) remained negative for anti-PCV2 antibodies for the duration of the 
study (Table 1). After experimental inoculation at approximately 7 months of age, anti-
PCV2-specific IgG antibodies were first detected on DPI 13 in 3/6 group 2 boars (PCV2a-
inoculated) and all boars in this group had detectable anti-PCV2 antibodies by DPI 23. Five 
of six boars in group 3 (PCV2b-inoculated) developed anti-PCV2-specific antibodies 
between DPI 16 and 27. The PCV2b boar that did not develop anti-PCV2 antibodies was 
euthanized at 23 DPI as predetermined by the experimental design.   
Quantitative real-time PCR 
 Serum samples. PCV2 DNA was not detected in serum samples of group 1 boars 
during the study (Table 1). PCV2 DNA in serum samples was detected in all group 2 boars 
by DPI 6 with the earliest detection on DPI 2 in 3/6 boars. Length of viremia ranged from 18 
to 43 days between individual group 2 boars with the last detection of PCV2 DNA in serum 
samples on DPI 48. PCV2 DNA in serum samples of group 3 boars was first detected on DPI 
6 in 3/6 boars and all boars in this group became viremic by DPI 16. Length of viremia 
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ranged from 8 to 84 days between individual group 3 boars and PCV2 DNA was still present 
in serum samples of one of the boars at the termination of the study on DPI 90. Figure 1 
summarizes the mean log transformed amounts of PCV2 DNA in positive serum samples 
during the study. 
 Semen samples. Inhibition of PCV2 DNA detection in semen samples was not 
observed in any of the semen samples as noted by consistent internal positive control levels. 
PCV2 DNA was not detected in raw semen samples collected from group 1 boars during the 
study (Table 1). The amount of detectable PCV2 DNA in semen varied among individual 
group 2 boars from 221 to 103,336 genomic copies/mL raw semen with peak shedding 
between 16 and 23 DPI. All group 2 boars were PCR positive on raw semen with shedding 
intervals ranging from 1 collection point to 11 consecutive collections (49 days). Intermittent 
shedding was not observed.  In group 3, 5/6 boars shed PCV2 DNA in raw semen with first 
and last detection on DPI 9 and 90, respectively. The amount of detectable PCV2 DNA in 
positive semen samples was similar to that of group 2 boars and shedding intervals ranged 
from 0 to 77 days (Fig. 2).       
 Blood swab samples. Group 1 blood swab samples were negative for PCV2 DNA at 
all collection time points tested (Table 1). PCV2 DNA in blood swab samples of group 2 
boars was first detected on DPI 2, and all boars were positive for PCV2 DNA by DPI 9 and 
remained positive until termination of the study. Earliest detection of PCV2b DNA in group 
3 boars was on DPI 9, PCV2 DNA was present in all blood swab samples by DPI 13, and 
PCV2 DNA was still present in blood swab samples on DPI 90. The mean log transformed 
PCV2 genomic copy numbers in positive blood swab samples over time are summarized in 
Fig. 3. 
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 PCV2 DNA was not detected in any semen samples on DPI 2 (0/12) and 4 (0/12). For 
DPI 6 and 9, 1/12 and 3/12 animals were PCV2 PCR positive on semen and only data 
starting from DPI 13 were used for statistical analysis. PCV2 DNA was detected in 2/12 
blood swab samples from 2 of 12 boars on DPI 6 and data prior to DPI 9 was excluded from 
the statistical analysis. The amount of PCV2 DNA in serum samples was significantly (P < 
0.05) higher than in semen from DPI 13 to 20.  Similarly, the amount of PCV2 DNA in 
serum samples was significantly (P < 0.05) higher than in blood swabs from DPI 13 to 20 (P 
< 0.05) and PCV2 DNA was detected earlier in serum samples than in semen samples or 
blood swabs. 
 Tissue samples. Group 1 boar tissues (lymph nodes, testes, epididymis, bulbourethral 
gland, seminal vesicle, and prostate) were negative for PCV2 DNA on DPI 23, 48, and 90. In 
contrast, lymph nodes and sex glands tested from all group 2 and 3 boars were positive for 
PCV2 DNA on each necropsy day. The group mean log transformed PCV2 genomic copy 
numbers in 0.25g of lymph node tissue for group 2 and 3 boars was 106±0.15 and 106.1±0.62, 
respectively (data not shown). Table 2 summarizes the amount of PCV2 DNA (genomic copy 
numbers per 0.25g tissue) in the sex glands of PCV2 inoculated boars. Significant differences 
in the amount of PCV2 DNA present in tissues were not observed between groups 2 and 3 or 
when compare by DPI (P > 0.05).   
Morphology 
 Mean percent normal sperm morphology prior to experimental inoculation was 79%, 
70%, and 68% for group 1, group 2, and group 3 boars, respectively. Sperm morphology was 
not significantly different between PCV2 inoculated and non-inoculated boars or PCV2a and 
PCV2b groups during weekly morphology evaluations during the study (data not shown).  
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 Macroscopic and microscopic evaluation  
 At DPI 23, no macroscopic or microscopic lesions were present in the group 1 boar.  
Macroscopic lesions in group 2 boars included moderately enlarged lymph nodes (2/2) and 
mottled-tan lungs (2/2) with 18-29% of the lungs grossly affected by lesions.  
Microscopically, 2/2 group 2 boars had mild to moderate nonsuppurative interstitial 
pneumonia, 1/2 had mild lymphoid depletion, and 1/2 had mild multifocal lymphocytic 
interstitial nephritis. Group 3 macroscopic lesions were limited to mottled-tan lungs in 2/2 
boars with 4-9 % of the lungs grossly affected by lesions. Microscopic lesions in group 3 
boars included mild multifocal nonsuppurative interstitial pneumonia in 2/2 boars, and mild 
multifocal lymphocytic interstitial nephritis in 1/2 boars. 
 At DPI 48, no macroscopic lesions were present in group 1 or 2 boars, and the group 
1 boar had no microscopic lesions. Microscopically, 1/2 group 2 boars had mild lymphoid 
depletion and multifocal mineralization in the prostate gland. In group 3, 1/2 boars had mild 
lymphadenopathy, 2/2 had moderate nonsuppurative interstitial pneumonia, 2/2 had mild 
lymphoid depletion, 2/2 had mild multifocal lymphocytic interstitial nephritis, and 1/2 had 
accumulation of low numbers of macrophages within the testicular interstitium. 
 On DPI 90, the euthanized group 1 boar had mild multifocal bronchiolar associated 
lymphoid hyperplasia. Microscopically, 2/2 group 2 boars had mild to moderate 
nonsuppurative interstitial pneumonia, 1/2 had mild lymphoid depletion and 1/2 had mild 
bronchiolar associated lymphoid hyperplasia. Macroscopic lesions in group 3 boars included 
mild lymphadenopathy and mild interstitial pneumonia with 6% of the lungs grossly affected 
by lesions in 1/2 boars. Microscopically, 2/2 group 3 boars had mild multifocal 
nonsuppurative interstitial pneumonia, and 1/2 had mild lymphoid depletion.  
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IHC 
 PCV2 antigen was not detected in any of the control boars. Low amounts of PCV2 
antigen was detected in lymphoid tissues (lymph nodes, tonsil, and spleen) in 2/2 group 2 and 
2/2 group 3 boars on DPI 23. One of two boars in group 2 and group 3 were PCV2 IHC 
positive in lymph nodes and tonsil on DPI 48.  No IHC signal was observed in lymphoid 
tissues of group 2 and 3 boars on DPI 90. PCV2 antigen was not detected in testes, 
epididymis, seminal vesicles, bulbourethral gland, prostate or penile tissue of necropsied 
boars in the study.  
 
Discussion 
 Currently, there is little information available in the peer-reviewed literature on 
shedding of PCV2 in semen. With other swine viruses such as PRRSV, extensive testing of 
serum, semen or blood swabs is done on a routine basis to monitor and decrease the risk of 
transmission.10,35,36,39,40  The objectives of this study were to determine if there is a difference 
in shedding pattern or quantity of virus in semen of boars infected with distinct PCV2 
genotypes and to correlate the incidence and amount of PCV2 within serum and blood swabs 
to that in semen. 
 In a previous PCV2 experimental boar inoculation model, detection of PCV2 DNA in 
semen was intermittent throughout the 47 days post-infection after intranasal inoculation.21 In 
the current study, the results indicate that shedding of PCV2 DNA in boar semen was 
continuous rather than intermittent. Differences in PCV2 DNA shedding between studies 
could be due to the low number of inoculated boars in both experiments, route of infection, 
differences in assays used for PCV2 detection, and differences in isolates used for 
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inoculation. In the current study, the boars were inoculated intranasally and intramuscularly 
to assure that all boars became infected at the same time and with a similar dose. This is not 
always possible by the intranasal route alone as pigs tend to sneeze or breathe hard during the 
inoculation process. In addition, it has been determined that real-time PCR has slightly better 
detection limits compared to nested PCR32 and there are differences in virulence among 
PCV2 isolates.27 
This is the first study to evaluate the amount of PCV2 DNA shed in semen of infected 
boars, and the results indicate that both PCV2a- and PCV2b- DNA are shed in low quantities 
in raw semen (221 to 103,336 PCV2 genomic copy numbers/mL). Moreover, we 
demonstrated that the amount of PCV2 in semen is lower than in serum.  
The inocula used in this study had an infectious titer of 104.3 TCID50 for PCV2b 
versus 104.5 TCID50 for PCV2a. PCV2b inoculated boars became viremic 3-7 days after 
viremia started in the PCV2a boars. This difference in time until detection of viremia onset 
could be due to the difference in amount of virus given at challenge; nevertheless, the inocula 
titer differences were minimal and both groups shed PCV2 DNA in semen at similar low 
quantities.  
Length of PCV2 shedding in semen varied among inoculated boars in this study.  In 
PCV2a-inoculated (group 2) boars, the narrowest incidence of detectable PCV2 DNA was 1 
collection point with the longest incidence of detection being 11 consecutive collections (49 
days). It should be noted that 2 boars within this group were shedding PCV2 DNA in semen 
but were randomly selected for necropsies on DPI 23 and 48, thus it is unknown how long 
shedding would have persisted in these boars. In the PCV2b-inoculated group (group 3), 1 
boar never shed detectable amounts of PCV2 DNA in semen. However, PCV2 DNA in 
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serum was first detected on DPI 16 and the boar was then euthanized on DPI 23 as 
predetermined by the experimental design. In all other inoculated boars, serum viremia 
preceded semen PCV2 DNA shedding. The range in days was 4-14 post serum detection. In 
addition, the boar that did not shed detectable amounts of PCV2 DNA in semen did however, 
have detectable levels of PCV2 DNA in tissues (lymph nodes, testes, epididymis, prostate, 
seminal vesicles, and bulbourethral gland) at necropsy.  Only 1 boar in group 3 stopped 
shedding prior to being euthanized. All other boars had detectable PCV2 DNA in semen at 
necropsy or until termination of the study. These results are supportive of similar 
observations in naturally infected boars where extended shedding of PCV2 DNA was 
observed in semen of young Landrace boars.23 In addition, the presence of PCV2 DNA in 
semen had no affect on morphology,23 which was further confirmed in this study. 
In the field, PCVAD is commonly associated with coinfections with other swine 
pathogens.7,33 In experimental PCV2 models, it has been confirmed that coinfections with 
Mycoplasma hyopneumoniae,29 PPV,1 and PRRS2,13,38 increase the incidence and severity of 
PCV2-associated lesions and disease. In the current study, rooms were cleaned daily and 
there were no new animal introductions. These conditions are considerably different than 
commercial boar studs and breeding herds. It can be hypothesized that environmental factors, 
introduction of naïve animals to the population, and coinfections may exacerbate the length 
of PCV2 shedding in semen which would further support observation of up 27.3 weeks of 
PCV2 shedding in semen of naturally infected boars.23   
 Recently, it has been shown that serum PCR is more sensitive than semen PCR for 
the detection of PRRSV in experimentally challenged boars early in the disease phase.35 
Moreover, there was agreement between blood swab samples and serum samples when used 
76 
 
for the detection of PRRSV RNA in the first 6 days post-challenge in boars.36   In the current 
study, PCV2 DNA was detected in serum prior to and in higher amounts than in semen or 
blood swab samples. In the later course of infection, blood swab samples remained positive 
for PCV2 DNA longer than semen and serum samples. One group 2 boar did not have 
detectable PCV2 in serum after DPI 34, yet quantitative real-time PCR detected PCV2 DNA 
in blood swab samples at all collection points thereafter including at termination of the study 
on DPI 90. Previously, in experimentally PCV2 inoculated gilts, plasma viremia was 
observed up to 21 days post-inoculation. However, peripheral blood mononuclear cells 
(PBMC) were positive out to 49 DPI in the same animals.34 Since blood swab samples 
contain erythrocytes, plasma and PBMC, it is reasonable to conclude that blood swab 
samples in the current study were positive due to cell-associated PCV2. It is possible that the 
lack of PCR positive blood swab samples in the early stages of infection were influenced by 
the low numbers of boars used. Cell associated PCV2 infection may not necessarily be 
associated with viremia or PCV2 DNA shedding in semen. 
 Nine out of twelve PCV2a and PCV2b inoculated boars had detectable amounts of 
PCV2 DNA in serum at necropsy. One PCV2b and two PCV2a inoculated boars necropsied 
at DPI 90 were not viremic; however, blood swab samples and tissues (lymph nodes and sex 
glands) were positive for PCV2 DNA. These results indicate and support that PCV2 DNA is 
cell associated in the later stages of infection. However, it is unknown how long PCV2 
remains in the cell associated state in the post viremic phase of infection. 
 PCV2 antigen was detected in sex glands of a naturally infected diseased boar.26 In 
contrast, in the current study no boar was clinically affected and PCV2 antigen was not 
observed in sex glands of inoculated boars. PCV2 DNA levels in all sex glands ranged from 
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103.3 to 107.3 PCV2 copy numbers per 0.25g tissue. In contrast, IHC staining for PCV2 
antigen was observed in lymphoid tissues at different necropsy points and this correlated 
with a minimum of 107.5 PCV2 DNA copies in 0.25g of tissue. Previously, it was estimated 
that 108 genomic copies of PCV2 are needed to detect viral antigen in tissues by IHC.5 It 
needs to be taken into account that the previously published PCR and IHC assays5 and the 
PCR and IHC assays used in this study30 are different and this might explain the slight 
discrepancies in detection limits between studies.   
 In summary, the results of the study indicate that both PCV2a- and PCV2b- DNA 
were present in semen and all sex glands of experimentally inoculated boars. The incidence 
of PCV2 DNA in semen and length of shedding may vary amongst individual boars. 
Furthermore, this study indicates that PCV2 DNA shedding in semen may be continuous 
rather than intermittent post infection. For boars in the early stages of infection with PCV2, 
serum appears to be the preferred sample for diagnostic testing. It remains to be determined if 
infectious PCV2 is shed in semen and a possible route of transmission and dissemination of 
PCV2 among swine populations. Furthermore, the effect of using PCV2-positive semen on 
herd reproductive performance needs to be further evaluated to make appropriate decisions 
on the amount of testing that is justifiable in boar studs. 
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Table 1. Summary of PCV2 DNA positive boars in serum, blood swab, and semen as determined by real-time PCR and anti-
PCV2-antibody positive pigs as measured by ELISA for non-inoculated (group 1) and boars inoculated with PCV2a (group 2) or 
PCV2b (group 3) over 90 days post inoculation (DPI).  
                     
*NA = not applicable
Group Sample DPI 
-3 1 2 4 6 9 13 16 20 23 27 34 41 48 55 62 69 76 83 90 
1 
                     
Serum PCR 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1 
Blood swab PCR NA* NA 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1 
Semen PCR NA NA 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1 
ELISA 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/2 0/2 0/2 0/2 0/1 0/1 0/1 0/1 0/1 0/1 
                      
2 
Serum PCR 0/6 0/6 3/6 5/6 6/6 6/6 6/6 6/6 6/6 6/6 3/4 3/4 2/4 2/4 0/2 0/2 0/2 0/2 0/2 0/2 
Blood swab PCR NA NA 2/6 2/6 2/6 6/6 6/6 6/6 6/6 4/6 4/4 4/4 4/4 3/4 2/2 2/2 2/2 2/2 2/2 1/2 
Semen PCR NA NA 0/6 0/6 1/6 2/6 4/6 6/6 5/6 3/6 2/4 2/4 2/4 2/4 1/2 0/2 0/2 0/2 0/2 0/2 
ELISA 0/6 0/6 0/6 0/6 0/6 0/6 3/6 3/6 5/6 6/6 4/4 4/4 4/4 4/4 2/2 2/2 2/2 2/2 2/2 2/2 
                      
3 
Serum PCR 0/6 0/6 0/6 0/6 3/6 5/6 5/6 6/6 6/6 6/6 4/4 4/4 4/4 4/4 2/2 2/2 2/2 2/2 2/2 1/2 
Blood swab PCR NA NA 0/6 0/6 0/6 5/6 6/6 5/6 5/6 5/6 4/4 4/4 4/4 4/4 2/2 2/2 2/2 2/2 2/2 2/2 
Semen PCR NA NA 0/6 0/6 0/6 1/6 5/6 5/6 5/6 5/6 4/4 4/4 4/4 4/4 1/2 1/2 1/2 1/2 1/2 1/2 
ELISA 0/6 0/6 0/6 0/6 0/6 0/6 0/6 1/6 2/6 3/6 4/4 4/4 4/4 4/4 2/2 2/2 2/2 2/2 2/2 2/2 
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Table 2. Summary of log transformed group mean ± standard error of PCV2 genomic copies 
in 0.25 grams of tissue from testes, epididymis, bulbourethral gland, seminal vesicle, and 
prostate of PCV2a (group 2) and PCV2b (group 3) inoculated boars at necropsy (DPI 23, 48, 
and 90).   
*DPI = Days post inoculation 
 
DPI* Group 
Tissue 
Testes Epididymis Bulbourethral gland 
Seminal 
vesicle Prostate 
23 
2 5.1±0.86 4.9±1.05 5.9±0.81 6.7±0.79 5.7±0.05 
3 5.5±0.09 4.9±0.91 5.8±0.70 5.7±0.07 5.9±0.46 
48 
2 5.2±0.46 5.9±0.61 6.8±0.44 5.7±0.12 5.6±0.18 
3 5.2±0.44 5.4±0.35 5.6±0.02 4.9±0.29 5.2±0.36 
90 
2 5.1±1.11 4.4±0.07 4.9±0.79 4.4±0.89 5.4±1.28 
3 5.4±0.11 4.2±0.02 5.4±0.19 3.9±0.69 5.2±0.30 
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Fig. 1. Mean PCV2 genomic copies/mL (log transformed) in serum of non-inoculated boars 
(group 1; n = 3 from DPI 1 to 23, n = 2 from DPI 27 to 48, and n =1 from DPI 55 to 90), 
boars inoculated with PCV2a (group 2; n = 6 from DPI 1 to 23, n = 4 from DPI 27 to 48, and 
n =2 from DPI 55 to 90), and boars inoculated with PCV2b (group 3; n = 6 from DPI 1 to 23, 
n = 4 from DPI 27 to 48, and n =2 from DPI 55 to 90).  For all collection days in groups 2 
and 3, only positive serum samples were included in the group mean.   
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Fig. 2. Mean PCV2 genomic copies/mL (log transformed) in semen of non-inoculated boars 
(group 1; n = 3 from DPI -3 to 23, n = 2 from DPI 27 to 48, and n =1 from DPI 55 to 90), 
boars inoculated with PCV2a (group 2; n = 6 from DPI -3 to 23, n = 4 from DPI 27 to 48, 
and n =2 from DPI 55 to 90), and boars inoculated with PCV2b (group 3; n = 6 from DPI -3 
to 23, n = 4 from DPI 27 to 48, and n =2 from DPI 55 to 90).  For all collection days in 
groups 2 and 3, only positive semen samples were included in the group mean.  
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Fig. 3. Mean PCV2 genomic copies/mL (log transformed) present in blood swabs of non-
inoculated boars (group 1; n = 3 from DPI 2 to 23, n = 2 from DPI 27 to 48, and n =1 from 
DPI 55 to 90), boars inoculated with PCV2a (group 2; n = 6 from DPI 2 to 23, n = 4 from 
DPI 27 to 48, and n =2 from DPI 55 to 90), and boars inoculated with PCV2b (group 3; n = 6 
from DPI 2 to 23, n = 4 from DPI 27 to 48, and n =2 from DPI 55 to 90).  For all collection 
days in groups 2 and 3, only positive blood swab samples were included in the group mean.  
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Abstract 
  Porcine circovirus type 2 (PCV2) is an economically important pathogen. It has been 
demonstrated that PCV2 DNA can be detected in boar semen by PCR; however, the 
biological relevance of this is unknown. The objectives of this study were to determine if 
semen positive for PCV2 DNA is infectious (1) in a swine bioassay, or (2) when used for 
artificial insemination. For the first objective, 4-week-old pigs were inoculated 
intraperitoneally with PCV2 DNA-negative (bioassay-control; n = 3), PCV2a DNA-positive 
(bioassay-PCV2a; n = 3), or PCV2b DNA-positive (bioassay-PCV2b; n = 3) raw semen, or 
PCV2 live virus (bioassay-positive; n = 3), respectively. Pigs inoculated with PCV2 DNA-
positive semen and PCV2 live virus became viremic and developed anti-PCV2 antibodies 
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indicating that the PCV2 DNA present in semen was infectious. For the second objective, 
three Landrace gilts were inseminated with PCV2 DNA-negative semen (gilts-controls) from 
experimentally-infected boars, and six gilts were artificially inseminated with semen positive 
for PCV2a DNA (gilts-PCV2a; n = 3) or PCV2b DNA (gilts-PCV2b; n = 3). Serum samples 
collected from the gilts in all groups remained negative for anti-PCV2 antibodies for the 
duration of the experiment. In addition, fetal serum samples from all 105-day-gestation 
fetuses were negative for anti-PCV2 antibodies or PCV2 DNA. Under the conditions of this 
study, PCV2 DNA-positive semen was not infectious when used to artificially inseminate 
gilts; however, it was demonstrated to be infectious in a swine bioassay model and therefore 
is a potential means of PCV2 transmission amongst swine herds.  
 
1. Introduction 
 Porcine circovirus type 2 (PCV2) is associated with many disease entities among 
growing and mature swine, including reproductive failure in pregnant females [29].  In 
breeding herds, natural infection of pregnant animals with PCV2 has been associated with 
reproductive failure manifested as abortions, mummification of fetuses and stillbirths with 
identification of PCV2 antigen associated with lesions in fetal tissues [17, 26, 57].   
 Vertical transmission of PCV2 can occur due to viremia of the dam leading to 
transplacental infection of in utero fetuses [17, 26, 34, 57]. The virus is capable of replicating 
in fetal tissues [13, 43, 59] and has a tropism for mitotically active cells within tissues which 
change depending on fetal age [42].  
Currently little is known about the role of PCV2 in semen and the transmission of 
PCV2 to dams or fetuses.  Artificial insemination has become standard practice by most large 
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production systems in North America in recent decades which followed the trend occurring 
in Europe [9]. In 2001, it was estimated that nearly 60% of the swine herds in North America 
were practicing artificial insemination [50] as compared with Europe where estimates 
approach 90% or greater [9, 19, 21]. The main advantage of artificial insemination is genetic 
improvement [37]. However, semen may be a source for virus introduction and rapid spread 
[11], and monitoring boar centers particularly for porcine reproductive and respiratory 
syndrome virus (PRRSV) is a common practice to prevent disease transmission [41]. 
Currently, monitoring for PCV2 is not routinely done at Veterinary Diagnostic Laboratories.
 Detection of PCV2 DNA in semen has been accomplished by using nested PCR 
(nPCR) techniques [14, 18, 23], quantitative real-time PCR (qPCR) [33], and virus isolation 
[14].  PCV2 DNA was found to be shed intermittently or continuously in experimentally 
challenged boars [18, 20]. The amount of PCV2 DNA in semen is generally in low quantities 
and serum viremia usually precedes detection in semen [18, 20]. In addition, shedding of 
PCV2 DNA in semen has been reported up to 27.3 months in naturally infected boars [23].  
All associated sex glands contain PCV2 DNA after infection [20] and PCV2 antigen can also 
be detected in interstitial macrophages and fibroblast-like cells in sex glands of affected 
boars [27].                                                                                                                                                             
 To date, it is unclear whether the PCV2 present in semen is infectious and if artificial 
insemination with PCV2 DNA-positive semen can cause PCV2 transmission or reproductive 
failure. To assess the infectivity of PCV2 DNA in semen and its role in transmission of 
PCV2, two studies were designed: The first objective was to determine if PCV2 DNA-
positive semen is infectious in a swine bioassay model. The second objective was to 
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determine whether PCV2 DNA-positive semen used for artificial insemination is infectious 
to PCV2 naïve gilts, can be transmitted to offspring, or induce reproductive failure.  
 
2.  Materials and Methods 
2.1. Animals 
2.1.1. Swine bioassay study 
Twelve, four-week-old mixed breed pigs were purchased from a commercial farm negative 
for antibodies to PCV2, PRRSV, and swine influenza virus (SIV).   
 
2.1.2. Artificial insemination study 
Nine, three-week-old purebred Landrace gilts were purchased from a farm negative for 
antibodies to PRRSV and SIV and positive for antibodies to PCV2.   
 
2.2. Semen 
 Raw semen negative for PCV2 DNA, raw semen positive for PCV2a DNA, and raw 
semen positive for PCV2b DNA used in this study was collected from a PCV2 experimental 
trial in which boars were intranasally and intramuscularly inoculated with PCV2a and 
PCV2b, respectively [20, 33]. The PCV2a isolate (ISU-40895) and the PCV2b isolate (NC-
16845) were originally obtained from finishing pigs with microscopic lesions consistent with 
PCVAD and associated with PCV2 antigen. Both isolates have previously been shown to 
cause disease in experimentally-infected pigs [30]. The raw semen samples tested negative 
for the presence of porcine circovirus type 1 (PCV1) DNA, porcine parvovirus (PPV) DNA, 
or PRRSV RNA by PCR [3, 15]. Aliquots of fresh raw semen were saved and placed into 
sterile 5ml polystyrene round-bottom tubes (Falcon®, BD Biosciences, San Jose, CA, USA) 
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and stored at -80°C.  The remaining raw semen was extended at a 1:1 dilution with a 
commercially available semen extender (TriXcell, IMV International, Minneapolis, MN, 
USA), which was warmed to match semen temperature, and the extended semen was then 
cooled to approximately 17°C.  A portion of each semen sample was further diluted with 
semen extender to approximately 5 billion sperm per 80ml insemination dose. The extended 
semen was stored at 17°C for up to 96 hrs and rotated twice daily.  
 
2.3. Animals, housing, experimental design, and inoculation 
Both experimental protocols were approved by the Iowa State University Institutional 
Animal Care and Use Committee.  
 
2.3.1. Swine bioassay study  
The pigs were randomly divided into 4 groups (Table I) and each group was housed 
in a separate room on arrival at the isolation facility. Each room was equipped with an ante-
room where personnel protective equipment (face masks, boots, gloves, and disposable 
covers) were supplied for room entrance by animal care takers, and each room was ventilated 
separately. Animals were contained in a 1.5 × 2.5 m pen supplied with a nipple drinker and a 
self feeder. Animals were fed ad libidum a balanced, pelleted, complete feed ration free of 
animal proteins and antibiotics (Nature’s Made, Heartland Coop, IA, USA).   
Inoculation was done intraperitoneally for all groups using an aseptic technique and a 
24 gauge, ½ inch hypodermic needle as described [54]. The bioassay-control group received 
7ml of PCV2 DNA-negative raw semen, the bioassay-PCV2a group received 7ml PCV2a 
DNA-positive raw semen, and the bioassay-PCV2b group received 7ml PCV2b DNA-
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positive raw semen. The number of PCV2 genomic copy numbers/ml of raw semen was 105.6 
and 105.8 for PCV2a and PCV2b, respectively.  The PCV2a and PCV2b isolates shared 95.7% 
nucleotide sequence identity. The bioassay-positive group received 3ml of PCV2a live virus 
(ISU-40895) generated by transfection of PK-15 cells with the PCV2a ISU-40895 infectious 
DNA clone [8] at a dose of 104.5 TCID50 combined with 4 mLs of sterile saline.  
Serum samples were collected prior to inoculation (Day 0 post inoculation; DPI 0) 
and weekly thereafter. On DPI 49, all pigs were humanely euthanized by lethal overdose of 
intravenous (auricular vein) pentobarbital (Fatal-Plus®, Vortech Phamaceutical, LTD, 
Dearborn, MI, USA). At necropsy, gross lesions were assessed on each pig and tissues from 
all major organ systems were collected for microscopic examination and 
immunohistochemistry (IHC).  
 
2.3.2. Artificial insemination study 
 The gilts were randomly divided into 3 treatment groups (Table II) and isolation 
rooms at 8 months of age. The general room set-up was similar to that described for the 
bioassay pigs. The gilts were housed in a 2 × 4 m pen supplied with a nipple drinker. 
Animals were fed daily approximately 2.5 kg of a balanced ground corn-soy based complete 
feed ration free of animal proteins and antibiotics (Nature’s Made, Heartland Coop, IA, 
USA). Prior to artificial insemination, gilts were individually synchronized for estrus 
detection for 17 consecutive days using a commercially available liquid altrenogest 
(Matrix®, Intervet Inc., Millsboro, DE, USA), that was added to the daily feeding at the 
recommended dosage (15mg). Twenty-four hours after termination of the treatment, each 
animal received a 5ml intramuscular injection of gonadotropin (P.G. 600®, Intervet Inc., 
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Millsboro, DE, USA) and was then bred by artificial insemination upon estrus detection.   
Each gilt was artificially inseminated three times during standing estrus with 24 hours 
between each insemination to ensure coverage of ovulation.  Initially, 80 ml of 1:1 extended 
raw semen (40 ml raw semen and 40 ml extender) (collected on the same day) was used. For 
second and third artificial insemination matings, semen extended to approximately 5 billion 
sperm per 80ml dose was used (5 ml of raw semen to 75 ml extender).  
To evaluate a potential negative effect of the semen extender used on infectivity of 
the PCV2, an equal amount of extender was added to PCV2 live virus in a 1:1 dilution. In 
addition and as a control, PCV2 live virus was diluted with minimum essential medium 
(MEM) in a dilution of 1:1. The PCV2 titer was estimated by immunofluorescence assay 
(IFA) with PCV2 a specific antibody as described [8] at 0, 8, 24, 48, and 96 hours post 
dilution. 
 Serum samples from all gilts were collected prior to insemination and weekly 
thereafter. At approximately 5 and 8 weeks post artificial insemination, ultrasonography was 
used to confirm pregnancy. Necropsy was performed at 105 days of gestation and gilts were 
euthanized by intravenous (auricular vein) overdose of pentobarbital. All fetuses were 
immediately extracted and fetal serum was collected.  
 
2.4. Serology 
 All weekly collected serum samples were analyzed for presence of anti-PCV2 IgG 
antibodies with an opening reading frame 2 (ORF2) based PCV2 ELISA as previously 
described [25]. A serum with a sample to positive ratio (s/p) equal or greater than 0.2 was 
considered to be positive. 
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2.5. Quantitative real-time polymerase chain reaction 
 Serum samples collected weekly from the bioassay pigs and individual fetal serum 
samples were tested for the presence and amount of PCV2 DNA by quantitative real-time 
PCR as described [32]. 
 
2.6. Sequencing 
 PCR products from the PCV2a or PCV2b positive semen, the PCV2 inoculum, and 
serum from one randomly selected pig at 49 DPI in each of the bioassay groups (bioassay-
PCV2a, bioassay-PCV2b, and bioassay-positive) was sequenced and compared to each other. 
A nested PCR was used to amplify the entire ORF2 gene for sequencing and subsequent 
sequence comparison as previously described [28]. 
 
2.7. Necropsy  
 At necropsy, percentage of lungs affected by lesions ranging from 0-100% [12] and 
presence and degree of lymphadenopathy were evaluated [32]. Both fresh tissues and tissues 
fixed in 10% buffered formalin were collected. Tissues included lung (all lobes), liver, 
spleen, kidney, tonsil, ileum, colon, thymus, multiple lymph nodes (tracheobronchial, 
mediastinal, mesenteric, iliac, superficial inguinal) and myocardium. In addition, uterus, 
ovary and placenta were collected from the breeding animals.  
 
2.8. Microscopic evaluation 
 The formalin fixed tissue samples were routinely processed and stained with 
hematoxylin and eosin for microscopic evaluation. Lungs, lymph nodes, and other lymphoid 
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tissues (tonsil and spleen) were scored for the presence and severity of PCV2-associated 
lesions as previously described [31] by a veterinary pathologist blinded to the treatment 
group.   
 
2.9. Immunohistochemistry 
 Immunohistochemical (IHC) staining for detection of PCV2-antigen in formalin 
fixed, paraffin embedded tissue was performed on selected lymphoid tissues 
(tracheobronchial, mediastinal, mesenteric, iliac, superficial inguinal thymus, tonsil, spleen 
and Peyer’s patches) collected from all bioassay pigs as described [51]. Additionally, 
sections of ovary, uterus, and lymphoid tissue (tonsil and iliac lymph node) from all gilts 
were tested by IHC for presence of PCV2 antigen. The distribution and amount of PCV2 
antigen in individually examined tissue sections were scored ranging from 0 (no signal) to 3 
(strong signaling) as previously described [32]. 
 
3.  Results 
3.1. Swine bioassay study 
 All DPI 0 serum samples were negative for anti-PCV2 antibodies. Furthermore, the 
bioassay-control pigs remained free of anti-PCV2 IgG antibodies for the duration of the 
study. One of three bioassay-PCV2a pigs had detectable anti-PCV2 antibodies from DPI 28 
onwards (Table III). The remaining two bioassay-PCV2a pigs developed anti-PCV2 IgG 
antibodies by DPI 49. Two of three bioassay-PCV2b pigs developed detectable anti-PCV2 
antibodies by DPI 49. All three of the bioassay-positive pigs had detectable anti-PCV2 IgG 
antibodies by DPI 14 and remained positive for the duration of the trial. 
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 PCV2 DNA was not detected in the weekly collected bioassay-control serum samples 
for the entire duration of the study nor from any animal on DPI 0. PCV2 DNA was detected 
in 1/3 bioassay-PCV2a pigs at DPI 21, 2/3 at DPI 28, and 3/3 at DPI 35 (Table III). All pigs 
remained PCV2 viremic until termination of the study. Two of three bioassay-PCV2b pigs 
were positive for PCV2 DNA in serum on DPI 21, and 3/3 pigs were PCV2 DNA positive 
from DPI 35 until DPI 49.  PCV2 DNA was detected in 3/3 serum samples from bioassay-
positive pigs on DPI 7, and all pigs in this group remained viremic until DPI 49. The 
sequence of the entire PCV2 ORF2 PCR product collected in each treatment group on DPI 
49 was 99.9% similar to the original inoculum.  
 Macroscopic lesions were not present in the bioassay-control animals. Gross lesions 
in the bioassay-PCV2a animals included mild-to-moderate fibrinous peritonitis with mild 
lymphadenopathy (2/3), diffuse non-collapsing lungs (1/3), and liver abscessation (1/3). 
Bioassay-PCV2b gross lesions included fibrinous peritonitis (2/3) and mild 
lymphadenopathy (1/3). All bioassay-positive animals had diffuse non-collapsing lungs with 
mild-to-moderate lymphadenopathy in 2/3 pigs.    
 Microscopically, 1/3 bioassay-control pigs had mild multifocal lymphocytic 
inflammation expanding interstitial lung parenchyma. The microscopic lesions in the 
bioassay-PCV2a animals included moderate multifocal lymphohistiocytic interstitial 
pneumonia (3/3), mild multifocal lymphocytic interstitial nephritis (1/3), and mild multifocal 
lymphocytic myocarditis (1/3). Microscopic lesions in the bioassay-PCV2b pigs included 
mild-to-moderate multifocal lymphohistiocytic interstitial pneumonia in all pigs.  Lesions in 
the bioassay-positive group included mild to moderate multifocal lymphohistiocytic 
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interstitial pneumonia (3/3), mild multifocal lymphocytic interstitial nephritis (3/3) and mild 
lymphoid depletion (1/3).   
 Low amounts of PCV2 antigen were detected in lymph node sections of 2/3 bioassay-
positive pigs. PCV2 antigen was not detected in tissue sections of bioassay-control pigs, 
bioassay-PCV2a pigs, or bioassay-PCV2b pigs. 
 
3.2. Artificial insemination study 
 In the extender-dilution-in vivo-assay, the starting titer of the PCV2 live virus diluted 
with semen extender was determined to be 104.2 TCID50 per ml while the control virus stock 
diluted with MEM had a titer of 104.5 TCID50 per ml (Table IV). The PCV2 titers slightly 
decreased after dilution, and the final titer of PCV2 at 96 hours post dilution was 104.0 
TCID50 per ml and 103.66 TCID50 per ml for the MEM diluted PCV2 and the extender diluted 
PCV2, respectively (Table IV). 
 Three of 3 control gilts, 2/3 gilts-PCV2a, and 3/3 gilts-PCV2b were confirmed 
pregnant by ultrasonography at 35 and 56 days post insemination. One animal in the gilt-
PCV2a group was breed on two consecutive estrus cycles, but failed to become pregnant.     
 The total number of fetuses retrieved from the gilts-control group was 25 with litter 
sizes of 4, 7, and 14 fetuses (+1 mummy). The total number of fetuses retrieved from the 
gilts-PCV2a group was 16 with litters of 5 and 11 fetuses. The total number of fetuses 
retrieved from gilts-PCV2b group was 40 with litters of 9, 13, and 18 fetuses (+1 mummy). 
Gross lesions were not observed in any of the fetuses. 
 At the time of artificial insemination, all gilts were negative for anti-PCV2 antibodies 
as determined by ELISA (s/p ratio < 0.2). None of the gilts developed anti-PCV2 IgG 
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antibodies during the 105 days post artificial insemination.  No gross lesions were observed 
during necropsy, no microscopic lesions were present in examined tissues, and IHC staining 
of lymphoid tissue, ovary and uterus were negative for PCV2 antigen in all gilts. All 79 fetal 
serum samples collected at 105 days of gestation were negative for anti-PCV2 antibodies and 
for PCV2 DNA. 
 
4.  Discussion 
 Transmission of PCV2 is presently not well characterized, however, detection of 
PCV2 DNA has been reported in secretions and excretions including feces, urine, saliva, 
ocular, nasal, colostrum and semen of infected pigs [1, 16, 18, 47-49]. Rapid spread of 
porcine circovirus associated disease (PCVAD) across North America in recent years has 
raised questions about the risk of transmission of PCV2 in semen; however, epidemiological 
investigations have not confirmed the relationship between PCV2 positive semen and 
incidence of PCVAD [4, 39, 56].  
 Semen transmission of certain viruses has been documented and is considered 
economically important for the swine industry, especially with the wide usage of artificial 
insemination. A recent review summarized viruses potentially shed in boar semen [11]. 
Currently, many North American boar stud operations frequently test for the presence of 
PRRSV by many methods for surveillance purposes [36, 40], yet the presence of other 
viruses associated with reproductive failure including PCV2 are infrequently tested for, 
although in one report 30% (13/43) of boars tested where found to contain PCV2 DNA in 
semen [23]. In other geographical locations, PCV2 DNA was detected in 28 of 60 (47 %) and 
26 of 98 (27 %) semen samples obtained from 30 and 49 Korean swine herds [14, 15], 18% 
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(86/472) of semen samples from Austrian and German boars [44], and 22% (67/304) of 
semen samples collected from 4 Brazilian farms.1 Other European countries have begun to 
test boar semen for exportation for the presence of PCV2 DNA to prevent the possible spread 
of PCVAD.2  
 The significance of PCV2 in semen is currently unknown and the purpose of this 
study was to try to expand the knowledge base on this topic.  Due to the cytotoxicity of 
semen [45] and the non-cytopathic effect of PCV2 in cell culture, virus isolation techniques 
can be misleading and unrewarding. Thus, highly sensitive PCR methodologies are currently 
used to determine if PCV2 is present in semen. Polymerase chain reaction techniques can 
detect the presence of PCV2 DNA using small amounts of semen; however, positive PCR 
results do not necessarily correlate with presence of infectious virus. Previously, a swine 
bioassay model was developed to confirm the infectivity of PRRSV in semen [52]. In this 
study, a similar bioassay model was used to test the infectivity of PCV2 DNA present in 
semen.  
The results of the PCV2 swine bioassay confirm that PCV2a and PCV2b present in 
semen are infectious as evidenced by the detection of PCV2 viremia, seroconversion in the 
recipients after inoculation, and microscopic lesions compatible with PCV2 infection in 
growing pigs. In the experimental PCV2 pig model using intranasal and/or intramuscular 
inoculations, anti-PCV2 antibodies can be detected between 21-28 DPI [32]. The delayed 
antibody response to PCV2 observed in pigs intraperitoneally injected with PCV2 DNA-
                                                 
1 Ciacci-Zanella J.R., Zanella E.L., Locatelli M.L., Brambatti J.L., Simon N.L., Coldebella M., Detection of 
porcine circovirus 2 in semen collected from naturally infected boar studs in Brazil, Proc. 5th International 
Symposium on Emerging and Re-emerging Pig Disease, Karkow, 2007, pp. 94. 
2 Wallgren P., Blomqvist G., Thorén P., Elander J., Wallgren M., Incidence of PCV2 in semen collected at 
Swedish boar stations, Proc. 20th International Pig Veterinary Society Congress, Durban, 2008, volume II, pp. 
62.   
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positive semen when compared to pigs inoculated with PCV2 live virus may be dose related. 
Additional considerations for delayed response in antibody production may be due to natural 
constituents present in semen [55] or different antigens present competing for an 
immunological response [6]. The peritonitis present at necropsy may have been in part 
induced by antigens present in the semen or possibly by bacterial contamination during 
intraperitoneal inoculation and this may have contributed to some of the microscopic lesions 
observed. Additionally, PCV2 antigen was not detected in tissues from bioassay-PCV2a pigs, 
or bioassay-PCV2b pigs in this study. This result may be due to the detection limits of IHC 
because it has been previously estimated that 108 PCV2 genomic copies are needed in tissue 
sections for visualization of IHC signaling [2].  
 Artificial insemination with semen containing PCV2 DNA did not result in dam or 
fetal infection in this study even with the initial insemination being diluted 1:1 with extender. 
This may indicate that low exposure to PCV2 in semen may be of lesser consequence.  In 
most field situations, a single semen collection from a boar is typically diluted into many 
insemination doses and commonly mixed with semen samples from other boars further 
decreasing the amount of PCV2 in a dose of semen typically used for artificial insemination.  
However, PCV2 has the ability to infect and replicate in different stages (zona pellucida free 
morulae, early blastocysts and hatched blastocysts) of in vivo produced embryonic cells with 
increasing susceptibility of infection in the later stages [22]. It has been shown that PCV2 
with an approximate diameter of 17nm in size did not infect intact zona pellucida morulae, 
although 20nm diameter fluorescent beads could pass through zona pellucida pores. PCV2 is 
a difficult virus to inactivate, thus PCV2 present in semen may be a risk for infection [22]. 
PCV2 is associated with the cell fraction portion of semen [33]. This may indicate that there 
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is a higher risk of PCV2 infection during fertilization because spermatozoa may be 
associated with PCV2 DNA.  
 Differences in virulence and tropism of PCV2 isolates have been suggested as a 
possible reason for PCV2-associated reproductive failure when compared to PCV2-
associated diseases in growing swine [7, 24]. Two PCV2 isolates were used in this study and 
both originated from growing pigs with PCVAD. However, it is unknown whether these 
isolates were also associated with reproductive failure in the field.  
 In swine, the route of PCV2 exposure is likely fecal-oral [46] and fetal infection has 
been associated with viremia of the dam [34]. It was recently reported that reproductive 
failure was associated with insemination of PCV2 spiked semen in PCV2 positive dams [38]. 
The dams were intranasally inoculated 60 days prior to insemination, and it was unknown 
whether dams were still viremic at the time of insemination with PCV2 spiked semen. The 
dams may have been viremic which could have contributed to the reproductive failure [38]. 
In support of this, in a different study it has been shown that PCV2 experimentally inoculated 
gilts had detectable PCV2 DNA in peripheral blood mononuclear cells at 63 DPI [35].   
 The results of our study indicate that PCV2 DNA present in semen ranging from 105.6 
to 105.8 genomic copies/ml did not cause reproductive failure, development of dam associated 
anti-PCV2 antibodies, or fetal infection. In addition, the semen extender used in the study 
was found to have only a minimal effect on the viability and infectivity of PCV2.  
The amount of PCV2 present in semen is likely important for determining whether 
PCV2 infection of the dam occurs. Previously, non-extended raw semen has been shown to 
infect PRRS negative gilts [58], but extended semen, though causing a reduction of 
pregnancy rates, did not cause seroconversion or infection [53]. This indicates that the dose 
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of viruses in semen plays a major role in transmissibility. In further support of this, only 20% 
of negative gilts inseminated with PRRSV at doses of 2,000 and 20,000 TCID50/50ml semen 
seroconverted while semen containing PRRSV at ≥ 200,000 TCID50/50ml semen was 
infectious in 100% of the negative gilts.3 Alternatively, other possible explanations for not 
having PCV2 infection in the gilts may be related to the increased numbers of inflammatory 
cells that are present in the uterus associated with innate immunity during proestrus, estrus, 
and early diestrus [5], age related differences in susceptibility, or the influence of altrenogest 
(Matrix®) on and uterine defense mechanisms [10].  
 In summary, we determined that PCV2a and PCV2b shed in semen were infectious in 
a swine bioassay model. We also determined that low doses of PCV2 (105.6 -105.8 PCV2 
genomic copies per ml) in extended semen when used for artificial insemination does not 
cause reproductive failure, seroconversion, or PCV2 viremia in naïve gilts and their 
offspring. The authors acknowledge that the amount of PCV2 present in semen is a possible 
contributing factor in transmissions of PCV2 via semen to swine herds that utilize artificial 
insemination. We also are aware of potential PCV2 isolate differences in association with 
reproductive failure.  Further investigations are needed and currently under way.   
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Table I.  Swine bioassay study: Experimental design. 
 
 
† Number of pigs in each group 
‡ PCV2 genomic copy numbers/ml of raw semen  
£ Tissue culture infectious dose (TCID50) 
* Intraperitoneally 
Group n† Inoculum Amount Dose Route 
Bioassay-control 3 PCV2 DNA-negative semen 7 ml - IP* 
Bioassay-PCV2a 3 PCV2a DNA-positive semen 7 ml 105.6‡ IP 
Bioassay-PCV2b 3 PCV2b DNA-positive semen 7 ml 105.8‡ IP 
Bioassay-positive 3 PCV2 live virus 3 ml 104.5£ IP 
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Table II.  Artificial insemination study: Experimental design. Each sow was inseminated three times (dose 1, 2, 3) 24hrs apart 
during estrus. 
Group n† Inoculum Raw semen‡ 
Artificial insemination‡ 
Route 1st dose 2nd & 3rd dose 
Gilts-
Control 3 PCV2-DNA-negative semen - - -   AI* 
Gilts-
PCV2a 3 PCV2a-DNA-positive semen 10
5.6 105.3 104.4 AI 
Gilts-
PCV2b 3 PCV2b-DNA-positive semen 10
5.8 105.5 104.6 AI 
       
† Number of pigs in each group 
‡ PCV2 genomic copy numbers/ml *Artificial insemination  
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Table III.  Swine bioassay study: Incidence (number of pigs affected / number of pigs per 
group) of PCV2 DNA in serum (Serum PCR) and anti-PCV2 antibodies in serum (ELISA) 
by group at different days post inoculation (DPI). 
Group Sample DPI 0 7 14 21 28 35 42 49 
Bioassay-control Serum PCR 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 ELISA* 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 
Bioassay-PCV2a Serum PCR 0/3 0/3 0/3 1/3 2/3 3/3 3/3 3/3 ELISA 0/3 0/3 0/3 0/3 1/3 1/3 2/3 3/3 
Bioassay-PCV2b Serum PCR 0/3 0/3 0/3 2/3 2/3 3/3 3/3 3/3 ELISA 0/3 0/3 0/3 0/3 0/3 0/3 1/3 2/3 
Bioassay-positive Serum PCR 0/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 ELISA 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 
 
* Pigs with a sample to positive ratio equal to or greater than 0.2 were considered positive 
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Table IV.  Effect of semen extender on the survivability of PCV2 in cell culture 
 
 
 
 
 
* PCV2 + MEM = 1:1 dilution of PCV2 live virus with minimum essential medium 
†PCV2 + extender = 1:1 dilution of PCV2 live virus with semen extender 
‡Titer: expressed as 50% tissue infective dose per ml 
 
 
 
 
Sample 
Time 
0 hrs 8 hrs 24 hrs 48 hrs 96 hrs 
PCV2 + MEM* 10 4.5‡ 10 4.5 10 4.2 10 4.0 10 4.0 
PCV2 + extender† 10 4.2 10 4.0 10 3.66 10 3.66 10 3.66 
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Abstract 
Porcine circovirus type 2 (PCV2) is associated with reproductive failure in female pigs. The 
role of PCV2 in semen has not been elucidated. The objectives of this study were to 
determine (1) if semen spiked with PCV2 causes infection in PCV2 naïve mature female pigs 
and (2) if delivery of PCV2 via artificial insemination causes reproductive failure or fetal 
infection. Nine sows were randomly allocated into 3 groups of 3 sows each and artificially 
inseminated with PCV2 DNA-negative semen (group 1), PCV2 DNA-negative semen spiked 
with PCV2a (group 2) or PCV2b (group 3). All sows in groups 2 and 3 developed PCV2 
viremia at 7 to 14 days following insemination. No group 2 sows became pregnant after 
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insemination while all group 3 sows (3/3) farrowed at the expected date. At parturition, pre-
suckle serum samples were collected and live-born piglets, stillborn fetuses, and mummified 
fetuses were necropsied. All live-born piglets (n=8) in group 3 were PCV2 viremic at birth. 
Stillborn fetuses (n=2) had gross lesions of congestive heart failure. Mummified fetuses 
(n=25) varied in crown-rump length from 7-27 cm indicating fetal death between 42 and 105 
days of gestation. PCV2 antigen was detected in the myocardium by immunohistochemistry 
(IHC) of 7/8 (88%) live-born piglets, 2/2 (100%) of the stillborn fetuses, and 25/25 (100%) 
of the mummified fetuses. In addition, 4/25 mummified fetuses had PCV2 antigen associated 
with smooth muscle cells and fibrocytes. The results of this study indicate that intrauterine 
administration of PCV2 causes reproductive failure in naïve sows. 
  
Introduction 
Porcine circovirus type 2 (PCV2) is a small, non-enveloped, single stranded, circular 
DNA virus of approximately 1.7kb with three known genotypes capable of causing porcine 
circovirus-associated disease (PCVAD) in swine: PCV2a, PCV2b, and the more recently 
described PCV2c.25,38 PCV2 was first described in association with wasting disease in 
nursery pigs with otherwise high health status.10 Since its initial description, PCV2 has been 
implicated and associated with multiple disease manifestations in growing and mature pigs 
consisting of pneumonia, diarrhea, and reproductive failure.5 Clinical disease related to 
PCV2 is now collectively described as PCVAD. Currently, most swine herds worldwide are 
seropositive for PCV2.1 Subclinical PCV2 infections are common and only a small 
percentage of infected animals develop clinical PCVAD.25  
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Reproductive failure is a broad term in swine and refers to failure of implantation 
resulting in irregular return to estrus, failure of pregnancy progressing to term due to 
expulsion of all embryos or fetuses (abortion), or reduced litter size due to increased numbers 
of non-viable piglets at parturition.2 Indications are that PCV2-associated reproductive 
failure can, depending on the timing of infection, manifest at all stages of pregnancy (early 
embryonic death; abortion; reduced litter size); and are more frequently observed in newly 
populated swine farms22,4,40 or associated with gilts entering an existing operation.13 
PCV2-associated systemic illness of the pregnant dam can be observed after 
infection, and can be vertically transmitted during dam viremia.22,30,40 PCV2 has a tropism 
for myocardial tissues in fetuses when inoculated in utero at 57, 75, or 92 days of gestation, 
and infection generally results in myocardial necrosis, inflammation, and fibrosis.22,35,40 
However, if infection occurs in late gestation, the cellular tropism of PCV2 is shifted from 
myocardiocytes to antigen presenting cells and lymphoid tissues.34  
In recent years, PCVAD rapidly spread across major swine producing regions of 
North American causing devastating morbidity and mortality especially in post-weaned pigs, 
which subsequently was thought to be associated with introduction of PCV2b genotype in 
affected areas.6 With the overwhelming incidence of PCVAD, potential transmission routes 
of PCV2 across pig populations were re-evaluated. Currently, the main route of PCV2 
transmission is thought to be fecal-oral.36 However, PCV2 can been detected in semen of 
infected boars.12,14,15,17 Infected boars shed PCV2 continuously for extended periods of time 
without showing clinical signs or changes in semen quality parameters.15,17 Furthermore, 
artificial insemination techniques are commonly used for dam matings and semen may be 
transported over great distances. Important swine viral diseases such as PRRSV have been 
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shown to be transmitted with boar semen.9 Thus, the objectives of this study were to 
determine if semen spiked with PCV2 has the ability to cause infection in PCV2 naïve 
mature female swine and if delivery of PCV2 via artificial insemination causes reproductive 
failure or fetal infection. 
 
Materials and Methods 
Animals and housing 
 Nine primiparous and multiparous 7- to 30-month-old crossbred conventional 
specific-pathogen-free (SPF) sows were used in the study. The animals were purchased from 
a source farm known to be serologically negative for PCV2, PRRSV, swine influenza virus 
(SIV), PPV, swine hepatitis E virus, and encephalomyocarditis virus (EMCV). At the Iowa 
State University research facility, the sows were individually housed in nine rooms in a BSL-
2 facility. Each room was approximately 2.5 × 3 m in size, had separate ventilation, 
contained an individual water nipple, and had an anteroom where personal protective gear 
was applied to personnel entering the room. The sows were fed approximately 2 kg of a 
balanced corn-soybean based ration formulated for gestation daily until day 90 of pregnancy 
when the amount of feed was increased to approximately 3 kg.  
 
Experimental design 
 The experimental protocol for the study design was approved by the Iowa State 
University Institutional Animal Care and Use Committee. At the research facility, the sows 
were randomly allocated into one of three groups. Group 1 (n = 3) sows served as negative 
controls and were artificially inseminated with extended PCV2 DNA-negative semen upon 
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estrus detection. Groups 2 (n = 3) and 3 (n = 3) sows were artificially inseminated with 
extended semen spiked with PCV2a or PCV2b, respectively, as described below. The sows 
were allowed to gestate, carry pregnancy to term, and to farrow naturally. At parturition, pre-
suckle serum samples were obtained from all piglets. Immediately after collection of blood, 
all piglets were humanely euthanized by intravenous overdose of pentobarbital for tissue 
evaluation. 
 
Estrus synchronization  
 All sows were synchronized for estrus detection prior to artificial insemination.   A 
commercially available product (Matrix®, Intervet Inc., Millsboro, DE) was administered to 
each sow at the recommended dosage for 15 connective days. Twenty-four hours after the 
last administration, each sow received 5ml of gonadotropin (P.G. 600®, Intervet Inc., 
Millsboro, DE) intramuscularly in the neck.  
 
Semen  processing 
 Semen, which was determined to be free of PCV2 DNA by quantitative real-time 
PCR29 was extended using a commercially available semen extender (TriXcell, IMV 
International, Minneapolis, MN) that had been reconstituted with sterile water and warmed to 
match semen temperature. Each 80ml insemination dose was adjusted to contain 
approximately 5 billion sperm per ml. Extended semen was stored at 17°C, rotated daily, and 
used within 4 days of collection.  
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Inoculation 
 One day prior to expected estrus, all sows were crated for breeding in individual 0.7 × 
2 m crates which allowed the sows to lie down but prevented full turns and access to the floor 
drain. During estrus, all groups were artificially inseminated with extended semen once a day 
for 3 consecutive days. Immediately prior to artificial insemination of group 2 and 3 sows, 
5ml of PCV2a or PCV2b was added to the 80ml dose of extended semen, respectively.  
 The PCV2 isolates used in this study originated from finishing pigs clinically affected 
by PCVAD.7,26  The PCV2a isolate ISU-40895 and the PCV2b isolate NC-16485 had an 
infectious titer with respective infectious DNA clones of 104.4 and 104.2 TCID50 per ml, 
respectively. Both PCV2 isolates were produced in a similar manner by transfecting PK-15 
cells as described previously.8 The PCV2a and PCV2b isolates shared 95.7% nucleotide 
sequence identity. Inocula titers were determined by using an immunofluorescence assay 
(IFA) with a PCV2 specific antibody,8 and the PCV2 inocula were stored at -80°C until use.  
 
Sample Collection 
 Serum samples were collected via venapuncture of the jugular vein using a 
Vacutainer system from all sows prior to PCV2 inoculation on days post-inoculation (DPI) -1 
and then weekly thereafter until parturition. At parturition, colostral samples from each sow 
were obtained in a sterile centrifuge tube and pre-suckle serum samples were collected from 
all viable piglets by venapuncture using a vacutainer system. All samples were stored at -
80°C until tested. 
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Serology 
 Pre-suckle piglet sera, sow sera, and colostral samples were tested for anti-PCV2 IgG 
antibodies using a PCV2 recombinant capsid protein (ORF2)-based ELISA.21 Samples with a 
sample-to-positive ratio (S/P) equal or greater than 0.2 were considered to be positive. 
 Sow serum samples collected on DPI -1 and DPI 112 were tested for the presence of 
anti-PRRSV, anti-SIV H1N1, anti-SIV H3N2 antibodies by ELISA (IDEXX Laboratories, 
Inc., Westbrook, ME), anti-PPV antibodies by hemaglutination inhibition,19 and anti- EMCV 
antibodies by virus neutralization (National Veterinary Service Laboratory, Ames, IA; 
protocol number BPPRL2109).  
 
PCR  
 Colostrum samples, pre-suckle piglet serum samples, and sow serum samples were 
tested for the presence and amount of PCV2 DNA by quantitative real-time PCR as 
previously described.28 PCV2 DNA was extracted using a commercially available isolation 
kit (QIAamp® DNeasy blood & tissue kit, Qiagen, Valencia, CA) following the 
manufacturer’s protocol and recommendations. Quantitative real-time PCR parameters were 
the same as previously described.28 
  
Virus isolation and sequencing 
A tissue pool containing myocardium, spleen, and tonsil from group 3 stillborn 
piglets (n=2) was homogenized with 5ml of phosphate buffed saline. The homogenate was 
tested for the presence of PCV2 by virus isolation on continuous porcine kidney cell line 
(PK-15) as previously described.31 The tissue homogenate was considered positive if virus 
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replication was detected after two blind passages. Immunofluorescence microscopy using 
polyclonal anti-PCV2 was used to demonstrate PCV2 within transfected PK-15 cells.31 
  Cultured PCV2 virus for stillborn homogenized tissue was sequenced and compared 
to the original inoculum. A nested PCR was used to amplify the entire ORF2 gene and 
subsequent sequence comparison was done as previously described.24 
 
Necropsy   
 All expelled live-born piglets were humanely euthanized and all piglets including 
stillborns and mummified fetuses were necropsied. Gross lesions were evaluated and crown-
to-rump length was used for determination of the approximate time of fetal death during 
gestation.39 Tissues collected from the piglets included heart, lungs, liver, kidney, brain, 
spleen, tonsil, thymus and pinna (ear notch). In addition, placental sections were collected. A 
similar set of tissues was collected for mummified fetuses depending on the degree of 
decomposition.  
 
Microscopic evaluation and immunohistochemistry  
 Tissue sections were collected in 10% neutral buffered formalin, routinely processed, 
stained with hematoxylin and eosin, and evaluated by a veterinary pathologist who was 
blinded to the treatment status. Immunohistochemical (IHC) staining to detect PCV2 antigen 
was performed as previously described using rabbit polyclonal antisera.37 The presence and 
amount of PCV2 antigen in selected tissue sections (myocardium, lungs, pinna, tonsil and 
placenta) was blindly scored as previously described.27  
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Statistical analysis 
Summary statistics (mean and standard error) for log transformed genomic copies of 
PCV2 DNA in collected samples (sow colostrum and pre-suckle piglet serum) was 
performed using JMP 7.0.2 (SAS Institute, Cary, NC).  
 
Results 
Estrus and pregnancy 
 Four to five days after gonadotropin administration, all synchronized females 
exhibited signs of estrus as expected and were artificially inseminated. Visible signs of estrus 
detection were not observed in group 1, 2, or 3 animals during the subsequent two estrus 
cycles (around 21 and 42 days). Starting at approximately 12 weeks of gestation, all groups 1 
and 3 sows showed visible abdominal distension and mammary development. None of the 
group 2 sows had visible signs of pregnancy and these sows were later confirmed to be not 
pregnant. 
 Group 1 and group 3 animals carried pregnancy to term and farrowed between 114 
and 117 DPI.  The numbers of live-born piglets, stillborns, and mummified fetuses are 
summarized in Table 1. Group 3 mummified fetuses varied in crown-to-rump length from 7 
to 27cm (Fig. 1) indicating fetal death between 42 and 105 days of gestation. 
 
Serology 
 All serum samples collected on DPI -1 were negative for anti-PCV2 antibodies. 
PCV2 specific antibodies were not detected in pre-suckle serum samples from group 1 
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piglets or group 1 sows at parturition and colostral samples were negative for anti-PCV2 
antibodies in this group.   
All group 2 and group 3 sow serum samples were positive for anti-PCV2 IgG 
antibodies on DPI 112 and ELISA S/P ratios ranged from 0.4 to 1.0. Anti-PCV2 antibodies 
were detected in 1/1, 2/2, and 1/5 pre-suckle live-born piglet serum samples of individual 
group 3 litters. All group 3 colostral samples were positive for PCV2 antibodies at parturition 
with S/P ratios ranging from 0.4 to 0.8. 
Specific IgG antibodies against PRRSV, SIV, PPV, and EMCV were not detected in 
DPI -1 or DPI 112 serum samples collected from groups 1, 2, or 3 sows.  
 
PCR and sequencing 
 All sows were negative for PCV2 DNA on DPI -1. PCV2 genomic DNA was not 
detected in weekly serum samples or in colostral samples of group 1 sows during the study. 
Similarly, all pre-suckle serum samples collected from group 1 piglets were negative for 
PCV2 genomic DNA.  
All group 2 females had detectable PCV2 DNA in serum samples by DPI 7. Length 
of viremia varied among group 2 sows; individual females had detectable PCV2 DNA in 
serum for 7, 11, and 14 consecutive weeks (Table 2).  
In group 3, 2/3 sows had PCV2 viremia on DPI 7, and 3/3 were viremic on DPI 14. 
Similar to group 2, the length of PCV2 viremia varied amongst the group 3 sows. PCV2 
genomic DNA was detected for 3 weeks and 6 weeks in two of the three sows. The third sow 
in group 3, in which serum PCV2 DNA was first detected on DPI 14, remained viremic until 
parturition which corresponds to 15 weeks (Table 2). All group 3 colostral samples were 
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positive for PCV2 genomic DNA with a log10 mean genomic PCV2 copy numbers ±standard 
error (SE) of 105.0±0.5 per ml colostrum. Pre-suckle serum samples from all live born piglets 
in this group (n=8) were positive for PCV2 DNA with a mean log10 PCV2 genomic copies of 
± SE of 106.7±0.4 per ml serum.  
 
Virus isolation and sequencing 
PCV2 was isolated from the homogenized tissue pool of myocardium, spleen, and 
tonsil from group 3 stillborn piglets after 2 blinded cell culture passages. Viral sequencing of 
the cultured PCV2 isolate showed 100% sequence identity to the ORF 2 gene in the original 
PCV2b inoculum.  
  
Gross Lesions  
 Gross abnormalities were not observed in group 1 live-born piglets, group 1 stillborn 
fetuses, or group 3 live-born piglets. 
The two group 3 stillborn fetuses were 23 and 27 cm in crown-to-rump length. Both 
had mild to moderate abdominal distension with approximately 8-10 ml of straw-colored 
fluid in the abdominal cavity with occasional strands of fibrin adhered to viscera. The 
thoracic cavities of both pigs contained approximately 10 and 30 ml of a similar fluid, 
respectively. The hearts were 2 to 3 times enlarged, had a globose appearance, and had 
irregular pale streaks within the myocardium (Fig. 2). On cut section, pale streaks were 
present within the walls of both ventricles and the interventricular septum. Eccentric dilation 
of both the left and right ventricle was evident, and there was mild interlobular pulmonary 
edema. Hepatomegaly with an enhanced lobular pattern was present in both stillborn piglets 
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along with mild to moderate perirenal and mesocolonic edema. In addition, one of the two 
piglets had multifocal splenic petechial hemorrhages and a small, barely visible, thymus. 
    The larger mummified fetuses (>23 cm crown-to-rump length) in group 3 litters had 
abdominal distension with marked amounts of serosanguineous to clear subcutaneous edema, 
and mild to moderate amounts of serosanguineous abdominal fluid (approximately 8-15 ml). 
Similar to the stillborns, the mummified fetuses had hepatomegaly and cardiomegaly. 
 
Microscopic evaluation 
 Microscopic lesions were not observed in placental sections from any groups or 
tissues from group 1 live-born or stillborn piglets.  
In group 3 live-born piglets, 4/8 pigs had multifocal to locally extensive regions 
where myocardiocytes were lost, fragmented, or occasionally vacuolated with absent or 
condensed nuclei. Replacing lost myocardiocytes were low amounts of loosely arranged 
fibrous connective tissue and edema which also separated adjacent myocardiocytes. Low 
numbers of lymphocytes were occasionally present within regions of myocardial necrosis or 
separating myocardiocytes. Other microscopic changes in live-born group 3 piglets included 
splenic periarterial sheaths composed of macrophages and rare multinucleated giant cells 
rather than lymphocytes in 2 of 8 piglets (Fig. 3), and mild to moderate interlobular 
pulmonary edema in 2 of 8 piglets. 
 Stillborn group 3 fetuses had similar but more extensive myocardial lesions compared 
to the live-born piglets. Rare basophilic intranuclear inclusion bodies were occasionally 
observed in myocardiocytes of stillborn fetuses. Furthermore, 1/2 stillborn fetuses had locally 
extensive hemorrhage that separated myocardiocytes with prominent dense linear bands of 
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fibrous connective tissue replacing lost myocardiocytes (Fig. 4). Occasional cardiomyocytes 
were multifocally mineralized. In liver sections, both fetuses had apoptotic and coagulative 
necrosis of hepatocytes with individualization. Mild vacuolar change, congestion, and 
hemorrhage were also apparent. Splenic lesions were observed in 1/2 stillborn fetuses with 
periarterial sheaths being composed of macrophages and rare multinucleated giant cells 
rather than lymphocytes.   
 All twenty-five group 3 mummified fetuses had myocardial necrosis with fibrous 
connective tissue similar to stillborn fetuses. In addition, locally extensive regions of 
myocardium were mineralized in 8/25 mummified fetuses.   
 
Immunohistochemistry (IHC) 
IHC for PCV2 antigen on heart, lung, tonsil, and pinna (ear notch) tissues of group 1 
live-born piglets and stillborn fetuses revealed no detectable PCV2 antigen. Placental tissue 
from all sows was also negative for PCV2 antigen. 
Seven of eight group 3 live-born piglets had low to abundant amounts of PCV2 
antigen within the myocardium and 1/8 had moderate tonsil-associated PCV2 antigen. PCV2 
antigen was not detected in sections of lung tissues or ear notches.  
Both stillborn fetuses in group 3 had moderate to abundant staining of PCV2 antigen 
in myocardial tissue (Fig. 4 insert). PCV2 antigen was also detected in tonsillar tissue 
sections with mild to moderate IHC staining. Lung and pinna were negative.   
All 25 group 3 mummified fetuses had abundant PCV2 antigen in myocardial tissue 
and in tonsils. Furthermore, smooth muscle cells and fibroblasts stained positively for PCV2 
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antigen in the lung of 4/25 and the pinna of 2/25 of the mummified fetuses in group 3 (Fig. 
5).  
 
Discussion 
 Reproductive failure, manifesting as either irregular return to estrus, abortion, or 
increased numbers of non-viable pigs in term litters, has been previously attributed to PCV2 
infection in both field and experimental scenarios.22,30,40 However, the role of semen 
transmission has not been appropriately evaluated as a potential source of dam or fetal 
infection. In boars, PCV2 infection is not typically associated with clinical disease or 
abnormalities in sperm morphology; however, low amounts of PCV2 DNA are frequently 
detected in semen. 14,15,17 The potential for semen transmission is apparent; however, 
previous epidemiological reports have not found a direct correlation between semen and 
PCV2 transmission.11,33   
 Previously, PCV2-positive semen collected from experimentally-inoculated Landrace 
boars was found to be infectious in a swine bioassay model; however, when the same semen 
was extended and used to artificially inseminate PCV2-naïve gilts, PCV2 transmission was 
not observed.16 Thus, to further investigate the role of semen in the transmission of PCV2, 
the virus inoculum was added to each extended semen dose to determine if PCV2 is capable 
of infecting the dam via this route. To ensure that PCV2 infection did not occur by other 
routes (orally), the inseminated mature females were crated and not allowed to turn around, 
from the day of estrus detection until 3 days after the last inoculation. The results showed 
that both PCV2a and PCV2b were capable of inducing infection via the intrauterine route as 
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evidenced by PCV2 viremia and seroconversion. This indicates that the intrauterine route is a 
potential route of PCV2 infection.  
 In group 1, pregnancy was achieved in all females after insemination, and pregnancy 
was maintained to term. Similarly, all group 3 sows artificially inseminated with extended 
semen spiked with PCV2b became pregnant and maintained pregnancy to term. 
Alternatively, all group 2 females failed to become pregnant or maintain pregnancy after 
artificial insemination.  This may in part be due to the low numbers of sows used in the study 
(because of cost prohibitions and lack of availability of PCV2 negative animals), usage of the 
PCV2a genotype, the slight difference in inocula titer, or combinations of these events.  
However, estrus was not observed in any group 2 sow around 21 or 42 days post 
insemination which corresponded to the regular return to estrus intervals. Thus, it can be 
speculated that conception may have occurred, but was terminated with subsequent 
resorption similar to what is reported with PPV infection.18  
 In previous field and experimental cases of PCV2-associated reproductive failure, 
abortion was observed,30,40 but was not a feature in the current study. The occurrence of early 
termination of a pregnancy may be related to differences in virulence between viruses, acute 
severe systemic illness of the pregnant female, or acute fetal death of the majority of the 
fetuses. Based on the observations of this study, previous findings, and results reported by 
other groups,4,20 we believe that PCV2-associated reproductive failure is more insidious and 
causes gradual embryonic loss or fetal death. Thus, PCV2-associated reproductive failure 
should be considered in situations when increased numbers of stillborn and/or mummified 
fetuses in term litters are observed. 
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 When fetuses were inoculated intrauterine with PCV2 at different stages of gestation, 
it was found that transmission between fetuses did not occur, but that the virus was able to 
replicate in fetal tissues, especially in the myocardium.35 In contrast, the results of this study 
indicated that in utero transmission between fetuses occurred. This is supported by the 
variable crown-to-rump lengths of the mummified fetuses indicating death of individual 
fetuses anytime between 42 and 105 days of gestation, similar to what occurs with PPV virus 
infection.18 The long PCV2 viremia noted in some of the sows may have contributed to 
transplacental infection at different times during gestation; however, 2 of 3 sows did not have 
detectable PCV2 DNA in serum samples by 49 days of gestation, although live-born piglets 
in the corresponding litters had anti-PCV2 antibodies, indicating infection after the onset of 
fetal immunocompetence (approximately 70 days). 
 After artificial insemination with PCV2-spiked semen in the current study, gross 
lesions of chronic myocardial dysfunction and cardiac dilatation were present in the two 
stillborn fetuses in group 3. These results are similar to  previously described field cases.4,22 
The observed pulmonary, mesocolonic, and perirenal edema can be attributed to either the 
associated heart failure or related to PCV2-associated vasculitis.23 Microscopic evaluation of 
fetal myocardial tissues showed extensive necrosis, lymphocytic inflammation, edema, 
mineralization, and fibrosis similar to what has been previously reported.4,22,40 Occasionally, 
mummified fetuses in this study had abundant myocardial fibrosis and extensive 
mineralization. Other groups have reported depletion of lymphocytes from splenic 
periarterial sheaths in live-born and stillborn fetuses,4 which we also observed and 
additionally demonstrated the presence of macrophages and multinucleated giant cells, 
suggestive of chronic infection.  
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In this study, and similar to previous studies, abundant PCV2-antigen was detected in 
myocardial tissue. Interestingly, in PCV2-infected live-born, stillborn, and mummified 
fetuses in which antigen was observed by IHC, the myocardium always contained antigen 
while lymphoid tissue (tonsil) contained detectable PCV2 antigen only sporadically (Table 
3).  This reinforces that myocardial tissue is the best tissue for accurate diagnosis of PCV2-
associated fetal infection.  
 At parturition, all pre-suckle serum samples from group 1 piglets were negative for 
PCV2 DNA and specific antibodies. In contrast, all pre-suckle serum samples collected from 
normal-appearing live-born piglets born in group 3 contained PCV2 DNA. In a previous 
report, when the timing of fetal infection was manipulated by direct fetal inoculation after 75 
days of gestation, PCV2 antibodies were generally detected in pre-suckle serum samples and 
the fetuses were non-viremic.35 Alternatively, if fetuses were infected at 57 days of gestation, 
anti-PCV2 antibodies were not detected 21 days after inoculation, but fetal serum samples 
were  positive for PCV2 DNA.35 Interestingly, approximately 50% of the group 3 live-born 
piglets had detectable anti-PCV2 antibodies. This indicates that fetal infection in these piglets 
occurred after the fetuses reached immunocompetence (approximately 70 days of gestation).  
The remaining live-born piglets without measurable amounts of PCV2 antibodies 
may have been infected just prior to parturition and therefore did not have time for 
development of PCV2 antibodies, or they may have been infected prior to 
immunocompetence. Interestingly, of the live-born piglets in group 3 that did not have anti-
PCV2 antibodies, all had mild to marked amounts of PCV2 antigen in heart detected by IHC. 
Previous reports suggest that PCV2 replication in myocardial tissue diminishes as fetuses 
near full development.34 With marked PCV2 antigen in a portion of the seronegative live-
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born piglets, it can be speculated that these animals may have been chronically infected. The 
exact mechanism of PCV2 persistent (chronic) infection is unknown, but persistent infection 
is supported by previous reports detecting PCV2 viremia of experimentally infected animals 
at 90 DPI,15 PCV2 DNA in tissues at 125 DPI,3 and detectable viremia in naturally infected 
pigs for 22 weeks.32  
 In conclusion, intrauterine placement of PCV2 was capable of causing both viremia 
in the sow and fetal infection, but did not result in abortion. The role of PCV2 in early 
embryonic death resulting in resorption and irregular returns to estrus is less clear based on 
the results. However, semen transmission should be considered as a means for transmission 
of PCV2, potentially resulting in intra-uterine infection of piglets, and perhaps leading to 
persistent infection. Furthermore, PCV2 infection should be considered if increased numbers 
of stillborn and mummified fetuses are expelled at parturition. Myocardium is preferred for 
identification of PCV2 antigen and DNA in fetuses.   
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Table 1.  Total number of expelled piglets and fetuses by litter at parturition after artificial  
insemination of PCV2-negative semen or extended semen spiked with PCV2a or PCV2b. 
 
 
 
Group Inocula Sow ID Total born Live-born Stillborn Mummified 
1 Negative 
1 11 10 1 0 
2 10 9 1 0 
3 10 10 0 0 
2 PCV2a 
4 0 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
3 PCV2b 
7 8 1 0 7 
8 12 5 1 6 
9 15 2 1 12 
144 
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Table 2. Summary of PCV2 DNA detected in sow sera by PCR, after artificial insemination of sows with PCV2-negative semen 
(group 1, n=3) or extended semen spiked with PCV2a (group 2, n=3) or PCV2b (group 3, n=3). 
 
 
 
Group Inocula 
Days post inoculation 
-1 7 14 21 28 35 42 49 56 63 70 77 84 91 98 105 112 
1 Negative 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 
2 PCV2a 0/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 2/3 2/3 2/3 2/3 1/3 1/3 1/3 0/3 0/3 
3 PCV2b 0/3 2/3 3/3 3/3 2/3 2/3 2/3 1/3 1/3 1/3 1/3 1/3 1/3 1/3 1/3 1/3 1/3 
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Table 3.  Summary of findings in expelled piglets and fetuses at parturition from group 3 sows artificially inseminated with 
PCV2b-spiked extended semen. 
 
 
 
 
 
 
 
 
* Estimation of fetal death based on crown-rump length 
‡ Fetal crown to rump length (cm) 
† Not applicable  
Group 
 
 
Gestation 
age 
 
Ave. 
length 
(cm)‡ 
Length 
range 
(cm)‡ 
n 
Pre-suckle serum Microscopic lesions Immunohistochemistry 
PCV2 PCR 
PCV2 
antibodies 
Heart Heart Lung Tonsil Pinnae 
Live-born Term 29 26-31 8 8/8 4/8 4/8 7/8 0/8 1/8 0/8 
Stillborn 105- 114* 25 23-27 2   N/A† N/A 2/2 2/2 0/2 2/2 0/2 
Mummified 
70 – 105* 22.3 17-27 18 N/A N/A 18/18 18/18 4/11 5/5 2/11 
42-70* 11.3 7-16 7 N/A N/A 7/7 7/7 N/A N/A N/A 
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Fig. 1. Stillborn and mummified fetuses expelled at parturition from a group 3 (intrauterine 
PCV2b inoculation) sow with varying crown-to-rump lengths.  
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Fig. 2. Heart, stillborn fetus, group 3. Globose appearance with multifocal pale streaks within 
the myocardium. Bar = 1cm 
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Fig. 3. Spleen, live-born piglet, group 3. Splenic periarterial sheath composed of 
macrophages and rare multinucleated giant cells rather than lymphocytes. HE, 400×. Bar = 
50µm.  
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Fig. 4. Heart, stillborn fetus, group 3.  Myocardiocytes are multifocally lost and replaced by 
prominent linear bands of fibrous connective tissue. The adjacent myocardium is necrotic 
and degenerative with separation of myocardiocytes by lymphocytes and edema. HE, 100×. 
Bar = 200µm. Insert. Heart, live-born piglet, group 3. Immunohistochemistry, abundant 
PCV2 antigen with myocardiocytes. 400×. Bar = 50µm.  
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Fig. 5. Pinna, mummified fetus, group 3. Immunohistochemistry, PCV2 antigen present in 
fibroblast-like cells within the dermis surrounding hair follicle 
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Abstract 
The objectives of this study were to determine if vaccination against PCV2 or previous PCV2 
infection of the dam are sufficient to prevent fetal infection when dams are artificially 
inseminated with PCV2-spiked semen. Nine sows were divided into three groups of three 
dams each: The PCV2 naïve negative control group 1 was artificially inseminated with 
extended PCV2 DNA negative semen during estrus whereas the extended semen used in the 
vaccinated group 2 (PCV2 vaccine was given eight weeks before insemination) and PCV2-
exposed group 3 (infected with PCV2 12 weeks before insemination) was spiked with 5 ml 
of PCV2 inoculum with a titer of 104.2 TCID50 per ml at each mating. The dams in the 
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vaccinated and PCV2 exposed groups were positive for PCV2 antibody but negative for 
PCV2 DNA in serum at the time of insemination. Three negative control dams, two 
vaccinated dams, and three dams with previous PCV2 exposure became pregnant and 
maintained pregnancy to term. After artificial insemination, viremia was detected in 1/3 
vaccinated dams and in 2/3 dams with previous PCV2 exposure. At farrowing, PCV2 
infection was not detected in any piglets or fetuses expelled from the negative control dams 
or dams with previous PCV2 exposure. In the litters of the vaccinated dams, 15/24 live-born 
piglets were PCV2 viremic at birth with 6/26 fetuses having detectable PCV2 antigen in 
tissues. The results from this study indicate that vaccine-induced immunity did not prevent 
fetal infection in the sow model using semen spiked with PCV2. 
 
1. Introduction 
Reproductive failure is one of the multiple disease entities, known as porcine 
circovirus-associated diseases (PCVAD), associated with porcine circovirus type 2 (PCV2) 
infection [1]. Porcine circovirus type 2 is a small, non-enveloped, circular, single stranded 
DNA virus in the family Circoviridae [2]. Reproductive failure associated with PCV2 in 
pregnant swine may clinically result in acute systemic illness in the dam, abortion, increased 
non-viable fetuses at parturition (mummified and stillborn fetuses) or weak born piglets [3-5] 
and has typically been reported in gilts or in co-mingled pregnant females [6,7]. 
In the pregnant dam, PCV2 is capable of crossing the placenta during viremia and 
infecting the fetuses in utero [4]. In early to mid gestation fetuses, PCV2 has a predilection 
for myocardial tissue [8] resulting in myocardial necrosis, non-suppurative myocarditis, and 
fibrosis [5]. If fetal infection occurs during late gestation, myocardium is less affected and 
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more PCV2 DNA can be detected in lymphoid tissue [9]. Porcine circovirus type 2 can 
spread from fetus to fetus in utero resulting in death at different stages of gestation. 
Occasionally, affected fetuses have gross lesions of heart failure which may include an 
enlarged globose heart, congested liver, pulmonary edema, ascites, and increased thoracic 
fluid [10]. 
The source of PCV2 in reported cases of reproductive failure is often unknown 
though boars can shed infectious PCV2 in semen [11]. Recently PCV2-associated 
reproductive failure was reproduced in PCV2 naïve dams using semen spiked with PCV2 for 
artificial insemination [10]. In that experiment, dams carried pregnancy to term without 
clinical signs, but delivered increased numbers of mummified fetuses, stillborn fetuses with 
gross lesions of heart failure, and live-born piglets that were PCV2 viremic at birth indicating 
that dam and fetal PCV2 infection can be associated with contaminated semen [10]. 
However, the role of dam immunity in semen transmission of PCV2 has not been evaluated, 
though most swine herds are seropositive [1]. To add more complexity to the scenario, 
multiple PCV2 vaccines have become available in recent years and are currently being 
implemented to control PCVAD in the growing phase or in isolation facilities for sow farm 
replacement females. It is unknown whether the immunity induced by PCV2-vaccination can 
protect against fetal PCV2 infection. Thus, the objectives of this study were to determine if 
dam vaccination against porcine circovirus type 2 (PCV2) or dam immunity induced by 
previous PCV2 infection of the dam are sufficient to prevent fetal infection when dams are 
artificially inseminated with PCV2 spiked semen.  
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2. Materials and Methods 
2.1. Experimental design and animals  
The experimental protocol was approved by the Iowa State University Institutional 
Animal Care and Use Committee. Nine multiparous conventional crossbred specific-
pathogen-free (SPF) dams were included in the study. The dams were obtained from a source 
herd serologically negative for PCV2, porcine parvovirus (PPV), porcine reproductive and 
respiratory syndrome virus (PRRSV), swine influenza virus (SIV), and encephalomyocarditis 
virus (EMCV). Prior to the artificial insemination, dams were moved to a BSL-2 facility and 
housed by group in separate rooms. Negative control dams in group 1 (n = 3) were artificially 
inseminated with extended PCV2 DNA negative semen during estrus. Dams in group 2 (n = 
3) were vaccinated with a commercially available PCV2 vaccine per labeled instructions as 
indicated by the manufacturer eight weeks before artificial insemination with extended 
semen spiked with PCV2. Dams in group 3 (n = 3) were challenged with PCV2 (strain NC-
16485) intranasally 12 weeks earlier and were artificially inseminated with extended semen 
spiked with PCV2 (Table 1). Dams were allowed to gestate and maintain pregnancy to term. 
At parturition, dams farrowed naturally and presuckle serum samples were obtained from all 
live-born piglets. Immediately after collection of blood, all live-born piglets were euthanized 
by intravenous overdose of pentobarbital for tissue collection and evaluation. 
 
2.2. Pre-challenge in group 3 dams 
Group 3 dams were inoculated with PCV2 (strain NC-16485) 12 weeks before 
artificial insemination. Each dam received 5 ml of the PCV2 inoculum at a dose of 104.2 
tissue culture infectious dose (TCID50) per ml intranasally. 
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2.3. Vaccine 
Eight weeks prior to artificial insemination with PCV2 spiked semen, group 2 dams 
were intramuscularly injected in the neck with 1 ml of a killed, baculovirus expressed, 
commercially available PCV2 vaccine (Ingelvac®, CircoFLEX™, Boehringer Ingelheim, 
Vetmedica Inc., St. Joseph, MO, USA; serial number 309-024). The vaccine used in the 
study is licensed for healthy pigs three weeks of age or older for the reduction of 
inflammation and lymphoid depletion associated the PCV2 infection. Before dam 
vaccination, the vaccine was stored according to the manufacturer’s instructions.  
 
2.4. Estrus synchronization and semen 
 All dams in the study were synchronized for estrus using a commercially available 
product (Matrix®, Intervet Inc., Millsboro, DE, USA) as previously described [10]. Briefly, 
15 mg of altrenogest was added to each dam’s daily feeding for 15 consecutive days. 
Following removal, all dams were intramuscularly treated with 5 ml of gonadotropin (P.G. 
600®, Intervet Inc., Millsboro, DE, USA).   
Semen used for the artificial insemination was collected from a PCV2 naïve boar 
(from the original source herd) by gloved-hand technique using an insulated mug containing 
a disposable plastic liner with a tear-away filter (US BAG™ System, Minitube®, Verona, 
WI, USA). Semen was free of PCV2 DNA as determined by a quantitative real-time PCR for 
PCV2 [12] and extended (TriXcell, IMV International, Minneapolis, MN, USA) as 
previously described [10]. Each artificial insemination dose consisted of 80 ml which 
contained approximately five billion sperm per ml. Insemination doses were stored at 17°C, 
rotated daily, and used within four days post extension [10].  
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2.5. Inoculation (artificial insemination) 
 The PCV2 isolate used in this study was PCV2b strain NC-16485 which was 
previously shown to cause PCV2-associated reproductive failure in the spiked semen model 
[10]. The infectious titer of the PCV2 inoculum was 104.2 TCID50 per ml as determined by 
using an immunofluorescence assay (IFA) with a PCV2 specific antibody [13]. The PCV2 
inoculum was produced by transfecting PK-15 cells with an infectious DNA clone of the 
PCV2b strain NC-16485 as described previously [14], and stored at -80°C until thawed for 
insemination.  
During standing estrus, approximately 4 days post gonadotropin injection, all dams 
were artificially inseminated for three consecutive days at 24 hrs intervals to achieve 
coverage of ovulation [10]. Negative control dams were artificially inseminated with PCV2 
negative extended semen while vaccinated dams and dams previously exposed to PCV2 were 
inseminated with extended semen spiked with 5 ml of PCV2 as previously described [10]. 
Briefly, PCV2 inoculum was thawed at the day of insemination and added to the individual 
extended semen doses just prior to insemination. Insemination doses were inverted multiple 
times after the PCV2 inoculum was added. 
  
2.6. Sample Collection (serum and colostrum) 
 Dam serum samples were collected prior to artificial insemination (Days post 
insemination 0; DPI 0) and weekly thereafter until farrowing. At parturition, dam colostral 
samples were obtained in a sterile 50 ml centrifuge tube and presuckle serum samples were 
collected from all viable piglets as previously described [10]. All samples were stored at -
80°C until tested. 
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2.7. Serology 
 Serum samples (dam and piglet presuckle) and colostral samples were tested for 
specific anti-PCV2 IgG antibodies using a PCV2 recombinant capsid opening reading frame 
2 (ORF2) protein based ELISA [15]. Serum and colostral samples with a sample-to-positive 
ratio (S/P) equal or greater than 0.2 were considered to be positive. 
 Dam sera collected on DPI 0 and DPI 112 from all groups were tested for specific 
anti-PRRSV antibodies and anti-SIV-H1N1 and H3N2-antibodies by ELISA (IDEXX 
Laboratories, Inc., Westbrook, ME, USA), for the presence of anti-PPV-antibodies by 
hemaglutination inhibition [16], and for the presence of anti-EMCV antibodies by virus 
neutralization (National Veterinary Service Laboratory, Ames, IA; protocol number 
BPPRL2109).  
 
2.8. PCR and sequencing 
 All collected sera (dam and piglet presuckle) and colostral samples were tested for the 
presence and amount of PCV2 DNA by quantitative real-time PCR as previously described 
[17]. Extraction of PCV2 DNA was done using a commercially available isolation kit 
(QIAamp® DNA Mini Kit, Qiagen, Valencia, CA, USA) following the manufacturer’s 
protocol and recommendations.  
The PCV2 DNA from a group 2 pre-suckle serum sample was partially sequenced 
after amplification of the ORF2 gene by nested PCR as previously described [18]. The 
resulting sequence was then compared to that of the original virus inoculum used to spike the 
semen before artificial insemination.  
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2.9. Necropsy, microscopic evaluation, and immunohistochemistry  
   After collection of blood, live-born piglets were euthanized and all expelled fetuses 
(mummified, stillborn, and live-born) from all groups were necropsied and evaluated for 
gross lesions. Crown-to-rump measurement was used to determine the approximate time of 
fetal death during gestation of mummified and stillborn fetuses [19]. Fresh and 10% neutral 
buffered formalin fixed tissues samples were collected from all stillborn and live-born piglets 
which included heart, lungs, liver, kidney, brain, spleen, tonsil, thymus and pinnae (ear 
notch) as previously described [10]. A similar set of tissues were collected from mummified 
fetuses if organ recognition was possible during necropsy. Sections of placenta from each 
dam were also collected after expulsion.  
Formalin-fixed tissue samples were routinely processed, paraffin embedded, and 
stained with hematoxylin and eosin after adequate fixation. Stained tissue sections were 
evaluated by a veterinary pathologist blinded to the treatment status.  
Myocardium, lungs, pinnae, tonsil and placenta were evaluated for the presence and 
amount of PCV2 antigen [20] by immunohistochemistry (IHC) using a rabbit polyclonal 
antisera as previously described [21].  
 
2.10. Statistical analysis 
Summary statistics (mean and standard error) for log transformed genomic copies of 
PCV2 DNA in collected samples (sow serum, colostrum, and pre-suckle piglet serum) was 
performed using JMP 7.0.2 (SAS Institute, Cary, NC, USA).  
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3. Results 
3.1. Artificial insemination and pregnancy 
 After synchronization, dams in all groups showed visible signs of estrus and were 
artificially inseminated for three consecutive days according to the experimental protocol. 
Pregnancy was confirmed in all negative control dams and dams previously exposed to 
PCV2 35 days post insemination by ultrasonography. Two of three vaccinated dams were 
found to be pregnant (Table 1). All pregnant dams maintained pregnancy and farrowed 
between 115 and 118 days post first insemination. The numbers of live-born piglets, 
stillborns, and mummified fetuses in each group are summarized in Table 1. Crown-to-rump 
measurements of stillborns and mummified fetuses born to vaccinated dams were 18.0, 24.0, 
24.5 and 27.0 cm indicating fetal death between 77 and 105 days of gestation. Nonviable 
fetuses born to sows with previous PCV2 exposure had crown-to-rump lengths of 7.0, 11.5, 
16.0 and 25.5 cm (death between 42 and 100 days).  
 
3.2. Serology 
 Serum samples collected at DPI 0 and DPI 112 and colostral samples from negative 
control dams were negative for anti-PCV2 IgG antibodies. Vaccinated dams and dams 
previously exposed to PCV2 were positive for anti-PCV2 antibodies in serum prior to 
insemination (DPI 0) and at parturition (DPI 112) (Table 2). Colostral samples from 
vaccinated dams and PCV2 exposed dams were also positive for anti-PCV2-IgG at 
parturition (Table 2). Specific antibodies against PRRSV, SIV, PPV, and EMCV were not 
detected in any of the dams at DPI 0 or DPI 112 serum samples.  
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 Presuckle serum samples from live-born piglets in all groups were negative for anti-
PCV2 antibodies (Table 2).  
 
3.3. PCR and sequencing 
 Genomic PCV2 DNA was not detected in any of the DPI 0 dam serum samples or in 
weekly samples from the negative control dams during gestation. Once confirmed pregnant, 
1/3 vaccinated dams had low amounts of detectable PCV2 DNA in serum (103.4 log 
transformed genomic copies/ml) at one time point (DPI 42). Two of three dams with 
previous PCV2 exposure had detectable PCV2 DNA in serum during gestation (Table 2). 
Detection occurred at one collection point for each dam, DPI 7 and DPI 14 (103.2 and 103.1 
log transformed genomic copies/ml, respectively).  
Colostrum samples collected at parturition from all negative control dams and dams 
with previous PCV2 exposure were negative for PCV2 DNA. One of two vaccinated dams 
had detectable PCV2 DNA in colostrum (103.0 log transformed DNA copies/ml) (Table 2). 
This particular sow was viremic for PCV2 on DPI 42.  
Presuckle serum collected from live-born piglets born to negative control dams and 
PCV2 exposed dams were negative for PCV2 DNA. Of the 24 live-born piglets born to 
vaccinated dams, 15 were viremic for PCV2 at birth (6/13 and 9/11 from respective litters) 
(Table 2). The mean amount of PCV2 DNA genomic copies/ml (±SE) in serum was 105.0 
±0.46 and ranged from 102.7 to 108.8.  
Sequence analysis of PCV2 amplified in one pre-suckle serum sample from a live-
born piglet born to a vaccinated dam revealed 100% sequence identity to the original PCV2 
inoculum used during artificial insemination. 
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3.4. Gross lesions, microscopic evaluation, and immunohistochemistry 
 Gross lesions at necropsy were not observed in live-born or stillborn piglets born to 
negative control dams or PCV2 exposed dams. In the litters of the vaccinated dams, 1/24 
live-born pigs had a firm heart with multifocal to coalescing regions of pallor (Figure 1). 
Gross lesions were unapparent in the other piglets born to vaccinated dams.  
 Microscopic evaluation of examined tissues revealed no remarkable lesions in the 
piglets and fetuses from negative control dams or PCV2 exposed dams. The microscopic 
lesions observed in piglets born to vaccinated sows were limited to the live-born piglet with 
macroscopic heart changes. In this piglet, approximately 50% of normal myocardium was 
replaced by numerous fibroblast-like cells, modest amounts of dense and loosely arranged 
collagen bundles, inflammatory cells composed of eosinophils, lymphocytes, fewer 
macrophages and rare multinucleated giant cells (Figure 2). Adjacent myocardiocytes were 
occasionally fragmented or swollen and vacuolated. Rarely, deeply basophilic intranuclear 
botyroid inclusion bodies were seen within myocardiocytes. Additionally, lymphoid 
depletion was present in tonsil and spleen of this piglet.  
   Porcine circovirus type 2 antigen was not detected by immunohistochemistry (IHC) 
in sections of heart, lung, tonsil, and pinnae of live-born, still-born, or mummified fetuses in 
litters from the negative controls or PCV2 exposed dams. In addition, placenta sections from 
all dams were negative for PCV2 antigen by IHC. However, multiple piglets (including the 
piglet with macroscopic and microscopic heart lesions; Figure 2, insert) and mummified 
fetuses from both vaccinated dams (3/12 and 3/16, respectively) had IHC signaling in heart 
and tonsil (Table 2). Viral antigen in tissue varied from minimal to marked amounts. In 
affected piglets, all hearts and 50% of tonsillar sections were found to be PCV2 positive.  
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4. Discussion 
Previously it was shown by our group that PCV2 acquired during artificial 
insemination was capable of causing PCV2-associated reproductive failure and fetal infection 
in PCV2 naïve dams [10]. However, currently very few herds are seronegative for PCV2 and 
the previous study may not have been representative of the dynamics occurring within the 
swine industry, though all-gilt-farms or gilts entering production herds may be seronegative 
and have reproductive failure associated with PCV2 [6,7]. In the current study, we repeated 
our previous study using dams from the same source farm that were either vaccinated with a 
commercially available PCV2 vaccine eight weeks prior to artificial insemination with PCV2 
spiked semen or were intranasally inoculated with the homologous PCV2 isolate (strain NC-
16845) 12 weeks before insemination. The same PCV2 inoculum (passage and titer) and 
materials and methods were used as in our previous study [10]. Because of limited dam 
availability a positive control group was not repeated. The authors are aware that the 
previous study [10] was small, and if repeated, may have slightly different testing outcomes.  
There are currently four PCV2 vaccines all based on the PCV2a genotype available to 
combat PCVAD in growing pigs. Three vaccines are licensed for administration during the 
nursery phase of production, while the fourth vaccine is labeled for sows as a pre-farrow 
vaccination to protect growing swine via maternally derived antibodies. There are no PCV2 
vaccines that are licensed to prevent in utero fetal infection. In growing swine, PCV2 
vaccines have been shown to induce neutralizing antibodies, to significantly reduce PCV2 
shedding in feces, and to improve mortality in the field [22-26]. Vaccination has also been 
shown to block detectable viremia in connection with heterologous challenge (PCV2b) [23]. 
There is little information about vaccination of pregnant dams in the literature; however, 
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there are reports of sow vaccination reducing pre-wean mortality and increasing numbers of 
live-born piglets (decreased stillborn and mummified fetuses) [27-32]. In these reports, 
vaccination was given during gestation.  
In the present study, it was our goal to determine if vaccination before breeding can 
protect against fetal infection. The results showed that PCV2 viremia (103.4 log transformed 
genomic copies/ml) still occurred in one vaccinated dam at one collection point, and this dam 
also had detectable PCV2 DNA in colostrum at parturition. This differs considerably from 
our previously published data using PCV2 naïve dams in which peak detection of PCV2 
DNA in serum occurred between 14-21 days post-insemination in all inoculated dams with 
amounts ranging from 103.1 to 105.3 log transformed genomic copies/ml [10]. Length of 
viremia was also longer in the previous study (3-15 weeks) and PCV2 DNA was detected in 
all dam colostral samples.  
Though only one vaccinated dam had detectable viremia during gestation, both 
pregnant animals in this group farrowed viremic live-born piglets. Viral DNA was identified 
in 15/24 live-born piglets. None of these piglets had access to colostrum before testing and 
there were limited gross (1 piglet) and microscopic lesions associated with PCV2 infection. 
The results indicate that vaccine-induced antibodies will not protect against fetal infection 
after challenge via insemination. It can be speculated that vaccination may reduce the 
numbers of non-viable fetuses (stillborn and mummified) as compared to offspring from 
naïve dams as observed in our previous study [10]. Furthermore, it can be speculated that 
vaccination prior to breeding (8 weeks) does not affect conception rates.            
Porcine circovirus type 2 exposed dams used in this study had been infected with 
homologous PCV2 virus three months before insemination. A previous study reported PCV2-
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associated reproductive failure and fetal infection following insemination with PCV2 positive 
semen in PCV2 antibody positive dams that were infected with a homologous PCV2 strain 
60 days prior [33]. In that particular study, PCV2 dam viremia was not measured at 
insemination. Thus, it is unknown if the dams were still viremic at insemination and this may 
be the reason for the associated reproductive failure. Other studies have shown that PCV2-
induced immunity can block viremia after challenge with homologous or heterologous PCV2 
strains [23], which is consistent with our finding in this study.  Even though 2/3 PCV2 
exposed dams became viremic after artificial insemination thereby increasing the potential of 
PCV2 crossing the placenta, fetal infection was not detected as measured by absence of 
PCV2 antibodies, viremia, or IHC signaling in tested serum and tissue samples. In addition, 
PCV2 DNA was not detected in colostrum or was PCV2 antigen detected in placenta. 
Possible consideration for the differences in the findings of vaccinated and PCV2 
exposed dams may include the low number of dams used in the model, dosage of vaccine, or 
challenge with a homologous PCV2 isolate in the PCV2 exposed dams versus heterologous 
challenge in the vaccinated dams.  
In summary, PCV2-vaccine induced immunity in dams was unable to prevent in utero 
fetal infection in the spiked semen model which is in contrast to dams previously exposed to 
homologous virus. It is important to raise the awareness of swine veterinarians that PCV2-
associated reproductive failure (abortions and increased numbers of stillborn and mummified 
fetuses) may not be grossly apparent in vaccinated sows, but PCV2 fetal infection may still 
be occurring. The authors acknowledge that the amount of PCV2 used to spike semen in this 
study may be more than what can occur in the field, and thus results may be different with 
smaller inoculation doses. In addition, other PCV2 vaccines may show different results; 
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however, this study indicates that vaccine-induced immunity may be not be protective in 
preventing fetal infection possibly resulting in transmission of PCV2 to other piglets at 
different stages of production. 
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Table 1. Experimental design, pregnancy and litter characteristics for negative controls dams artificially inseminated with PCV2 
negative semen and vaccinated or PCV2 exposed dams inseminated with PCV2-spiked semen at estrus.  
 
‡PCV2 vaccination occurred 8 weeks prior to artificial insemination with PCV2-spiked semen 
§Inoculation with PCV2 occurred 12 weeks prior to artificial insemination with PCV2-spiked semen
Group n Treatment Inoculation Pregnancy 
Litter characteristics 
Total born Live-born stillborn mummified 
1 3 None None 3/3 32 31 1 0 
2 3 PCV2 vaccination‡ PCV2-spiked semen 2/3 28 24 2 2 
3 3 Previous PCV2 exposure§ PCV2-spiked semen 3/3 29 25 1 3 
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Table 2.  Anti-PCV2 antibody sample-to-positive ratio (s/p) prior to artificial insemination (day post inoculation 0; DPI 0) and on 
DPI 112 , number of dams PCV2 viremic during gestation, colostral associated PCV2 antibodies levels and PCV2 DNA at 
parturition, and number of piglets with detectable PCV2 DNA and anti-PCV2 antibodies in serum and tissues (IHC stains). 
Negative controls dams (Group 1) were artificially inseminated with PCV2 negative semen and vaccinated dams (Group 2) and 
dams with previous PCV2 exposure (Group 3) were inseminated with PCV2-spiked semen at estrus. 
‡ Measured in sows that farrowed only 
§ Number of live-born piglets per group 
* Number of total expelled piglets (live-born) and fetuses (stillborn and mummified) per group 
 Dam Characteristics  Piglet Characteristics 
Group 
PCV2 antibody s/p 
PCV2 viremia 
Colostrum‡  
DPI 0 DPI 112 PCV2 antibodies PCV2 DNA  PCV2 viremia§ 
PCV2 
antibodies§ 
PCV2 
IHC* 
1 ‐  ‐  0/3 0/3 0/3  0/31 0/31 0/32 
2 0.56 ±0.05 0.63 ±0.14 1/3 2/2 (0.27±0.02) 1/2  15/24 0/24 6/28 
3 0.58±0.2 0.62±0.15 2/3 3/3 (0.43±0.08) 0/3  0/25 0/25 0/29 
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Fig. 1. Live-born piglet born to a vaccinated dam, heart.  A Epicardial surface showing 
multifocal to coalescing regions of pallor. B Formalin fixed cross section of heart in which 
approximately 50% percent of myocardial tissue is replaced by regions of pallor.  Bar = 1cm 
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Fig. 2. Live-born piglet born to a vaccinated dam, heart. Myocardiocytes are multifocally lost 
or degenerate and replaced by lymphocytes, plasma cells, macrophages, eosinophils and 
fibroblasts. HE, 400×. Bar = 50µm. Insert. Heart. Immunohistochemistry, abundant PCV2 
staining. 400×. Bar = 50µm.  
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Abstract 
The aims of the study were to determine if porcine circovirus type 2 (PCV2) vaccination of 
the dam is effective in preventing fetal PCV2 infection and reproductive failure. Twelve 
pregnant, PCV2-naïve sows were randomly divided into 4 groups with 3 sows in each group. 
Group 1 sows served as non-inoculated, non-vaccinated negative controls, group 2 sows were 
vaccinated with a commercially available PCV2 vaccine at 28 days of gestation and were not 
inoculated, group 3 sows were vaccinated at 28 days gestation and inoculated with PCV2b at 
56 days of gestation, and group 4 sows were inoculated with PCV2b but non-vaccinated. 
Serum samples from all sows were collected weekly throughout the gestation period and 
sows were allowed to farrow naturally. At parturition, sow colostrum samples, presuckle 
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serum samples, and tissues from the piglets were collected. Reproductive failure was not 
observed under the study conditions. PCV2 vaccination induced PCV2-specific IgG and 
serum neutralizing antibodies in sows from groups 2 and 3 and prevented detectable PCV2 
viremia in the dams after challenge. In group 3, PCV2 DNA was detected in colostrum 
samples, fetuses, and live-born pigs; however, microscopic lesions or PCV2-specific antigen 
were not present in any of the fetuses in this group. The results from this study indicate that 
vertical transmission of PCV2 can occur in PCV2 vaccinated dams.       
 
Introduction 
 Porcine circovirus type 2 (PCV2) is a non-enveloped, single stranded, circular, DNA 
virus of approximately 1.7kb and is classified in the Circoviridae family, genus Circovirus 
(38). PCV2 has three currently recognized genotypes: PCV2a, PCV2b, and PCV2c 
(Opriessnig et al., 2007; Dupont et al., 2008). Multiple disease entities are recognized with 
PCV2 infection in swine and include pneumonia, diarrhea, wasting, and reproductive failure 
(Opriessnig et al., 2007). Porcine circovirus associated disease (PCVAD) is used to describe 
the multisystemic disease manifestations related to PCV2 infection.  
PCV2 was first described in growing high-health status pigs in Canada (9), and later 
found to be associated with reproductive disease in mature animals (24, 39). PCV2-
associated reproductive failure was first reported in Canada. Clinically, the cases were 
characterized by late-term abortions, decreased numbers of viable piglets, and increased 
numbers of stillborns and mummified fetuses (24, 39). Gross lesions of PCV2-associated 
fetal infection included dilated cardiomyopathy, pulmonary edema, hepatomegaly, and 
ascites. The most consistent microscopic changes associated with PCV2 infection of fetuses 
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include myocardial degeneration, necrosis, fibrosis, and nonsuppurative myocarditis (39). 
These changes are due to an apparent PCV2 tropism for fetal myocardiocytes (34). However, 
this tropism diminishes in late gestation and increased levels of PCV2 DNA can be detected 
in lymphoid tissues (33). In addition, PCV2 was found to be capable of crossing the placenta 
and causing fetal infection in PCV2 negative sows during viremia after intranasal inoculation 
(29). It has been demonstrated that PCV2 inoculation of sows three weeks before parturition 
can result in lethargy, abortion, and delivery of stillborn piglets as early as 7 days post 
inoculation (29). 
 During 2004-2005, PCVAD in growing pigs spread rapidly throughout North 
American resulting in severe disease characterized by high morbidity, mortality, and 
decreased growth efficiencies. Molecular characterization of the PCV2 involved in these 
outbreaks identified PCV2b, which had not been previously reported in North America (2). 
Thereafter, multiple PCV2 vaccines became available for disease prevention. However, an 
approved sow vaccine to protect against PCV2-associated reproductive failure is not 
currently available in the U.S. The objectives of this study were to determine if PCV2 
vaccination of the dam is effective in preventing fetal PCV2 infection and reproductive 
losses. 
 
Material and Methods 
Animals and breeding 
 Twelve, specific-pathogen-free (SPF), crossbred sows of uniform genetics were 
purchased from a single herd serologically negative for PCV2, porcine reproductive and 
respiratory syndrome virus (PRRSV), porcine parvovirus (PPV), swine influenza virus (SIV), 
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and encephalomyocarditis virus (EMCV). All sows were synchronized for estrus detection 
using a commercial product (Matrix®, Intervet Inc., Millsboro, DE, USA) according to the 
manufacturer’s recommended dose (15mg/sow/day) and duration (15 days). Twenty-hours 
after removal, each sow received 5 ml of gonadotropin (P.G. 600®, Intervet Inc., Millsboro, 
DE, USA) intramuscularly and was then artificially inseminated with PCV2 DNA-free 
extended semen (28) for 3 consecutive days upon estrus detection. Sow pregnancy was 
confirmed at 28 days of gestation by ultrasonography.  
 
Experimental design and sample collection 
 The experimental protocol was approved by the Iowa State University Institutional 
Animal Care and Use Committee. Sows were randomly divided into 4 groups of 3 sows each. 
All groups were housed separately in a biosafety level 2 facility for the duration of the study. 
Group 1 sows served as non-inoculated and non-vaccinated controls. Group 2 and 3 sows 
were vaccinated with a licensed commercially available PCV2 vaccine at 28 days of 
gestation. At 56 days of gestation, all sows in groups 3 and 4 sows were oronasally 
inoculated with an infectious PCV2b virus stock. All sows were allowed to farrow naturally.  
Serum samples were collected from all sows prior to breeding and weekly thereafter 
until parturition. At parturition, sow colostrum samples and live-born piglet presuckle serum 
samples were collected.  All piglets and fetuses (stillborn and mummified) from these sows 
were necropsied on the day of parturition.   
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Vaccination 
Groups 2 and 3 sows received 1 ml of a killed, baculovirus expressed, commercially 
available PCV2 vaccine (Ingelvac®, CircoFLEX™, Boehringer Ingelheim, Vetmedica Inc.; 
serial number 309-024) intramuscularly in the neck at 28 days of gestation. The PCV2 
vaccine is labeled for administration in healthy pigs greater than 3 weeks of age for the 
reduction of inflammation and lymphoid depletion associated with PCV2 infection. The 
vaccine was stored according to the manufacturer’s instructions until used.  
 
Inoculation 
Sows from groups 3 and 4 were oronasally inoculated with 5 ml (2.5 ml per nostril) 
of PCV2b virus stock (strain NC-16485) (18) with an infectious titer of approximately 104.2 
TCID50 per ml at 56 days of gestation. The PCV2b virus stock was produced by transfecting 
PK-15 cells with an infectious clone as previously described (7), and the titer of the PCV2b 
virus stock was determined by using an immunofluorescence assay (IFA) with a PCV2 
specific antibody (7). The PCV2 inoculum was stored at -80°C until inoculation. 
 
Clinical assessment 
All sows were visually monitored weekly for clinical signs of PCV2-associated 
disease including weight loss, diarrhea, and dyspnea. In addition, sows from groups 2 and 3 
were visually monitored for 2 hours following vaccination for adverse reactions. Sows from 
groups 3 and 4 were monitored daily for pyrexia, lethargy, and vaginal discharge for 2 weeks 
following inoculation at 56 days of gestation. 
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Serology 
 Presuckle  live-born piglet serum samples, sow colostrum samples, and sow serum 
samples collected prior to insemination, and at 28, 56, 84, and 112 days of gestation were 
tested for anti-PCV2 antibodies using a PCV2 recombinant capsid protein-based ELISA as 
described previously (23). Samples having a sample-to-positive ratio (S/P) equal to or greater 
than 0.2 were considered to be positive. The S/P ratio for each sample was calculated by 
dividing the sample optical density (OD) at 450 nm by the positive control OD. The 
sensitivity and specificity of the PCV2 ELISA used in this study was previously determined 
to be 79.9% and 99.6%, respectively for a cut-off value of 0.2 (Nawagitgul et al., 2002). 
 The presence of anti-PCV2 neutralizing antibodies was assessed in all sow serum 
samples collected from all groups on 56 and 112 days of gestation using a fluorescence focus 
neutralization assay performed according to the standard operating procedure at the Iowa 
State University Veterinary Diagnostic Laboratory (32). PCV2 isolate ISU-98-15237 was 
used in the assay.  
In addition, sow serum samples collected on day 112 of gestation were tested for the 
presence anti-PRRSV antibodies by ELISA (IDEXX Laboratories, Inc., Westbrook, ME), 
anti-SIV-H1N1 and H3N2 antibodies by ELISA (IDEXX Laboratories, Inc., Westbrook, 
ME), anti-PPV antibodies by hemaglutination inhibition (21), and for anti-EMCV antibodies 
by virus neutralization (National Veterinary Service Laboratory, Ames, IA; protocol number 
BPPRL2109).  
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PCR 
 Sow serum samples, colostrum samples, and presuckle live-born piglet sera were 
tested by quantitative real-time PCR for presence and amount of PCV2 DNA (27). DNA 
extraction was carried out using a commercially available DNA extraction isolation kit 
(QIAamp® DNA Mini Kit, Qiagen, Valencia, CA) according to the manufacturer’s 
recommendations. The quantitative real-time PCR parameters, primers, and probes were as 
described previously (27).  
 
Necropsy and microscopic examination  
 Heart, lungs, liver, kidney, brain, spleen, tonsil, thymus and pinnae (ear notch) were 
collected from all live-born and stillborn piglets. A similar set of tissues was collected from 
mummified fetuses if post-mortem tissue identification was possible at necropsy. Placental 
samples from the dams were also obtained at parturition. Tissue sections were placed in 10% 
neutral buffered formalin, allowed to fix completely, paraffin-wax embedded, cut in 4 µm 
sections, and stained with hematoxylin and eosin. Stained tissues were evaluated for presence 
of microscopic lesions such as inflammation and lymphoid depletion in a blinded fashion by 
a veterinary pathologist. 
 
Immunohistochemistry (IHC) 
 Immunohistochemical (IHC) staining was performed on selected tissue sections 
(myocardium, lungs, pinnae, tonsil, and placenta) using a polyclonal rabbit anti-PCV2 serum 
for the detection of PCV2 antigen as described previously (37).  
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Statistical analysis 
Summary statistics from all groups were calculated to assess the overall quality of the 
data. Repeated data measurements (sow PCR and serology) were log transformed and 
analyzed using multivariate analysis of variance (MANOVA) to detect significant differences 
over time. If significant (P < .05), a non-parametric one-way ANOVA (Kruskal-Wallis) was 
used to analyze data at each time point followed by pair-wise comparisons using Wilcoxin 
rank-sum. For non-repeated measures (piglet viremia, piglet anti-PCV2 antibodies, colostral 
antibodies, and colostral PCV2 DNA), a non-parametric Kruskal-Wallis one-way ANOVA 
followed by pair-wise comparisons using Wilcoxin rank-sum was used.  Statistical analysis 
was performed using JMP 7.0.2 (SAS Institute, Cary, NC).  
 
Results 
Clinical assessment and farrowing 
Adverse vaccine reactions were not observed in groups 2 and 3 sows following 
vaccination. Clinical disease (pyrexia, lethargy, wasting, diarrhea, dyspnea, vaginal discharge 
or abortion) associated with PCV2 infection was not observed during gestation in groups 3 
and 4 sows. All sows maintained pregnancy and farrowed between 114-116 days post 
insemination. Table 1 summarizes litter characteristics by group. 
 
Serology 
All sows were negative for anti-PCV2 antibodies prior to insemination and 
seronegative for PRRSV, SIV (H1N1 and H3N2), PPV, and EMCV at parturition. Group 1 
sows (negative controls) remained negative for anti-PCV2 antibodies for the duration of the 
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study. Table 2 summarizes sow anti-PCV2 antibody development by group at 28, 56, 84, and 
112 days of gestation. All sows in groups 2, 3, and 4 had detectable anti-PCV2-antibodies at 
112 days of gestation. A significant effect of time (P = .027) was observed for the production 
of anti-PCV2 antibodies; however, differences between groups were not observed.   
PCV2 neutralizing antibodies were identified in all group 2, 3, and 4 sows during 
gestation whereas group 1 sows remained seronegative for PCV2 (Table 2). A significant 
effect of time (P < .001) was observed for serum neutralizing antibody production; however, 
significant group differences were not observed at 56 and 112 days of gestation.  
Colostrum-associated anti-PCV2 antibodies were present in all group 2, 3, and 4 sows 
but were not detected in group 1 (Table 3). A significant statistical difference was not 
observed between groups (P > .05). 
 Anti-PCV2 IgG antibodies were not detected in presuckle sera collected from group 
1, 2, and 4 live-born piglets. Conversely, 2 live-born piglets in group 3 (same litter) had 
detectable anti-PCV2 antibodies with S/P ratios of 0.26 and 0.47, respectively (Table 4).  
 
PCV2 DNA detection by PCR 
PCV2 DNA was not detected by quantitative real-time PCR amplification in weekly 
serum samples collected prior to artificial insemination or during gestation from group 1, 2, 
or 3 sows. In contrast, 2/3 group 4 sows developed detectable PCV2 viremia during 
gestation. PCV2 viremia in group 4 sows first appeared at 70 days of gestation. Sows 
remained PCV2 viremic for 4 to 7 consecutive weeks and 1/3 sows had detectable PCV2 
DNA in serum at parturition. Significant differences in sow viremia were not observed 
between groups (P > .05) (data not shown). 
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Colostrum samples collected at parturition were negative for PCV2 DNA in groups 1 
and 2. In contrast, PCV2 DNA was detected in 2/3 group 3 sows and 3/3 group 4 sows (Table 
3). The amount of PCV2 DNA present in colostrum of group 4 sows (mean log PCV2 
genomic copies/ml colostrum) was significantly (P = .042) higher than observed in group 3 
(Table 3).   
Presuckle sera collected from groups 1 and 2 live-born piglets did not contain PCV2 
DNA. PCV2 DNA was detected in sera from group 3 and group 4 live-born piglets (Table 4). 
Group 3 live-born viremic piglets originated in two different litters (1 and 2 piglets, 
respectively).  
 
Macroscopic lesions, microscopic examination, and immunohistochemistry 
 At necropsy, no gross lesions were observed in live-born piglets or stillborns from 
group 1, 2, 3, or 4 sows. Furthermore, no microscopic tissue changes associated with PCV2 
infection or PCV2 antigen were detected in live-born, stillborn, or mummified fetuses from 
group 1, 2, or 3 sows or in examined placental sections. However, one live-born piglet from a 
group 4 sow had mild multifocal myocardial degeneration and necrosis (Table 4) with 
lymphoid depletion in the tonsil and spleen. In this piglet, moderate to abundant amounts of 
PCV2 antigen were detected in myocardium and tonsil as determined by IHC stains (Table 
4). 
 
Discussion 
PCV2-associated viremia in the dam is the most likely source of fetal infection (29, 
30), though semen transmission appears to be a possible route (13, 14, 17, 18, 19, 35). 
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Previous experimental studies proved that PCV2 is capable of crossing the placenta in naïve 
sows after intranasal inoculation during late gestation (29). In the current study, oronasal 
PCV2 inoculation resulted in detectable viremia, development of anti-PCV2 antibodies, and 
the presence of PCV2 DNA in colostrum samples of group 4 (unvaccinated) sows. PCV2 
viremia of the dam resulted in transplacental infection of in utero fetuses confirming the 
potential of vertical transmission of PCV2 infection. In contrast to other experimental and 
field observations of PCV2-associated reproductive failure (11, 24, 29, 31, 39), abortion, dam 
illness, or increased numbers of non-viable piglets were not observed under the conditions of 
this study. Differences between studies may be related to differences in amount or virulence 
of the PCV2 isolate used for inoculation.  However, our findings suggest that vertical PCV2 
transmission in the field could occur at a higher incidence than what has been reported. 
In recent years, multiple PCV2 vaccines have become available to combat PCVAD. 
Currently, three vaccines are licensed for growing pigs 3-4 weeks of age or older and another 
vaccine is labeled for pre-farrowing usage on dams.  In a PCV2 vaccination study involving 
72 growing animals, vaccination prevented detectable PCV2-associated viremia and reduced 
PCV2 fecal and oral shedding of viral DNA (8). In another experimental study, vaccination 
induced neutralizing antibodies and reduced PCV2 viremia, fecal shedding, and PCV2-
associated microscopic lesions (25). Similar observations were made during field 
investigations involving PCV2-vaccinated and non-vaccinated pigs (6, 10, 15).  
To date, the performance of only one PCV2 vaccine has been experimentally studied 
in breeding animals. Sow vaccination reduced numbers of stillborn piglets at parturition, 
decreased pre-wean piglet mortality, improved sow mortality, and improved farrowing rates 
(Schøning et al., 2008; Bech et al., 2008; Ebbesen et al., 2008; Kunstmann et al., 2008; Joisel 
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et al., 2008; Delisle et al., 2008). Vaccination was found to be successful in reducing PCV2-
associated reproductive failure and improving sow performance under field conditions. 
However, to our knowledge, the effect of sow vaccination on fetal PCV2 replication in utero 
has not been investigated to date. 
Detectable differences in the immune response following vaccination of pregnant 
animals and differences in immune regulation in the uterus during pregnancy have been 
reported (22, 40).  In the current study, sows were vaccinated after confirmation of 
pregnancy due to limited availability of PCV2 naïve sows. PCV2 vaccination in pregnant 
animals had no detectable adverse effects when administered at 28 days of gestation, 
eliminated detectable PCV2 viremia and induced both serum neutralizing antibodies and 
colostral anti-PCV2-antibodies. However, vaccination did not prevent presence of PCV2 
DNA in colostral samples, fetal PCV2 viremia or the development of anti-PCV2 IgG 
antibodies in piglets following PCV2 challenge at 56 days of gestation. Possible 
considerations for the lack of PCV2 viremia in group 3 sows include limited detection rate 
due to the timing of serum collection (weekly) or the sensitivity of the PCR assay. 
Interestingly, live-born group 3 piglets that were viremic or had anti-PCV2 antibodies at birth 
did not have detectable PCV2 antigen in tissues (myocardium, lung, tonsil, or pinnae). This 
suggests that either fetal infection occurred later in gestation as compared to group 4 piglets 
or that dam vaccination reduced fetal PCV2 replication.  
Although PCV2 vaccination in this report did not prevent fetal infection, two group 3 
piglets developed specific anti-PCV2 antibodies in utero without having detectable presuckle 
viremia, microscopic lesions associated with fetal infection or detectable PCV2 antigen in 
tissue. This implies that immunocompetent fetuses (greater than 70 days of gestation) are 
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able to clear infection prior to parturition without associated microscopic lesions or 
detectable PCV2 antigen. This observation has not been previously reported and is similar to 
PPV infection in fetal swine (Mengeling, 2006)(20). 
In summary, PCV2 infection of naïve pregnant sows may not result in reproductive 
failure, but can be associated with fetal infection. PCV2 vaccination in pregnant sows 
induced neutralizing and anti-PCV2 antibodies in serum and colostrum, but did not prevent 
vertical transmission. Sow vaccination also did not prevent colostral shedding of PCV2 
which can be another route of vertical transmission.  Furthermore, a proportion of fetuses 
infected in utero were able to clear PCV2 infection prior to parturition.  
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Table 1. Summary of expelled piglets and fetuses by litter and group at parturition for non-
vaccinated and non-inoculated sows (group 1), sows vaccinated at 28 days of gestation 
(groups 2 and 3), or sows oronasally inoculated with PCV2b (groups 3 and 4) at 56 days of 
gestation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group Sow ID Total born Live-born Stillborn Mummified 
1 
1 11 10 1 0 
2 10 9 1 0 
3 16 14 2 0 
2 
4 18 14 2 2 
5 12 11 1 0 
6 13 11 0 2 
3 
7 15 12 2 1 
8 19 17 0 2 
9 16 16 0 0 
4 
10 12 11 0 1 
11 14 14 0 0 
12 10 10 0 0 
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Table 2. Prevalence and sow-associated mean group levels of IgG anti-PCV2 and serum neutralizing antibodies for sows non-
vaccinated and non-inoculated (group 1), vaccinated at 28 days of gestation (groups 2 and 3), or oronasally inoculated with PCV2b 
(groups 3 and 4) at 56 days of gestation.  
 
 
 
 
 
 
 
 
 
 * Mean group sample-to-positive ratio (±SE)  
‡ Mean log transformed serum neutralizing antibody levels (±SE) 
Group 
 Days of gestation 
 28  56  84  112 
 IgG 
antibodies* 
 
IgG 
antibodies* 
Neutralizing 
antibodies‡ 
 
IgG 
antibodies* 
 
IgG 
antibodies* 
Neutralizing 
antibodies‡ 
1  0/3 (0.00±0.00)  0/3 (0.00±0.00) 0/3 (1.81±0.00)  0/3 (0.00±0.00)  0/3 (0.00±0.00) 0/3 (1.81±0.00) 
2  0/3 (0.00±0.00)  2/3 (0.29±0.15) 3/3 (2.31±0.20)  2/3 (0.28±0.11)  3/3 (0.56±0.05) 3/3 (2.41±0.00) 
3  0/3 (0.00±0.00)  2/3 (0.08±0.15) 2/3 (2.11±0.30)  2/3 (0.29±0.15)  3/3 (0.43±0.11) 3/3 (2.51±0.10) 
4  0/3 (0.00±0.00)  0/3 (0.00±0.00) 0/3 (1.81±0.00)  1/3 (0.23±0.21)  3/3 (0.40±0.12) 3/3 (2.81±0.44) 
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Table 3. Prevalence (number of positive animals/total number of animals) and mean group 
IgG anti-PCV2 antibodies (sample-to-positive ratio ±SE) and log transformed PCV2 DNA 
(±SE) in colostrum of sows non-vaccinated and non-inoculated (group 1), vaccinated at 28 
days of gestation (groups 2 and 3), or oronasally inoculated with PCV2b (groups 3 and 4) at 
56 days of gestation.  
 
 
 
 
 
* Different superscripts (A, B) within the column indicate a significant (P < .05) difference 
in group mean PCV2 DNA amount.   
 
 
 
 
 
 
 
 
 
Group PCV2 antibodies PCV2 DNA 
1 0/3 (0.00±0.00) 0/3 (0.00±0.00)A* 
2 3/3 (0.75±0.22) 0/3 (0.00±0.00)A 
3 3/3 (0.49±0.12) 2/3 (2.41±1.20)A 
4 3/3 (0.50±0.14) 3/3 (4.68±1.15)B 
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Table 4. Incidence of PCV2 DNA and IgG anti-PCV2 antibodies in presuckle serum 
samples, light microscope associated lesions (myocardial necrosis, myocarditis, or fibrosis) 
and immunohistochemical staining for PCV2 antigen in tissue (heart, lung, tonsil and pinnae) 
by group for piglets from sows non-vaccinated and non-inoculated (group 1), vaccinated at 
28 days of gestation (groups 2 and 3), or oronasally inoculated with PCV2b (groups 3 and 4) 
at 56 days of gestation.  
 
 
* Total number of live-born piglets, stillborns and mummified fetuses by group  
  
Group 
 
 
n* 
Presuckle serum Microscopic lesions PCV2 antigen 
PCV2 
PCR 
PCV2 
antibodies Heart Heart Lung Tonsil Pinnae 
1 37 0/33 0/33 0/37 0/37 0/37 0/37 0/37 
2 43 0/36 0/36 0/43 0/43 0/43 0/43 0/43 
3 50 3/45 2/45 0/50 0/50 0/50 0/50 0/50 
4 36   1/35 0/35        1/36 1/36 0/36 1/36 0/36 
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CHAPTER 8.  GENERAL CONCLUSIONS 
 
Porcine circovirus type 2 (PCV2) is globally distributed, ubiquitous in swine herds, 
and considered one of the most economically important swine viruses affecting pig 
production (Opriessnig et al., 2007). Porcine circovirus associated disease (PCVAD) may be 
clinical or subclinical, generally manifests in growing pigs, is multifactorial, and can appear 
as multisystemic disease with wasting, pneumonia, and/or diarrhea. In sexually mature 
female pigs, PCV2 infection has been associated with reproductive failure at all stages of 
gestation. PCV2-associated reproductive failure may manifest as early embryonic death, in 
utero fetal death leading to increased non-viable fetuses at birth, or abortion.  
In 2005-2006, the effects of PCVAD were devastating for swine production with high 
morbidity and mortality in growing pigs throughout North America. These PCVAD 
outbreaks were attributed to PCV2b which was a newly recognized PCV2 genotype in North 
America. The rapid dissemination of PCV2b drove the need and interest in better 
understanding routes of transmission, particularly semen transmission. Multiple PCV2 
vaccines became commercially available in North America in 2006 as an effort to control 
production losses due to PCVAD; however, they are licensed for use only on growing pigs 
and their efficacy in breeding age animals is poorly understood. 
This thesis documents our efforts to characterize the role of boars in the transmission 
of PCV2, to determine the significance of semen-associated PCV2 and its role in PCV2-
associated reproductive failure, and to establish the role of dam immunity through previous 
infection or vaccination in preventing PCV2-associated reproductive failure. The information 
generated by this work is important to researchers studying the pathogenesis of PCV2, 
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veterinary diagnosticians investigating cases of reproductive failure, and for swine 
veterinarians and producers developing and implementing PCV2 prevention and control 
strategies.     
Previous to our experimental inoculation of mature boars with PCV2a or PCV2b, 
semen shedding of PCV2 was reported to occur intermittently post-infection (Larochelle et 
al., 2000), was more prevalent in younger boars, and Landrace and Duroc boars were found 
to have a higher incidence of semen shedding (McIntosh et al., 2006b). After intranasal and 
intramuscular inoculation of 7 month old Landrace boars, a difference in the amount of 
PCV2a and PCV2b in semen was not detected. We found that during the acute phase of 
infection PCV2 viremia precedes semen shedding, clinical signs in mature boars are 
unapparent, and PCV2 DNA in semen can be detected as early as 6 days post-infection 
(DPI). Peak PCV2 semen shedding occurs between 10-20 days post-infection for both 
PCV2a and PCV2b. In the later stages of infection, PCV2 semen shedding can occur in the 
absence of detectable viremia. We also determined that PCV2 semen shedding can be 
continuously shed for at least 90 days and we further confirmed that semen morphology and 
concentration is not affected by PCV2 infection (McIntosh et al., 2006a). Since our 
experiment was terminated at 90 DPI, we can only speculate that semen shedding of PCV2 
may occur longer than 3 months. Our boar model highlights that PCV2 infection and semen 
shedding is inconspicuous unless correct diagnostic testing is implemented.  
PCV2 detection in semen is not uncommon when testing is implemented (Kim et al., 
2001; Schmoll et al., 2008). The prevalence of PCV2 shedding in semen is highly variable 
within boar studs and is associated with the age of the boars tested (Reicks et al., 2007). The 
impact of semen-associated PCV2 on reproductive performance and piglet viability was the 
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primary aim of our semen infectivity study. Previously, multiple epidemiological studies 
have failed to associate contaminated semen with downstream PCVAD in growing pigs 
(Rose et al., 2003; Wallgren et al., 2004; Lawton et al., 2004). PCV2 present in raw semen 
collected from acutely infected PCV2a and PCV2b boars and intraperitoneally injected into 
4-week-old pigs was infectious. Inoculated bioassay pigs developed viremia, seroconverted, 
and had PCV2 antigen within lymphoid tissue. This part of the experiment proved that 
semen-associated PCV2 is infectious. When the same raw semen was extended and used for 
artificial insemination (AI) in PCV2 naïve gilts, active infection was not induced in the gilts 
or their offspring. The particular semen extender used in the experiment had no impact on the 
survivability of infectious PCV2 in semen (Madson et al., 2009d). Information gathered from 
this study confirms that PCV2a or PCV2b in semen is infectious and poses a potential 
biosecurity risk, but provides evidence that dam infection following AI is likely dose 
dependent. 
Dose dependent transmission of porcine reproductive and respiratory syndrome virus 
(PRRSV) and classical swine fever virus (CSFV) to susceptible dams has been documented 
after AI with contaminated semen (de Smit et al., 1999; Benfield et al., 2000). We designed 
our next study to determine if PCV2-spiked semen could transmit infectious PCV2 to naïve 
dams following AI and result in PCV2-associated reproductive failure. PCV2a and PCV2b 
inseminated dams developed viremia by two weeks post insemination indicating that 
placement of PCV2 in the reproductive tract of naïve dams can lead to dam infection. Dams 
inseminated with PCV2b-spiked semen became pregnant and maintained pregnancy to full 
term without clinical signs of PCV2 infection. Dams inseminated with PCV2a-spiked semen 
failed to conceive and did not return to estrus at a regular interval. At parturition, pregnant 
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dams delivered PCV2 viremic live-born piglets, stillborn fetuses with gross lesions of 
congestive heart failure, and mummified fetuses of variable sizes. Myocardium from piglets 
and fetuses contained PCV2 antigen and was the most consistent sample for correct diagnosis 
of PCV2-associated reproductive failure (Madson et al., 2009c). We successfully reproduced 
PCV2-associated reproductive failure using a spiked semen model and found PCV2 DNA in 
colostrum samples similar to previous reports (Shibata et al., 2006). Our AI model provides 
evidence that PCV2 contaminated semen can be a point source for PCV2 dissemination and 
infection if naïve dams are inseminated with contaminated semen.          
  PCV2 is globally distributed and the vast majority of sow farms are seropositive 
(Allan et al., 2000). Even though the majority of reports of PCV2-associated reproductive 
failure involve gilts, in utero PCV2 fetal infection has been reported in seropositive sows 
(Janke, 2000; Nielsen et al., 2004). Since the introduction of commercial PCV2 vaccines, 
veterinarians have utilized PCV2 vaccines in replacement gilts and in sows in breeding herds 
to induce maternal antibodies and pass on immunity to prevent disease in the growing pig 
population. Because the most breeding age animals have either been vaccinated and/or 
previously exposed to PCV2, our previous PCV2-spiked semen model using naïve dams is 
not a realistic representation of PCV2 transmission in the field. For this reason, we repeated 
our PCV2-spiked semen model in vaccinated dams or dams previously exposed to PCV2. 
One of three vaccinated dams and two of three previously exposed dams developed 
detectable PCV2 viremia post AI. Viremia was shorter in duration and occurred later than we 
observed in naïve dams. Two of three vaccinated and three of three previously exposed dams 
became pregnant and farrowed at term. In previously exposed dams, PCV2 fetal infection 
was not detected in the offspring. Alternatively, 15/24 live-born piglets born to vaccinated 
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sows were viremic at birth (Madson et al., 2008a). This demonstrates that PCV2 vaccination 
with a current killed commercial vaccine may not prevent fetal infection, whereas previous 
homologous PCV2 challenge can prevent fetal infection following artificial insemination 
with contaminated semen. 
 PCV2 vaccination has greatly reduced mortality and morbidity linked to PCVAD in 
growing pigs worldwide. Vaccination in pregnant dams has also been shown to reduce 
numbers of non-viable piglets at parturition, to decrease pre-wean mortality, and to decrease 
sow mortality in herds previously experiencing PCV2-associated reproductive disease 
(Schøning et al., 2008; Bech et al., 2008; Joisel et al., 2008). In our final study, we further 
investigated the role of PCV2 vaccination in breeding herds in order to prevent in utero fetal 
infection. During dam viremia, PCV2 crosses the placenta and potentially leads to fetal 
infection. We found that PCV2 vaccination during gestation has no detectable adverse effects 
on pregnancy and the recommended dose for growing pigs induces serum neutralizing and 
specific anti-PCV2 antibodies in dams. In the growing pig model, PCV2 vaccine can block 
detectable levels of viremia. Similarly, we demonstrated that PCV2 vaccination can block 
PCV2 viremia in the dam after heterologous PCV2 challenge. However, vaccination of the 
dam does not prevent in utero fetal infection. This experiment also provides further evidence 
that in utero fetuses that become infected at 70 days of gestation or later are able to clear 
PCV2 infection with minimal or no PCV2-associated lesions (Madson et al., 2009b).    
 The research described in this dissertation has contributed to the body of knowledge 
on semen transmission and dam immunity linked with PCV2-associated reproductive failure. 
Future work needs to be done to improve the efficacy and optimize the timing of boar 
vaccination to reduce or eliminate semen shedding of PCV2. Because coinfections have been 
201 
 
 
demonstrated to increase PCV2 replication and PCV2-associated disease in growing pigs, 
further work should also be done to understand the effect of various coinfections on the 
amount of PCV2 shed in semen of boars. The PCV2-spiked semen model could be used to 
establish an infectious dose for dam viremia following AI, to determine if there are 
differences among PCV2 isolates in their ability to replicate intrauterine, and to substantiate 
whether dam immunity protects against heterologous challenge. Field investigations designed 
to determine the true prevalence of in utero PCV2 infection should also be conducted. Since 
we observed normal appearing PCV2 viremic piglets in affected litters, it is important that 
live-born piglets from PCV2-infected dams be monitored in the growing phase to determine 
if they clear the infection and become otherwise normal, if they are persistently infected and 
become a source of virus replication and shedding, or if they succumb to clinical PCVAD.  
  
202 
 
 
REFERENCE CITED 
 1.  Allan,G., Krakowka,S., Ellis,J., 2002a. PCV2; ticking time bomb? Pig Progress 18, 
14-15. 
 2.  Allan,G., Meehan,B., Todd,D., Kennedy,S., McNeilly,F., Ellis,J., Clark,E.G., 
Harding,J., Espuna,E., Botner,A., Charreyre,C., 1998a. Novel porcine circoviruses 
from pigs with wasting disease syndromes. Vet.Rec. 142, 467-468. 
 3.  Allan,G.M., Caprioli,A., McNair,I., Lagan-Tregaskis,P., Ellis,J., Krakowka,S., 
McKillen,J., Ostanello,F., McNeilly,F., 2007. Porcine circovirus 2 replication in 
colostrum-deprived piglets following experimental infection and immune stimulation 
using a modified live vaccine against porcine respiratory and reproductive syndrome 
virus. Zoonoses Public Health 54, 214-222. 
 4.  Allan,G.M. and Ellis,J.A., 2000. Porcine circoviruses: a review. J.Vet.Diagn.Invest 
12, 3-14. 
 5.  Allan,G.M., McNeilly F., Meehan,B.M., Kennedy,S., Mackie,D.P., Ellis,J.A., 
Clark,E.G., Espuna,E., Saubi,N., Riera,P., Bøtner,A., Charreyre,C.E., 1999. Isolation 
and characterisation of circoviruses from pigs with wasting syndromes in Spain, 
Denmark and Northern Ireland. Vet.Microbiol. 66, 115-123. 
 6.  Allan,G.M., McNeilly,F., Cassidy,J.P., Reilly,G.A., Adair,B., Ellis,W.A., 
McNulty,M.S., 1995. Pathogenesis of porcine circovirus; experimental infections of 
colostrum deprived piglets and examination of pig foetal material. Vet.Microbiol. 44, 
49-64. 
 7.  Allan,G.M., McNeilly,F., Kennedy,S., Daft,B., Clarke,E.G., Ellis,J.A., Haines,D.M., 
Meehan,B.M., Adair,B.M., 1998b. Isolation of porcine circovirus-like viruses from 
pigs with a wasting disease in the USA and Europe. J.Vet.Diagn.Invest 10, 3-10. 
 8.  Allan,G.M., McNeilly,F., McNair,I., Meehan,B., Marshall,M., Ellis,J., Lasagna,C., 
Boriosi,G., Krakowka,S., Reynaud,G., Boeuf-Tedeschi,L., Bublot,M., Charreyre,C., 
2002b. Passive transfer of maternal antibodies to PCV2 protects against development 
of post-weaning multisystemic wasting syndrome (PMWS): experimental infections 
and a field study. The Pig Journal 50, 59-67. 
 9.  Allan,G.M., Phenix,K.V., Todd,D., McNulty,M.S., 1994. Some biological and 
physico-chemical properties of porcine circovirus. Zentralbl.Veterinarmed.B 41, 17-
26. 
 10.  Almond,G.W., Flowers,W.L., Batista,L., D'Allaire,S., 2006. Diseases of the 
reproductive system. In: Diseases of swine, ed. Straw BE, Zimmerman, J. J, 
D'Allaire, S., Taylor, D. J., 9th ed., pp. 113-148. 
203 
 
 
 11.  An,D.J., Roh,I.S., Song,D.S., Park,C.K., Park,B.K., 2007. Phylogenetic 
characterization of porcine circovirus type 2 in PMWS and PDNS Korean pigs 
between 1999 and 2006. Virus Res 129, 115-122. 
 12.  Andraud,M., Grasland,B., Durand,B., Cariolet,R., Jestin,A., Madec,F., Pierre,J.S., 
Rose,N., 2009. Modeling the time-dependent transmission rate for porcine circovirus 
type 2 (PCV2) in pigs using data from serial transmission experiments. J R Soc 
Interface 6, 39-50. 
 13.  Andraud,M., Grasland,B., Durand,B., Cariolet,R., Jestin,A., Madec,F., Rose,N., 2008. 
Quantification of porcine circovirus type 2 (PCV-2) within- and between-pen 
transmission in pigs. Vet Res 39, 43. 
 14.  Bane,D.P., James,J.E., Gradil,C.M., Molitor,T.W., 1990. In vitro exposure of 
preimplantation porcine embryos to porcine parvovirus. Theriogenology 33, 553-561. 
 15.  Bassami,M.R., Berryman,D., Wilcox,G.E., Raidal,S.R., 1998. Psittacine beak and 
feather disease virus nucleotide sequence analysis and its relationship to porcine 
circovirus, plant circoviruses, and chicken anaemia virus. Virology 249, 453-459. 
 16.  Bech,A.B. and Kunstmann,L., 2008. Effect of sow vaccination with Circovac® on the 
performances of 3 Danish herds in Northern Jutland. Proceedings of the 20th 
International Pig Veterinary Society Congress 2, 109. 
 17.  Benfield,D., Nelson,C., Steffen,M., Rowland,R., 2000. Transmission of PRRSV by 
artificial insemination using extended semen seeded with different concentrations of 
PRRSV. Proc American Association of Swine Practitioners 405-408. 
 18.  Biagini,P., 2004. Human circoviruses. Vet Microbiol 98, 95-101. 
 19.  Bielanski,A., Larochelle,R., Algire,J., Magar,R., 2004a. Distribution of PCV-2 DNA 
in the reproductive tract, oocytes and embryos of PCV-2 antibody-positive pigs. 
Vet.Rec. 155, 597-598. 
 20.  Bielanski,A., Larochelle,R., Magar,R., 2004b. An attempt to render oocytes and 
embryos free from the porcine circovirus type 2 after experimental in vitro exposure. 
Can J Vet Res 68, 222-225. 
 21.  Bischoff,R., Jedidia,S.B., Rocker,B., Kamphake,M.G., 2009. Longitudinal study on 
the efficacy of Ingelvac CircoFLEX (R) against Porcine Respiratory Disease 
Complex (PRDC). Praktische Tierarzt 90, 58-63. 
 22.  Blanchard,P., Mahé,D., Cariolet,R., Keranflec'h,A., Baudouard,M.A., Cordioli,P., 
Albina,E., Jestin,A., 2003a. Protection of swine against post-weaning multisystemic 
wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 
21, 4565-4575. 
204 
 
 
 23.  Blanchard,P., Mahé,D., Cariolet,R., Truong,C., Le,D.M., Arnauld,C., Rose,N., 
Eveno,E., Albina,E., Madec,F., Jestin,A., 2003b. An ORF2 protein-based ELISA for 
porcine circovirus type 2 antibodies in post-weaning multisystemic wasting 
syndrome. Vet.Microbiol. 94, 183-194. 
 24.  Bogdan,J., West,K., Clark,E., Konoby,C., Haines,D., Allan,G., McNeilly,F., 
Meehan,B., Krakowka,S., Ellis,J.A., 2001. Association of porcine circovirus 2 with 
reproductive failure in pigs: a retrospective study, 1995-1998. Can.Vet.J. 42, 548-
550. 
 25.  Bolin,S.R., Stoffregen,W.C., Nayar,G.P., Hamel,A.L., 2001. Postweaning 
multisystemic wasting syndrome induced after experimental inoculation of cesarean-
derived, colostrum-deprived piglets with type 2 porcine circovirus. J.Vet.Diagn.Invest 
13, 185-194. 
 26.  Brunborg,I.M., Jonassen,C.M., Moldal,T., Bratberg,B., Lium,B., Koenen,F., 
Schonheit,J., 2007. Association of myocarditis with high viral load of porcine 
circovirus type 2 in several tissues in cases of fetal death and high mortality in piglets. 
A case study. J Vet Diagn.Invest 19, 368-375. 
 27.  Brunborg,I.M., Moldal,T., Jonassen,C.M., 2004. Quantitation of porcine circovirus 
type 2 isolated from serum/plasma and tissue samples of healthy pigs and pigs with 
postweaning multisystemic wasting syndrome using a TaqMan-based real-time PCR. 
J.Virol.Methods 122, 171-178. 
 28.  Bureau,M., Dea,S., Sirard,M.A., 2005. Evaluation of virus decontamination 
techniques for porcine embryos produced in vitro. Theriogenology 63, 2343-2355. 
 29.  Calsamiglia,M., Fraile,L., Espinal,A., Cuxart,A., Seminati,C., Martin,M., Mateu,E., 
Domingo,M., Segales,J., 2007. Sow porcine circovirus type 2 (PCV2) status effect on 
litter mortality in postweaning multisystemic wasting syndrome (PMWS). Res.Vet 
Sci. 82, 299-304. 
 30.  Calsamiglia,M., Segalés,J., Quintana,J., Rosell,C., Domingo,M., 2002. Detection of 
porcine circovirus types 1 and 2 in serum and tissue samples of pigs with and without 
postweaning multisystemic wasting syndrome. J.Clin.Microbiol. 40, 1848-1850. 
 31.  Caprioli,A., McNeilly,F., McNair,I., Lagan-Tregaskis,P., Ellis,J., Krakowka,S., 
McKillen,J., Ostanello,F., Allan,G., 2006. PCR detection of porcine circovirus type 2 
(PCV2) DNA in blood, tonsillar and faecal swabs from experimentally infected pigs. 
Res.Vet Sci. 81, 287-292. 
 32.  Cariolet,R., Blanchard,P., Le Dimna,M., Mahé,D., Jolly,J.P., de Boisséson C., 
Truong,C., Ecobichon,P., Madec,F., Jestin,A., 2002. Experimental infection of 
pregnant SPF sows with PCV2 through tracheal and muscular routes. ssDNA Viruses 
of Plants, Birds, Pigs and Primates 128. 
205 
 
 
 33.  Carrasco,L., Segalés,J., Bautista,M.J., Gómez-Villamandos,J.C., Rosell,C., Ruiz-
Villamor,E., Sierra,M.A., 2000. Intestinal chlamydial infection concurrent with 
postweaning multisystemic wasting syndrome in pigs. Vet.Rec. 146, 21-23. 
 34.  Chae,C., 2004. Postweaning multisystemic wasting syndrome: a review of aetiology, 
diagnosis and pathology. Vet.J. 168, 41-49. 
 35.  Chae,C., 2005. A review of porcine circovirus 2-associated syndromes and diseases. 
Vet.J. 169, 326-336. 
 36.  Charreyre,C., Bésème,S., Brun,A., Bublot,M., Joisel,F., Lapostolle,B., Sierra,P., 
Vaganay,A., 2005. Protection of piglets against a PCV2 experimental challenge by 
vaccinating gilts with inactivated adjuvanted PCV2 vaccine. Proc Intern Conf 
"Animal Circoviruses and Associated Disease" 26-30. 
 37.  Cheung,A.K., 2003a. The essential and nonessential transcription units for viral 
protein synthesis and DNA replication of porcine circovirus type 2. Virology 313, 
452-459. 
 38.  Cheung,A.K., 2003b. Transcriptional analysis of porcine circovirus type 2. Virology 
305, 168-180. 
 39.  Cheung,A.K., 2004. Identification of an octanucleotide motif sequence essential for 
viral protein, DNA, and progeny virus biosynthesis at the origin of DNA replication 
of porcine circovirus type 2. Virology 324, 28-36. 
 40.  Cheung,A.K., 2006. Rolling-circle replication of an animal circovirus genome in a 
theta-replicating bacterial plasmid in Escherichia coli. J.Virol. 80, 8686-8694. 
 41.  Cheung,A.K., 2009. Homologous recombination within the capsid gene of porcine 
circovirus type 2 subgroup viruses via natural co-infection. Arch Virol 154, 531-534. 
 42.  Cheung,A.K., Lager,K.M., Kohutyuk,O.I., Vincent,A.L., Henry,S.C., Baker,R.B., 
Rowland,R.R., Dunham,A.G., 2007. Detection of two porcine circovirus type 2 
genotypic groups in United States swine herds. Arch.Virol. 152, 1035-1044. 
 43.  Choi,C. and Chae,C., 2001. Colocalization of porcine reproductive and respiratory 
syndrome virus and porcine circovirus 2 in porcine dermatitis and nephrology 
syndrome by double-labeling technique. Vet.Pathol. 38, 436-441. 
 44.  Choi,C., Kim,J., Kang,I.J., Chae,C., 2002a. Concurrent outbreak of PMWS and 
PDNS in a herd of pigs in Korea. Vet.Rec. 151, 484-485. 
 45.  Choi,J., Stevenson,G.W., Kiupel,M., Harrach,B., Anothayanontha,L., Kanitz,C.L., 
Mittal,S.K., 2002b. Sequence analysis of old and new strains of porcine circovirus 
associated with congenital tremors in pigs and their comparison with strains involved 
with postweaning multisystemic wasting syndrome. Can.J.Vet.Res. 66, 217-224. 
206 
 
 
 46.  Ciacci-Zanella,J.R., Zanella,E.L., Locatelli,M.L., Brambatti,J.L., Simon,N.L., 
Coldebella,M., 2007. Detection of porcine circovirus 2 in semen collected from 
naturally infected boar studs in Brazil. 5th International Symposium on Emerging and 
Re-emerging Pig Diseases 94. 
 47.  Ciacci-Zanella,J.R., Zanella,E.L., Morés,N., Neide,M., Kelen,A., Giseli,R., 
Almiro,D., Gava,D., 2008. Absence of apoptosis and cellular changes in the 
reproductive system of boars naturally infected with porcine circovirus 2 (PCV2). 
Proceedings of the 20th International Pig Veterinary Society Congress 1, 23. 
 48.  Clark,E.G., 1997. Post-weaning multisystemic wasting syndrome. Proc American 
Association of Swine Practitioners 28, 499-501. 
 49.  Cottrell,T.S., Friendship,R.M., Dewey,C.E., Allan,G., Walker,I., McNeilly,F., 1999. 
A study investigating epidemiological risk factors for porcine circovirus type II in 
Ontario. The Pig Journal 44, 10-17. 
 50.  Csagola,A., Cadar,D., Tuboly,T., 2008. Replication and transmission of porcine 
circovirus type 2 in mice. Acta Vet Hung 56, 421-427. 
 51.  Csagola,A., Kecskemeti,S., Kardos,G., Kiss,I., Tuboly,T., 2006. Genetic 
characterization of type 2 porcine circoviruses detected in Hungarian wild boars. 
Arch.Virol. 151, 495-507. 
 52.  Darwich,L., Pie,S., Rovira,A., Segalés,J., Domingo,M., Oswald,I.P., Mateu,E., 2003. 
Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by 
postweaning multisystemic wasting syndrome. J.Gen.Virol. 84, 2117-2125. 
 53.  Darwich,L., Segalés,J., Mateu,E., 2004. Pathogenesis of postweaning multisystemic 
wasting syndrome caused by Porcine circovirus 2: An immune riddle. Arch.Virol. 
149, 857-874. 
 54.  de Boisseson C., Beven,V., Bigarre,L., Thiery,R., Rose,N., Eveno,E., Madec,F., 
Jestin,A., 2004. Molecular characterization of Porcine circovirus type 2 isolates from 
post-weaning multisystemic wasting syndrome-affected and non-affected pigs. 
J.Gen.Virol. 85, 293-304. 
 55.  de Smit,A.J., Bouma,A., Terpstra,C., Van Oirschot,J.T., 1999. Transmission of 
classical swine fever virus by artificial insemination. Vet Microbiol 67, 239-249. 
 56.  Delisle,C., Delisle,G., Bridoux,N., Thibault,J.C., Longo,S., Joisel,F., 2008. Results of 
sow vaccination against PCV2 with Circovac in France: Improvement of reproduction 
parameters. Proceedings of the 20th International Pig Veterinary Society Congress 1, 
47. 
207 
 
 
 57.  Dorr,P.M., Baker,R.B., Almond,G.W., Wayne,S.R., Gebreyes,W.A., 2007. 
Epidemiologic assessment of porcine circovirus type 2 coinfection with other 
pathogens in swine. J Am.Vet Med.Assoc. 230, 244-250. 
 58.  Drolet,R., Larochelle,R., Morin,M., Delisle,B., Magar,R., 2003. Detection rates of 
porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and 
swine influenza virus in porcine proliferative and necrotizing pneumonia. Vet.Pathol. 
40, 143-148. 
 59.  Drolet,R., Thibault,S., D'Allaire,S., Thomson,J.R., Done,S.H., 1999. Porcine 
dermatitis and nephropathy syndrome (PDNS): An overview of the disease. Swine 
Health and Production 7, 283-285. 
 60.  Dulac,G.C. and Afshar,A., 1989. Porcine circovirus antigens in PK-15 cell line 
(ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs. 
Can.J.Vet.Res. 53, 431-433. 
 61.  Dupont,K., Nielsen,E.O., Baekbo,P., Larsen,L.E., 2008. Genomic analysis of PCV2 
isolates from Danish archives and a current PMWS case-control study supports a shift 
in genotypes with time. Vet Microbiol 128, 56-64. 
 62.  Ebbesen,T. and Kunstmann,L., 2008. Effect of sow vaccination with Circovac® on 
stillborn piglets. Proceedings of the 20th International Pig Veterinary Society 
Congress 2, 81. 
 63.  Edwards,S. and Sands,J.J., 1994. Evidence of circovirus infection in British pigs. 
Vet.Rec. 134, 680-681. 
 64.  Elbers,A.R., Hunneman,W.A., Vos,J.H., Zeeuwen,A.A., Peperkamp,M.T., van 
Exsel,A.C., 2000. Increase in PDNS diagnoses in the Netherlands. Vet.Rec. 147, 311- 
 65.  Ellis,J., Hassard,L., Clark,E., Harding,J., Allan,G., Willson,P., Strokappe,J., 
Martin,K., McNeilly,F., Meehan,B., Todd,D., Haines,D., 1998. Isolation of circovirus 
from lesions of pigs with postweaning multisystemic wasting syndrome. Can.Vet.J. 
39, 44-51. 
 66.  Ellis,J., Krakowka,S., Lairmore,M., Haines,D., Bratanich,A., Clark,E., Allan,G., 
Konoby,C., Hassard,L., Meehan,B., Martin,K., Harding,J., Kennedy,S., McNeilly,F., 
1999. Reproduction of lesions of postweaning multisystemic wasting syndrome in 
gnotobiotic piglets. J.Vet.Diagn.Invest 11, 3-14. 
 67.  Ellis,J., Spinato,M., Yong,C., West,K., McNeilly,F., Meehan,B., Kennedy,S., 
Clark,E., Krakowka,S., Allan,G., 2003. Porcine circovirus 2-associated disease in 
Eurasian wild boar. J.Vet.Diagn.Invest 15, 364-368. 
208 
 
 
 68.  Erlandson,K.R., Connor,J., Groth,D.D., 2007. Summary of finding from a pilot study 
on vaccination of mature boars with porcine circovirus type 2 vaccine. Proc Allen 
D.Leman Swine Conference 34, 100-101. 
 69.  Fachinger,V., Bischoff,R., Jedidia,S.B., Saalmuller,A., Elbers,K., 2008. The effect of 
vaccination against porcine circovirus type 2 in pigs suffering from porcine 
respiratory disease complex. Vaccine 26, 1488-1499. 
 70.  Fan,H.Y., Xiao,S., Tonga,T.Z., Wang,S.P., Xie,L.L., Jiang,Y.B., Chen,H.C., 
Fang,L.R., 2008. Immunogenicity of porcine circivirus type 2 capsid protein. 
Molecular Immunology 45, 653-660. 
 71.  Farnham,M.W., Choi,Y.K., Goyal,S.M., Joo,H.S., 2003. Isolation and 
characterization of porcine circovirus type-2 from sera of stillborn fetuses. 
Can.J.Vet.Res. 67, 108-113. 
 72.  Fenaux,M., Halbur,P.G., Gill,M., Toth,T.E., Meng,X.J., 2000. Genetic 
characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning 
multisystemic wasting syndrome in different geographic regions of North America 
and development of a differential PCR-restriction fragment length polymorphism 
assay to detect and differentiate between infections with PCV-1 and PCV-2. 
J.Clin.Microbiol. 38, 2494-2503. 
 73.  Fenaux,M., Opriessnig,T., Halbur,P.G., Elvinger,F., Meng,X.J., 2004. A chimeric 
porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV 
type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces 
protective immunity against PCV2 infection in pigs. J.Virol. 78, 6297-6303. 
 74.  Fenaux,M., Opriessnig,T., Halbur,P.G., Meng,X.J., 2003. Immunogenicity and 
pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus 
type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J.Virol. 77, 11232-11243. 
 75.  Ferreira,D., Sansot,B., Laval,A., 2001. Attempt to use serotherapy to control 
mortality in PMWS. Proc Conference of ssDNA Viruses, Plants, Birds, Pigs, and 
Primates 144. 
 76.  Flowers,W.L. and Esbenshade,K.L., 1993. Optimizing management of natural and 
artificial matings in swine. J Reprod.Fertil.Suppl 48, 217-228. 
 77.  Fort,M., Olvera,A., Sibila,M., Segales,J., Mateu,E., 2007. Detection of neutralizing 
antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and 
non-PMWS-affected pigs. Vet Microbiol 125, 244-255. 
 78.  Fort,M., Sibila,M., Allepuz,A., Mateu,E., Roerink,F., Segales,J., 2008. Porcine 
circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against 
PCV2 isolates of different genotypes and geographic origins. Vaccine 26, 1063-1071. 
209 
 
 
 79.  Gagnon,C.A., Tremblay,D., Tijssen,P., Venne,M.H., Houde,A., Elahi,S.M., 2007. 
The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. 
Can.Vet J 48, 811-819. 
 80.  Gava,D., Zanella,E.L., Morés,N., Ciacci-Zanella,J.R., 2008. Transmission of porcine 
circovirus 2 (PCV2) by semen and viral distribution in different piglet tissues. 
Pesquisa-Veterinaria-Brasileira 28, 70-76. 
 81.  Gerrits,R.J., Lunney,J.K., Johnson,L.A., Pursel,V.G., Kraeling,R.R., Rohrer,G.A., 
Dobrinsky,J.R., 2005. Perspectives for artificial insemination and genomics to 
improve global swine populations. Theriogenology 63, 283-299. 
 82.  Gibbs,M.J. and Weiller,G.F., 1999. Evidence that a plant virus switched hosts to 
infect a vertebrate and then recombined with a vertebrate-infecting virus. 
Proc.Natl.Acad.Sci.USA 96, 8022-8027. 
 83.  Gillespie,J., Juhan,N.M., DiCristina,J., Key,K.F., Ramamoorthy,S., Meng,X., 2008. A 
genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is 
genetically stable in vitro and in vivo. Vaccine 26, 4231-4236. 
 84.  Gillespie,T., Okones,J., Edler,R., Anderson,G., Kolb,J., Holck,J., 2006. Seasonally 
adjusted economic impact of PCV2 associated disease (PCVD) in a US grow/finish 
swine unit. Proceedings of the 19th International Pig Veterinary Society Congress 1, 
280. 
 85.  Grasland,B., Blanchard,P., Jan,B., Oger,A., Rose,N., Madec,F., Jestin,A., Cariolet,R., 
2008. Transmission of porcine circovirus of type 2 (PCV2) with semen. Proceedings 
of the 20th International Pig Veterinary Society Congress 2, 56. 
 86.  Grau-Roma,L., Hjulsager,C.K., Sibila,M., Kristensen,C.S., Lopez-Soria,S., Enoe,C., 
Casal,J., Botner,A., Nofrarias,M., Bille-Hansen,V., Fraile,L., Baekbo,P., Segales,J., 
Larsen,L.E., 2008. Infection, excretion and seroconversion dynamics of porcine 
circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome 
(PMWS) affected farms in Spain and Denmark. Vet Microbiol. 135, 272-282. 
 87.  Grau-Roma,L. and Segales,J., 2007. Detection of porcine reproductive and 
respiratory syndrome virus, porcine circovirus type 2, swine influenza virus and 
Aujeszky's disease virus in cases of porcine proliferative and necrotizing pneumonia 
(PNP) in Spain. Vet Microbiol. 119, 144-151. 
 88.  Gresham,A., Jackson,G., Giles,N., Allan,G., McNeilly,F., Kennedy,S., 2000. PMWS 
and porcine dermatitis nephropathy syndrome in Great Britain. Veterinary Record 
146, 143-143. 
210 
 
 
 89.  Grierson,S.S., King,D.P., Sandvik,T., Hicks,D., Spencer,Y., Drew,T.W., Banks,M., 
2004. Detection and genetic typing of type 2 porcine circoviruses in archived pig 
tissues from the UK. Arch.Virol. 149, 1171-1183. 
 90.  Guerin,B. and Pozzi,N., 2005. Viruses in boar semen: detection and clinical as well as 
epidemiological consequences regarding disease transmission by artificial 
insemination. Theriogenology 63, 556-572. 
 91.  Ha,Y., Ahn,K.K., Kim,B., Cho,K.D., Lee,B.H., Oh,Y.S., Kim,S.H., Chae,C., 2009. 
Evidence of shedding of porcine circovirus type 2 in milk from experimentally 
infected sows. Res Vet Sci 86, 108-110. 
 92.  Ha,Y., Jung,K., Chae,C., 2005. Lack of evidence of porcine circovirus type 1 and 
type 2 infection in piglets with congenital tremors in Korea. Vet.Rec. 156, 383-384. 
 93.  Ha,Y., Lee,Y.H., Ahn,K.K., Kim,B., Chae,C., 2008. Reproduction of postweaning 
multisystemic wasting syndrome in pigs by prenatal porcine circovirus 2 infection 
and postnatal porcine parvovirus infection or immunostimulation. Vet Pathol. 45, 
842-848. 
 94.  Hamel,A.L., Lin,L.L., Nayar,G.P., 1998. Nucleotide sequence of porcine circovirus 
associated with postweaning multisystemic wasting syndrome in pigs. J.Virol. 72, 
5262-5267. 
 95.  Harding,J. and Clark,E., 1997. Recognizing and diagnosing postweaning 
multisystemic wasting syndrome (PMWS). Swine Health and Production. 5, 201-203. 
 96.  Harding,J.C., 2004. The clinical expression and emergence of porcine circovirus 2. 
Vet.Microbiol. 98, 131-135. 
 97.  Harding,J.D., Done,J.T., Darbyshire,J.H., 1966. Congenital tremors in piglets and 
their relation to swine fever. Vet Rec 79, 388-390. 
 98.  Harding,J.D., Done,J.T., Harbourne,J.F., Randall,C.J., Gilbert,F.R., 1973. Congenital 
tremor type A 3 in pigs: an hereditary sex-linked cerebrospinal hypomyelinogenesis. 
Vet Rec 92, 527-529. 
 99.  Harms,P.A., Sorden,S., Halbur,P.G., Nawagitgul,P., Lager,K.M., Bolin,S.R., 
Paul,P.S., 2002. Role of maternal immunity to PCV2 and PRRSV co-infection in the 
pathogenesis of PMWS. Proc American Association of Swine Practitioners 307-311. 
 100.  Hassing,A.-G., Kristensen,C.S., Baekbo,P., 2003. Effect of sow on the mortality of 
pigs after weaning. 4th International Symposium on Emerging and Re-emerging Pig 
Diseases 193. 
 101.  Hasslung,F., Wallgren,P., Ladekjær-Hansen,A.S., Bøtner,A., Nielsen,J., Wattrang,E., 
Allan,G.M., McNeilly,F., Ellis,J., Timmusk,S., Belák,K., Segall,T., Melin,L., 
211 
 
 
Berg,M., Fossum,C., 2005. Experimental reproduction of postweaning multisystemic 
wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate 
of porcine circovirus type 2. Vet.Microbiol. 106, 49-60. 
 102.  Hérin,J.B., Fily,B., Longo,S., Joisel,F., 2007. Field results of the use of Circovac® a 
sow PCV2 vaccine in France under provisional license. Proc 5th International 
Symposium on Emerging and Re-emerging Pig Disease 125. 
 103.  Hesse,R., Kerrigan,M., Rowland,R.R., 2008. Evidence for recombination between 
PCV2a and PCV2b in the field. Virus Res 132, 201-207. 
 104.  Høgedal,P., Ovesen,A., Kunstmann,L., Haugegaard,S., Bille-Hansen,V., 2008. 
Porcine circovirus type 2 (PCV2) as a cause of foetal deaths in a newly established 
herd. Proceedings of the 20th International Pig Veterinary Society Congress 2, 221. 
 105.  Hoogland,M.J., Opriessnig,T., Halbur,P.G., 2006. Effects of adjuvants on porcine 
circovirus type 2-associated lesions. J.Swine Hlth Prod. 14, 133-139. 
 106.  Horlen,K.P., Schneider,P., Anderson,J., Nietfeld,J.C., Henry,S.C., Tokach,L.M., 
Rowland,R.R., 2007. A cluster of farms experiencing severe porcine circovirus 
associated disease: Clinical features and association with the PCV2b genotype. 
J.Swine Hlth Prod. 15, 270-278. 
 107.  Horlen,K.P., Dritz,S.S., Nietfeld,J.C., Henry,S.C., Hesse,R.A., Oberst,R., Hays,M., 
Anderson,J., Rowland,R.R., 2008. A field evaluation of mortality rate and growth 
performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med 
Assoc 232, 906-912. 
 108.  Huang,Y.Y., Walther,I., Martinson,S.A., Lopez,A., Yason,C., Godson,D.L., 
Clark,E.G., Simko,E., 2008. Porcine circovirus 2 inclusion bodies in pulmonary and 
renal epithelial cells. Vet Pathol. 45, 640-644. 
 109.  Janke,B.H., 2000. Case report: Porcine circovirus as a cause of reproductive 
problems. Proc Iowa Veterinary Medical Association. Ames, Iowa 101. 
 110.  Jensen,T.K., Vigre,H., Svensmark,B., Bille-Hansen,V., 2006. Distinction between 
porcine circovirus type 2 enteritis and porcine proliferative enteropathy caused by 
Lawsonia intracellularis. J.Comp Pathol. 135, 176-182. 
 111.  Johnson,C.S., Joo,H.S., Direksin,K., Yoon,K.J., Choi,Y.K., 2002. Experimental in 
utero inoculation of late-term swine fetuses with porcine circovirus type 2. 
J.Vet.Diagn.Invest 14, 507-512. 
 112.  Johnstone,A.C. and Lawton,D.E.B., 2008. Porcine dermatitis and nephropathy 
syndrome in New Zealand. New Zealand Veterinary Journal 56, 94-99. 
212 
 
 
 113.  Joisel,F., Brune,A., Schade,A., Longo,S., Charreyre,C., 2007a. Results of the 
vaccination against PCV2 diseases with Circovac® in 233 German sow herd: 
improvement on pig growth and decrease in antibiotic therapy. Proc 5th International 
Symposium on Emerging and Re-emerging Pig Disease 127. 
 114.  Joisel,F., Brune,A., Schade,A., Longo,S., Charreyre,C., 2007b. Results of the 
vaccination against PCV2 diseases with Circovac® in 233 German sow herds: 
decrease in mortality. Proc 5th International Symposium on Emerging and Re-
emerging Pig Disease 126. 
 115.  Joisel,F., Bune,A., Schade,A., Longo,S., Charreyre,C., 2008. Improvement of 
reproduction performance induced by PCV2 vaccination of sows and gilts with 
Circovac® in 277 German sow farms. Proceedings of the 20th International Pig 
Veterinary Society Congress 2, 72. 
 116.  Josephson,G. and Charbonneau,G., 2001. Case report of reporductive problem in a 
new startup operation. Swine Health and Production. 9, 258-259. 
 117.  Jung,K., Kim,J., Ha,Y., Choi,C., Chae,C., 2006. The effects of transplacental porcine 
circovirus type 2 infection on porcine epidemic diarrhoea virus-induced enteritis in 
preweaning piglets. Vet J. 171, 445-450. 
 118.  Kennedy,S., Segalés,J., Rovira,A., Scholes,S., Domingo,M., Moffett,D., Meehan,B., 
O'Neill,R., McNeilly,F., Allan,G., 2003. Absence of evidence of porcine circovirus 
infection in piglets with congenital tremors. J.Vet.Diagn.Invest 15, 151-156. 
 119.  Kim,J. and Chae,C., 2003a. Optimal enhancement of in situ hybridization for the 
detection of porcine circovirus 2 in formalin-fixed, paraffin-wax-embedded tissues 
using a combined pretreatment of thermocycler and proteinase K. Res.Vet.Sci. 74, 
235-240. 
 120.  Kim,J. and Chae,C., 2004a. A comparison of virus isolation, polymerase chain 
reaction, immunohistochemistry, and in situ hybridization for the detection of porcine 
circovirus 2 and porcine parvovirus in experimentally and naturally coinfected pigs. 
J.Vet.Diagn.Invest 16, 45-50. 
 121.  Kim,J. and Chae,C., 2005. Necrotizing lymphadenitis associated with porcine 
circovirus type 2 in pigs. Vet.Rec. 156, 177-178. 
 122.  Kim,J., Chung,H.K., Jung,T.W., Cho,W.S., Choi,C.S., Chae,C., 2002. Postweaning 
multisystemic wasting syndrome of pigs in korea: Prevalence, microscopic lesions 
and coexisting microorganisms. Journal of Veterinary Medical Science 64, 57-62. 
 123.  Kim,J., Ha,Y., Jung,K., Choi,C., Chae,C., 2004b. Enteritis associated with porcine 
circovirus 2 in pigs. Can.J.Vet.Res. 68, 218-221. 
213 
 
 
 124.  Kim,J., Han,D.U., Choi,C., Chae,C., 2001. Differentiation of porcine circovirus 
(PCV)-1 and PCV-2 in boar semen using a multiplex nested polymerase chain 
reaction. J.Virol.Methods 98, 25-31. 
 125.  Kim,J., Han,D.U., Choi,C., Chae,C., 2003b. Simultaneous detection and 
differentiation between porcine circovirus and porcine parvovirus in boar semen by 
multiplex seminested polymerase chain reaction. J.Vet.Med.Sci. 65, 741-744. 
 126.  Kim,J., Jung,K., Chae,C., 2004c. Prevalence of porcine circovirus type 2 in aborted 
fetuses and stillborn piglets. Vet.Rec. 155, 489-492. 
 127.  King,D., Dubuc,C., Painter,T., Holck,J., Edler,R., Johnson,C., Diaz,E., 2008. 
Biologic and economic benefits of controlling subclinical PCVAD with vaccination. 
Proc.39th American Association of Swine Veterinarians 159-161. 
 128.  Kiupel,M., Stevenson,G.W., Choi,J., Latimer,K.S., Kanitz,C.L., Mittal,S.K., 2001. 
Viral replication and lesions in BALB/c mice experimentally inoculated with porcine 
circovirus isolated from a pig with postweaning multisystemic wasting disease. 
Vet.Pathol. 38, 74-82. 
 129.  Kiupel,M., Stevenson,G.W., Galbreath,E.J., North,A., HogenEsch,H., Mittal,S.K., 
2005. Porcine circovirus type 2 (PCV2) causes apoptosis in experimentally inoculated 
BALB/c mice. BMC.Vet.Res. 48, 1-7. 
 130.  Kixmoller,M., Ritzmann,M., Eddicks,M., Saalmuller,A., Elbers,K., Fachinger,V., 
2008. Reduction of PMWS-associated clinical signs and co-infections by vaccination 
against PCV2. Vaccine 26, 3443-3451. 
 131.  Krakowka,S., Ellis,J.A., Meehan,B., Kennedy,S., McNeilly,F., Allan,G., 2000. Viral 
wasting syndrome of swine: experimental reproduction of postweaning multisystemic 
wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and 
porcine parvovirus. Vet Pathol. 37, 254-263. 
 132.  Krakowka,S., Hartunian,C., Hamberg,A., Shoup,D., Rings,M., Zhang,Y., Allan,G., 
Ellis,J.A., 2008. Evaluation of induction of porcine dermatitis and nephropathy 
syndrome in gnotobiotic pigs with negative results for porcine circovirus type 2. Am J 
Vet Res 69, 1615-1622. 
 133.  Kunstmann,L. and Lau,L., 2008. Effect of sow vaccination with Circovac® on the 
performance of 34 Danish herds. Proceedings of the 20th International Pig Veterinary 
Society Congress 2, 75. 
 134.  Ladekjær-Mikkelsen,A.S., Nielsen,J., Storgaard,T., Bøtner,A., Allan,G., McNeilly,F., 
2001. Transplacental infection with PCV-2 associated with reproductive failure in a 
gilt. Vet.Rec. 148, 759-760. 
214 
 
 
 135.  Ladekjær-Mikkelsen,A.-S., Nielsen,J., Stadejek,T., Storgaard,T., Krakowka,S., 
Ellis,J., McNeilly,F., Allan,G., Bøtner,A., 2002. Reproduction of postweaning 
multisystemic wasting syndrome (PMWS) in immunostimulated and non-
immunostimulated 3-week-old piglets experimentally infected with porcine circovirus 
type 2 (PCV2). Vet.Microbiol. 89, 97-114. 
 136.  Larochelle,R., Bielanski,A., Muller,P., Magar,R., 2000. PCR detection and evidence 
of shedding of porcine circovirus type 2 in boar semen. J.Clin.Microbiol. 38, 4629-
4632. 
 137.  Lawton,D.E., Morris,R.S., King,C.M., 2004. PMWS in New Zealand part 2: 
Epidemiological evidence for a novel agent. Proceedings of the18th International Pig 
Veterinary Society Congress 1, 128. 
 138.  LeCann,P., Albina,E., Madec,F., Cariolet,R., Jestin,A., 1997. Piglet wasting disease. 
Vet.Rec. 141, 660. 
 139.  Lefebvre,D., Barbé,F., Atanasova,K., Nauwynck,H., 2008. Inoculation of porcine 
foetuses with different genotypes and doses of PCV2. Proceedings of the 20th 
International Pig Veterinary Society Congress 1, 38. 
 140.  Liu,J., Chen,I., Du,Q., Chua,H., Kwang,J., 2006. The ORF3 protein of porcine 
circovirus type 2 is involved in viral pathogenesis in vivo. J.Virol. 80, 5065-5073. 
 141.  Liu,J., Chen,I., Kwang,J., 2005. Characterization of a previously unidentified viral 
protein in porcine circovirus type 2-infected cells and its role in virus-induced 
apoptosis. J.Virol. 79, 8262-8274. 
 142.  Lopéz-Soria,S., Segalés,J., Nofrarías,M., Calsamiglia,M., Ramirez,H., Minguez,A., 
Serrano,I.M., Marin,O., Callen,A., 2004. Genetic influence on the expression of PCV 
disease. Vet.Rec. 155, 504-504. 
 143.  Ma,C.M., Hon,C.C., Lam,T.Y., Li,V.Y., Wong,C.K., de,O.T., Leung,F.C., 2007. 
Evidence for recombination in natural populations of porcine circovirus type 2 in 
Hong Kong and mainland China. Journal of General Virology 88, 1733-1737. 
 144.  Madec,F., Eveno,E., Morvan,P., Hamon,L., Blanchard,P., Cariolet,R., Amenna,N., 
Morvan,H., Truong,C., Mahé,D., Albina,E., Jestin,A., 2000. Post-weaning 
multisystemic wasting syndrome (PMWS) in pigs in France: clinical observations 
from follow-up studies on affected farms. Livestock Prod Sci. 63, 223-233. 
 145.  Madec,F., Eveno,E., Morvan,P., Hamon,L., Morvan,H., Albina,E., Truong,C., 
Hutet,E., Cariolet,R., Arnauld,C., Jestin,A., 1999. La maladie de l'amaigrissement du 
porcelet (MAP) en France 1 - Aspects descriptifs, impact en élevage. [Porcine 
wasting disease (PWD) in France: 1 - Description of the disease and impact in 
affected herds]. Journées Recherche en Porcine France 31, 347-354. 
215 
 
 
 146.  Madsen,K.S., 2005. Management of disease control and epidemics in AI in Denmark. 
Theriogenology 63, 585-594. 
 147.  Madson,D.M., Opriessnig,T., Patterson,A.R., Ramamoorthy,S., Pal,N., Meng,X.J., 
Halbur,P.G., 2008a. PCV2 and semen contamination: practical implications. Proc 
16th Swine Disease Conference for Swine Practitioners 77-80. 
 148.  Madson,D.M., Patterson,A.R., Ramamoorthy,S., Pal,N., Meng,X., Opriessnig,T., 
2009a. Effect of natural or vaccine-induced porcine circovirus type 2 (PCV2) 
immunity on fetal infection after artificial insemination with PCV2 spiked semen. 
Theriogenology. In press. 
 149.  Madson,D.M., Patterson,A.R., Ramamoorthy,S., Pal,N., Meng,X., Opriessnig,T., 
2009b. Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 
replication in utero. Clin.Vaccine Immunol. 16, 830-834. 
 150.  Madson,D.M., Patterson,A.R., Ramamoorthy,S., Pal,N., Meng,X.J., Opriessnig,T., 
2009c. Reproductive failure experimentally induced in sows via artificial 
insemination with semen spiked with porcine circovirus type 2 (PCV2). Vet Pathol. 
46. 707-716. 
 151.  Madson,D.M., Ramamoorthy,S., Kuster,C., Pal,N., Meng,X.J., Halbur,P.G., 
Opriessnig,T., 2008b. Characterization of shedding patterns of porcine circovirus 
types 2a and 2b in experimentally inoculated mature boars. J Vet Diagn Invest. 20, 
725-734. 
 152.  Madson,D.M., Ramamoorthy,S., Kuster,C., Pal,N., Meng,X.J., Halbur,P.G., 
Opriessnig,T., 2009d. Infectivity of porcine circovirus type 2 DNA in semen from 
experimentally-infected boars. Vet Res 40:10. 
 153.  Maes,D., Nauwynck,H., Rijsselaere,T., Mateusen,B., Vyt,P., de,K.A., Van,S.A., 
2008. Diseases in swine transmitted by artificial insemination: an overview. 
Theriogenology 70, 1337-1345. 
 154.  Magar,R., Larochelle,R., Thibault,S., Lamontagne,L., 2000a. Experimental 
transmission of porcine circovirus type 2 (PCV2) in weaned pigs: a sequential study. 
J.Comp Pathol. 123, 258-269. 
 155.  Magar,R., Müller,P., Larochelle,R., 2000b. Retrospective serological survey of 
antibodies to porcine circovirus type 1 and type 2. Can.J.Vet.Res. 64, 184-186. 
 156.  Maldonado,J., Segalés,J., Martinez-Puig,D., Calsamiglia,M., Riera,P., Domingo,M., 
Artigas,C., 2005. Identification of viral pathogens in aborted fetuses and stillborn 
piglets from cases of swine reproductive failure in Spain. Vet.J. 169, 454-456. 
216 
 
 
 157.  Mankertz,A., Domingo,M., Folch,J.M., LeCann,P., Jestin,A., Segalés,J., 
Chmielewicz,B., Plana-Durán,J., Soike,D., 2000. Characterisation of PCV-2 isolates 
from Spain, Germany and France. Virus Res. 66, 65-77. 
 158.  Mankertz,A. and Hillenbrand,B., 2001. Replication of porcine circovirus type 1 
requires two proteins encoded by the viral rep gene. Virology 279, 429-438. 
 159.  Mankertz,A., Mankertz,J., Wolf,K., Buhk,H.J., 1998a. Identification of a protein 
essential for replication of porcine circovirus. J.Gen.Virol. 79 ( Pt 2), 381-384. 
 160.  Mankertz,A., Persson,F., Mankertz,J., Blaess,G., Buhk,H.J., 1997. Mapping and 
characterization of the origin of DNA replication of porcine circovirus. J.Virol. 71, 
2562-2566. 
 161.  Mankertz,J., Buhk,H.J., Blaess,G., Mankertz,A., 1998b. Transcription analysis of 
porcine circovirus (PCV). Virus Genes 16, 267-276. 
 162.  Mare,C.J. and Kluge,J.P., 1974. Pseudorabies virus and myoclonia congenita in pigs 
1. J Am Vet Med Assoc 164, 309-310. 
 163.  Mateusen,B., Maes,D.G., Van,S.A., Lefebvre,D., Nauwynck,H.J., 2007. Effect of a 
porcine circovirus type 2 infection on embryos during early pregnancy. 
Theriogenology 68, 896-901. 
 164.  Mateusen,B., Sanchez,R.E., Van,S.A., Meerts,P., Maes,D.G., Nauwynck,H.J., 2004. 
Susceptibility of pig embryos to porcine circovirus type 2 infection. Theriogenology 
61, 91-101. 
 165.  Mauch,C., 2004. Porcine circovirus (PCV) associated losses in pregnant gilts. Pig-
Journal 69-74. 
 166.  McCullough,K.C., Ruggli,N., Summerfield,A., 2009. Dendritic cells-At the front-line 
of pathogen attack. Vet Immunol Immunopathol. 128, 7-15. 
 167.  McIntosh,K.A., Harding,J.C., Parker,S., Ellis,J.A., Appleyard,G.D., 2006a. Nested 
polymerase chain reaction detection and duration of porcine circovirus type 2 in 
semen with sperm morphological analysis from naturally infected boars. 
J.Vet.Diagn.Invest 18, 380-384. 
 168.  McIntosh,K.A., Harding,J.C., Parker,S., Ellis,J.A., Appleyard,G.D., 2006b. Nested 
polymerase chain reaction detection and duration of porcine circovirus type 2 in 
semen with sperm morphological analysis from naturally infected boars. 
J.Vet.Diagn.Invest 18, 380-384. 
 169.  McKeown,N.E., Opriessnig,T., Thomas,P., Guenette,D.K., Elvinger,F., Fenaux,M., 
Halbur,P.G., Meng,X.J., 2005. Effects of porcine circovirus type 2 (PCV2) maternal 
217 
 
 
antibodies on experimental infection of piglets with PCV2. Clin.Diagn.Lab Immunol. 
12, 1347-1351. 
 170.  Medveczky,I. and Szabo,I., 1981. Isolation of Aujeszky's disease virus from boar 
semen. Acta Vet Acad Sci Hung 29, 29-35. 
 171.  Meehan,B.M., McNeilly,F., McNair,I., Walker,I., Ellis,J.A., Krakowka,S., 
Allan,G.M., 2001. Isolation and characterization of porcine circovirus 2 from cases of 
sow abortion and porcine dermatitis and nephropathy syndrome. Arch.Virol. 146, 
835-842. 
 172.  Meehan,B.M., McNeilly,F., Todd,D., Kennedy,S., Jewhurst,V.A., Ellis,J.A., 
Hassard,L.E., Clark,E.G., Haines,D.M., Allan,G.M., 1998. Characterization of novel 
circovirus DNAs associated with wasting syndromes in pigs. J.Gen.Virol. 79, 2171-
2179. 
 173.  Meerts,P., Misinzo,G., Lefebvre,D., Nielsen,J., Bøtner,A., Kristensen,C.S., 
Nauwynck,H.J., 2006. Correlation between the presence of neutralizing antibodies 
against porcine circovirus 2 (PCV2) and protection against replication of the virus 
and development of PCV2-associated disease. BMC.Vet.Res. 2, 6. 
 174.  Meerts,P., Misinzo,G., McNeilly,F., Nauwynck,H.J., 2005a. Replication kinetics of 
different porcine circovirus 2 strains in PK-15 cells, fetal cardiomyocytes and 
macrophages. Arch.Virol. 150, 427-441. 
 175.  Meerts,P., Misinzo,G., Nauwynck,H.J., 2005b. Enhancement of porcine circovirus 2 
replication in porcine cell lines by IFN-gamma before and after treatment and by 
IFN-alpha after treatment. J.Interferon Cytokine Res. 25, 684-693. 
 176.  Meerts,P., Nauwynck,H.J., Sanchez,R.E., Mateusen,B., Pensaert,M.B., 2004. 
Prevalence of porcine circovirus 2 (PCV2)-related wasting on Belgian farms with or 
without a history of postweaning multisystemic wasting syndrome. Vlaams 
Diergeneeskundig Tijdschrift 73, 31-38. 
 177.  Mengeling,W.L., 2006. Porcine Parvovirus. In: Diseases of swine, ed. Straw BE, 
Zimmerman, J. J, D'Allaire, S., Taylor, D. J., 9th ed., pp. 373-386. 
 178.  Mikami,O., Nakajima,H., Kawashima,K., Yoshii,M., Nakajima,Y., 2005. 
Nonsuppurative myocarditis caused by porcine circovirus type 2 in a weak-born 
piglet. J.Vet.Med.Sci. 67, 735-738. 
 179.  Mori,M., Sato,K., Akachi,S., Asahi,S., Taniguchi,S., Narita,M., 2000. Retrospective 
study of porcine circovirus 2 infection in Japan: seven cases in 1989. Vet Pathol. 37, 
667-669. 
218 
 
 
 180.  Morin,M., Girard,C., Elazhary,Y., Fajardo,R., Drolet,R., Lagace,A., 1990. Severe 
proliferative and necrotizing pneumonia in pigs: A newly recognized disease. Can 
Vet J 31, 837-839. 
 181.  Morozov,I., Sirinarumitr,T., Sorden,S.D., Halbur,P.G., Morgan,M.K., Yoon,K.J., 
Paul,P.S., 1998. Detection of a novel strain of porcine circovirus in pigs with 
postweaning multisystemic wasting syndrome. J.Clin.Microbiol. 36, 2535-2541. 
 182.  Nawagitgul,P., Harms,P.A., Morozov,I., Thacker,B.J., Sorden,S.D., 
Lekcharoensuk,C., Paul,P.S., 2002. Modified indirect porcine circovirus (PCV) type 
2-based and recombinant capsid protein (ORF2)-based enzyme-linked 
immunosorbent assays for detection of antibodies to PCV. Clin.Diagn.Lab Immunol. 
9, 33-40. 
 183.  Nawagitgul,P., Morozov,I., Bolin,S.R., Harms,P.A., Sorden,S.D., Paul,P.S., 2000. 
Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. 
J.Gen.Virol. 81, 2281-2287. 
 184.  Niagro,F.D., Forsthoefel,A.N., Lawther,R.P., Kamalanathan,L., Ritchie,B.W., 
Latimer,K.S., Lukert,P.D., 1998. Beak and feather disease virus and porcine 
circovirus genomes: intermediates between the geminiviruses and plant circoviruses. 
Arch.Virol. 143, 1723-1744. 
 185.  Nielsen,J., Ladekjær-Hansen,A.S., Bille-Hansen,V., Lohse,L., Bøtner,A., 2004. 
PCV2-associated disease following intrauterine infection. Proceedings of the 18th 
International Pig Veterinary Society Congress 1, 14. 
 186.  Núñez,A., McNeilly,F., Perea,A., Sánchez-Cordón,P.J., Huerta,B., Allan,G., 
Carrasco,L., 2003. Coinfection by Cryptosporidium parvum and porcine circovirus 
type 2 in weaned pigs. J.Vet.Med.B Infect.Dis.Vet.Public Health 50, 255-258. 
 187.  O'Connor,B., Gauvreau,H., West,K., Bogdan,J., Ayroud,M., Clark,E.G., Konoby,C., 
Allan,G., Ellis,J.A., 2001. Multiple porcine circovirus 2-associated abortions and 
reproductive failure in a multisite swine production unit. Can.Vet.J. 42, 551-553. 
 188.  O'Dea,M.A., Hughes,A.P., Davies,L.J., Muhling,J., Buddle,R., Wilcox,G.E., 2008. 
Thermal stability of porcine circovirus type 2 in cell culture. J Virol Methods 147, 61-
66. 
 189.  Olvera,A., Cortey,M., Segales,J., 2007. Molecular evolution of porcine circovirus 
type 2 genomes: phylogeny and clonality. Virology 357, 175-185. 
 190.  Olvera,A., Sibila,M., Calsamiglia,M., Segalés,J., Domingo,M., 2004. Comparison of 
porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning 
multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome 
naturally affected pigs. J.Virol.Methods 117, 75-80. 
219 
 
 
 191.  Opriessnig,T., Fenaux,M., Thomas,P., Hoogland,M.J., Rothschild,M.F., Meng,X.J., 
Halbur,P.G., 2006a. Evidence of breed-dependent differences in susceptibility to 
porcine circovirus type-2-associated disease and lesions. Vet Pathol. 43, 281-293. 
 192.  Opriessnig,T., Halbur,P.G., Yu,S., Thacker,E.L., Fenaux,M., Meng,X.J., 2006b. 
Effects of the timing of the administration of Mycoplasma hyopneumoniae bacterin 
on the development of lesions associated with porcine circovirus type 2. Vet.Rec. 
158, 149-154. 
 193.  Opriessnig,T., Janke,B.H., Halbur,P.G., 2006c. Cardiovascular lesions in pigs 
naturally or experimentally infected with porcine circovirus type 2. J.Comp Pathol. 
134, 105-110. 
 194.  Opriessnig,T., Kuster,C., Halbur,P.G., 2006d. Demonstration of porcine circovirus 
type 2 in the testes and accessory sex glands of a boar. J.Swine Hlth Prod. 14, 42-45. 
 195.  Opriessnig,T., Madson,D.M., Patterson,A.R., Ramamoorthy,S., Meng,X.J., 
Halbur,P.G., 2009a. Comparison of the efficacy of sow vaccination versus piglet 
vaccination for PCV2 and evaluation of the impact of revaccination with a 
homologous PCV2 vaccine. Proc American Association of Swine Veterinarians 147-
148. 
 196.  Opriessnig,T., Madson,D.M., Prickett,J.R., Kuhar,D., Lunney,J.K., Elsener,J., 
Halbur,P.G., 2008a. Effect of porcine circovirus type 2 (PCV2) vaccination on 
porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection. 
Vet Microbiol 131, 103-114. 
 197.  Opriessnig,T., McKeown,N.E., Zhou,E.M., Meng,X.J., Halbur,P.G., 2006e. Genetic 
and experimental comparison of porcine circovirus type 2 (PCV2) isolates from cases 
with and without PCV2-associated lesions provides evidence for differences in 
virulence. J.Gen.Virol. 87, 2923-2932. 
 198.  Opriessnig,T., Meng,X.J., Halbur,P.G., 2007. Porcine Circovirus Type 2 associated 
disease: Update on current terminology, clinical manifestations, pathogenesis, 
diagnosis, and intervention strategies. J Vet Diagn.Invest 19, 591-615. 
 199.  Opriessnig,T., Patterson,A., Jones,D., Juhan,N.M., Meng,X.J., Halbur,P.G., 2009b. 
Susceptibility of three different mouse lines to porcine circovirus type 2 infection and 
associated lesions. Canadian Journal of Veterinary Research. In press. 
 200.  Opriessnig,T., Patterson,A.R., Madson,D.M., Pal,N., Rothschild,M., Kuhar,D., 
Lunney,J.K., Juhan,N.M., Meng,X.J., Halbur,P.G., 2009c. Difference in severity of 
porcine circovirus type 2 (PCV2)-induced pathological lesions between Landrace and 
Pietrain pigs. J Anim Sci 87, 1582-1590. 
220 
 
 
 201.  Opriessnig,T., Patterson,A.R., Meng,X.J., Halbur,P.G., 2009d. Porcine circovirus 
type 2 in muscle and bone marrow is infectious and transmissible to naive pigs by 
oral consumption. Vet Microbiol 133, 54-64. 
 202.  Opriessnig,T., Ramamoorthy,S., Madson,D.M., Patterson,A.R., Pal,N., Carman,S., 
Meng,X.J., Halbur,P.G., 2008b. Differences in virulence among porcine circovirus 
type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides 
heterologous protection. Journal of General Virology 89, 2482-2491. 
 203.  Opriessnig,T., Roof,M., Layton,S.M., Madson,D.M., Halbur,P.G., 2008c. 
Experimental coinfection with porcine circovirus type 2 and Salmonella typhimurium 
or Lawsonia intracellularis. Proceedings of the 20th International Pig Veterinary 
Society Congress 1, 48. 
 204.  Opriessnig,T., Yu,S., Gallup,J.M., Evans,R.B., Fenaux,M., Pallares,F., Thacker,E.L., 
Brockus,C.W., Ackermann,M.R., Thomas,P., Meng,X.J., Halbur,P.G., 2003. Effect of 
vaccination with selective bacterins on conventional pigs infected with type 2 porcine 
circovirus. Vet.Pathol. 40, 521-529. 
 205.  Opriessnig,T., Yu,S., Thacker,E.L., Halbur,P.G., 2004. Derivation of porcine 
circovirus type 2-negative pigs from positive breeding herds. J.Swine Hlth Prod. 12, 
186-191. 
 206.  Ostanello,F., Caprioli,A., Di,F.A., Battilani,M., Sala,G., Sarli,G., Mandrioli,L., 
McNeilly,F., Allan,G.M., Prosperi,S., 2005. Experimental infection of 3-week-old 
conventional colostrum-fed pigs with porcine circovirus type 2 and porcine 
parvovirus. Vet.Microbiol. 108, 179-186. 
 207.  Ouardani,M., Wilson,L., Jette,R., Montpetit,C., Dea,S., 1999. Multiplex PCR for 
detection and typing of porcine circoviruses. J.Clin.Microbiol. 37, 3917-3924. 
 208.  Pal,N., Huang,Y.W., Madson,D.M., Kuster,C., Meng,X.J., Halbur,P.G., 
Opriessnig,T., 2008. Development and validation of a duplex real-time PCR assay for 
the simultaneous detection and quantification of porcine circovirus type 2 and an 
internal control on porcine semen samples. J Virol Methods 149, 217-225. 
 209.  Pallarés,F.J., Halbur,P.G., Opriessnig,T., Sorden,S.D., Villar,D., Janke,B.H., 
Yaeger,M.J., Larson,D.J., Schwartz,K.J., Yoon,K.J., Hoffman,L.J., 2002. Porcine 
circovirus type 2 (PCV-2) coinfections in US field cases of postweaning 
multisystemic wasting syndrome (PMWS). J.Vet.Diagn.Invest 14, 515-519. 
 210.  Park,J.S., Ha,Y., Kwon,B., Cho,K.D., Lee,B.H., Chae,C., 2009. Detection of porcine 
circovirus 2 in mammary and other tissues from experimentally infected sows. J 
Comp Pathol. 140, 208-211. 
221 
 
 
 211.  Park,J.-S., Kim,J., Ha,Y., Jung,K., Choi,C., Lim,J.-K., Kim,S.-H., Chae,C., 2005. 
Birth abnormalities in pregnant sows infected intranasally with porcine circovirus 2. 
J.Comp Pathol. 132, 139-144. 
 212.  Pensaert,M.B., Sanchez,R.E., Jr., Ladekjær-Mikkelsen,A.S., Allan,G.M., 
Nauwynck,H.J., 2004. Viremia and effect of fetal infection with porcine viruses with 
special reference to porcine circovirus 2 infection. Vet.Microbiol. 98, 175-183. 
 213.  Pescador,C.A., 2007. Co-infection by porcine circovirus type 2 and porcine 
parvovirus in aborted fetuses and stillborn piglets in southern Brazil. Pesquisa-
Veterinaria-Brasileira 27, 425-429. 
 214.  Pittman,J.S., 2008. Reproductive failure associated with porcine circovirus type 2 in 
gilts. J.Swine Hlth Prod.16, 144-148. 
 215.  Pogranichniy,R.M., Yoon,K.J., Harms,P.A., Sorden,S.D., Daniels,M., 2002. Case-
control study on the association of porcine circovirus type 2 and other swine viral 
pathogens with postweaning multisystemic wasting syndrome. J.Vet.Diagn.Invest 14, 
449-456. 
 216.  Pogranichniy,R.M., Yoon,K.J., Harms,P.A., Swenson,S.L., Zimmerman,J.J., 
Sorden,S.D., 2000b. Characterization of immune response of young pigs to porcine 
circovirus type 2 infection. Viral Immunol. 13, 143-153. 
 217.  Pogranichniy,R.M., Yoon,K.J., Harms,P.A., Swenson,S.L., Zimmerman,J.J., 
Sorden,S.D., 2000a. Characterization of immune response of young pigs to porcine 
circovirus type 2 infection. Viral Immunol. 13, 143-153. 
 218.  Pogranichniy,R.M., Yoon,K.J., Yaeger,M., Vaughn,E., Stammer,R., Roof,M., 2004. 
Efficacy of experimental inactivated PCV2 vaccines for preventing PMWS in CDCD 
pigs. Proc American Association of Swine Veterinarians 35, 443-444. 
 219.  Pujols,J., Lopez-Soria,S., Segales,J., Fort,M., Sibila,M., Rosell,R., Solanes,D., 
Russell,L., Campbell,J., Crenshaw,J., Weaver,E., Polo,J., 2008. Lack of transmission 
of porcine circovirus type 2 to weanling pigs by feeding them spray-dried porcine 
plasma. Vet Rec 163, 536-538. 
 220.  Quintana,J., Balasch,M., Segalés,J., Calsamiglia,M., Rodríguez-Arrioja,G.M., Plana-
Durán,J., Domingo,M., 2002. Experimental inoculation of porcine circoviruses type 1 
(PCV1) and type 2 (PCV2) in rabbits and mice. Vet.Res. 33, 229-237. 
 221.  Quintana,J., Segalés,J., Rosell,C., Calsamiglia,M., Rodríguez-Arrioja,G.M., 
Chianini,F., Folch,J.M., Maldonado,J., Canal,M., Plana-Durán,J., Domingo,M., 2001. 
Clinical and pathological observations on pigs with postweaning multisystemic 
wasting syndrome. Vet.Rec. 149, 357-361. 
222 
 
 
 222.  Reicks,D.L., Davies,P.R., Rossow,K., 2007. Cross-sectional and longitudinal studies 
of PCV2 infection in 4 boar studs. Proc 2007 Allen D.Leman Swine conference 34, 
104-109. 
 223.  Reicks,D.L. and Leuwerke,B.C., 2008. The effect of vaccination to porcine circovirus 
type 2 on detection in serum, blood swab, and semen. Proceedings of the 20th 
International Pig Veterinary Society Congress 1, 14. 
 224.  Reicks,D.L., Munoz-Zanzi,C., Mengeling,W., Christopher-Hennings,J., Lager,K., 
Polson,D., Dee,S., Rossow,K., 2006a. Detection of porcine reproductive and 
respiratory syndrome virus in semen and serum of boars during the first six days after 
inoculation. J.Swine Hlth Prod. 14, 35-41. 
 225.  Reicks,D.L., Munoz-Zanzi,C., Rossow,K., 2006b. Sampling of adult boars during 
early infection with porcine reproductive and respiratory syndrome virus for testing 
by polymerase chain reaction using new blood collection technique (blood swab 
method). J.Swine Hlth Prod. 14, 258-264. 
 226.  Ritzmann,M., Wilhelm,S., Zimmermann,P., Etschmann,B., Bogner,K.H., Selbitz,H.J., 
Heinritzi,K., Truyen,U., 2005. [Prevalence and association of porcine circovirus type 
2 (PCV2), porcine parvovirus (PPV) and porcine reproductive and respiratory 
syndrome virus (PRRSV) in aborted fetuses, mummified fetuses, stillborn and 
nonviable neonatal piglets]. Dtsch.Tierarztl.Wochenschr. 112, 348-351. 
 227.  Rodríguez-Arrioja,G.M., Segalés,J., Calsamiglia,M., Resendes,A.R., Balasch,M., 
Plana-Durán,J., Casal,J., Domingo,M., 2002. Dynamics of porcine circovirus type 2 
infection in a herd of pigs with postweaning multisystemic wasting syndrome. 
Am.J.Vet.Res. 63, 354-357. 
 228.  Rodríguez-Arrioja,G.M., Segalés,J., Rosell,C., Quintana,J., Ayllón,S., Camprodón,A., 
Domingo,M., 1999. Aujeszky's disease virus infection concurrent with postweaning 
multisystemic wasting syndrome in pigs. Vet.Rec. 144, 152-153. 
 229.  Rodríguez-Arrioja,G.M., Segalés,J., Rosell,C., Rovira,A., Pujols,J., Plana-Durán,J., 
Domingo,M., 2003. Retrospective study on porcine circovirus type 2 infection in pigs 
from 1985 to 1997 in Spain. J.Vet.Med.B Infect.Dis.Vet.Public Health 50, 99-101. 
 230.  Rose,N., Blanchard,P., Cariolet,R., Grasland,B., Amenna,N., Oger,A., Durand,B., 
Balasch,M., Jestin,A., Madec,F., 2007. Vaccination of Porcine Circovirus type 2 
(PCV2)-infected Sows against Porcine Parvovirus (PPV) and Erysipelas: Effect on 
Post-weaning Multisystemic Wasting Syndrome (PMWS) and on PCV2 Genome 
Load in the Offspring. J Comp Pathol. 136, 133-144. 
 231.  Rose,N., Larour,G., Le,D.G., Eveno,E., Jolly,J.P., Blanchard,P., Oger,A., Le,D.M., 
Jestin,A., Madec,F., 2003. Risk factors for porcine post-weaning multisystemic 
223 
 
 
wasting syndrome (PMWS) in 149 French farrow-to-finish herds. Prev.Vet.Med. 61, 
209-225. 
 232.  Rosell,C., Segalés,J., Plana-Durán,J., Balasch,M., Rodríguez-Arrioja,G.M., 
Kennedy,S., Allan,G.M., McNeilly,F., Latimer,K.S., Domingo,M., 1999. 
Pathological, immunohistochemical, and in-situ hybridization studies of natural cases 
of postweaning multisystemic wasting syndrome (PMWS) in pigs. J.Comp Pathol. 
120, 59-78. 
 233.  Rosell,C., Segalés,J., Ramos-Vara,J.A., Folch,J.M., Rodríguez-Arrioja,G.M., 
Duran,C.O., Balasch,M., Plana-Durán,J., Domingo,M., 2000. Identification of 
porcine circovirus in tissues of pigs with porcine dermatitis and nephropathy 
syndrome. Vet.Rec. 146, 40-43. 
 234.  Rovira,A., Balasch,M., Segalés,J., Garcia,L., Plana-Dúran,J., Rosell,C., Ellerbrok,H., 
Mankertz,A., Domingo,M., 2002. Experimental inoculation of conventional pigs with 
porcine reproductive and respiratory syndrome virus and porcine circovirus 2. J.Virol. 
76, 3232-3239. 
 235.  Sanchez,R., Nauwynck,H., Pensaert,M., 2001. Serological survey of porcine 
circovirus 2 antibodies in domestic and feral pig populations in Belgium. Proc 
Conference of ssDNA Viruses, Plants, Birds, Pigs, and Primates 122. 
 236.  Sanchez,R.E., Jr., Meerts,P., Nauwynck,H.J., Ellis,J.A., Pensaert,M.B., 2004. 
Characteristics of porcine circovirus-2 replication in lymphoid organs of pigs 
inoculated in late gestation or postnatally and possible relation to clinical and 
pathological outcome of infection. J.Vet.Diagn.Invest 16, 175-185. 
 237.  Sanchez,R.E., Jr., Meerts,P., Nauwynck,H.J., Pensaert,M.B., 2003. Change of porcine 
circovirus 2 target cells in pigs during development from fetal to early postnatal life. 
Vet.Microbiol. 95, 15-25. 
 238.  Sanchez,R.E., Jr., Nauwynck,H.J., McNeilly,F., Allan,G.M., Pensaert,M.B., 2001. 
Porcine circovirus 2 infection in swine foetuses inoculated at different stages of 
gestation. Vet.Microbiol. 83, 169-176. 
 239.  Sanford,S.E., 2002. PCV-2 related reproductive failure in startup herds. Proceedings 
of the 17th International Pig Veterinary Society Congress 1, 171. 
 240.  Sangild,P.T., 2003. Uptake of colostral immunoglobulins by the compromised 
newborn farm animal. Acta Vet Scand Suppl 98, 105-122. 
 241.  Schmoll,F., Lang,C., Steinrigl,A.S., Schulze,K., Kauffold,J., 2008. Prevalence of 
PCV2 in Austrian and German boars and semen used for artificial insemination. 
Theriogenology 69, 814-821. 
224 
 
 
 242.  Schøning,T., Nielsen,P., Lau,L., 2008. Effect of Circovac® (Merial) on porcine 
circovirus type 2 (PCV2) sow reproductive failure and mortality: A case report. 
Proceedings of the 20th International Pig Veterinary Society Congress 2, 108. 
 243.  Schultz,R.D., Adams,L.S., Letchworth,G., Sheffy,B.E., Manning,T., Bean,B., 1982. 
A method to test large numbers of bovine semen samples for viral contamination and 
results of a study using this method. Theriogenology 17, 115-123. 
 244.  Segalés,J., 2006. Clinico-pathological features in PMWS: PMWS herd and individual 
case definitions. Proc American Association of Swine Veterinarians: PCV2/PMWS 
seminar #12 37, 1-7. 
 245.  Segalés,J., Allan,G.M., Domingo,M., 2005a. Porcine circovirus diseases. Anim Hlth 
Res.Rev. 6, 119-142. 
 246.  Segalés,J., Calsamiglia,M., Olvera,A., Sibila,M., Badiella,L., Domingo,M., 2005b. 
Quantification of porcine circovirus type 2 (PCV2) DNA in serum and tonsillar, 
nasal, tracheo-bronchial, urinary and faecal swabs of pigs with and without 
postweaning multisystemic wasting syndrome (PMWS). Vet.Microbiol. 111, 223-
229. 
 247.  Segales,J., Piella,J., Marco,E., Mateu-de-Antonio,E.M., Espuna,E., Domingo,M., 
1998. Porcine dermatitis and nephropathy syndrome in Spain. Vet Rec 142, 483-486. 
 248.  Segalés,J., Piñeiro,C., Lampreave,F., Nofrarías,M., Mateu,E., Calsamiglia,M., 
Andrés,M., Morales,J., Piñeiro,M., Domingo,M., 2004a. Haptoglobin and pig-major 
acute protein are increased in pigs with postweaning multisystemic wasting syndrome 
(PMWS). Vet.Res. 35, 275-282. 
 249.  Segalés,J., Rosell,C., Domingo,M., 2002. Reproductive failure associated to porcine 
circovirus type 2 infection in Spain? Proc 17th International Pig Veterinary Society 
Congress 2, 171. 
 250.  Segalés,J., Rosell,C., Domingo,M., 2004b. Pathological findings associated with 
naturally acquired porcine circovirus type 2 associated disease. Vet.Microbiol. 98, 
137-149. 
 251.  Segales,J., Sitjar,M., Domingo,M., Dee,S., Del,P.M., Noval,R., Sacristan,C., De 
las,H.A., Ferro,A., Latimer,K.S., 1997. First report of post-weaning multisystemic 
wasting syndrome in pigs in Spain. Vet Rec 141, 600-601. 
 252.  Shibata,I., Okuda,Y., Kitajima,K., Asai,T., 2006. Shedding of porcine circovirus into 
colostrum of sows. J.Vet.Med.B Infect.Dis.Vet.Public Health 53, 278-280. 
 253.  Shibata,I., Okuda,Y., Yazawa,S., Ono,M., Sasaki,T., Itagaki,M., Nakajima,N., 
Okabe,Y., Hidejima,I., 2003. PCR detection of Porcine circovirus type 2 DNA in 
225 
 
 
whole blood, serum, oropharyngeal swab, nasal swab, and feces from experimentally 
infected pigs and field cases. J.Vet.Med.Sci. 65, 405-408. 
 254.  Sibila,M., Calsamiglia,M., Segalés,J., Blanchard,P., Badiella,L., Le,D.M., Jestin,A., 
Domingo,M., 2004. Use of a polymerase chain reaction assay and an ELISA to 
monitor porcine circovirus type 2 infection in pigs from farms with and without 
postweaning multisystemic wasting syndrome. Am.J.Vet.Res. 65, 88-92. 
 255.  Sibila,M., López-Soria,S., Segalés,J., Nofrarías,M., Ramírez,H., Mínguez,A., 
Serrano,J.M., Marín,O., Callén,A., 2005. PCV2 load dynamics in two PMWS 
affected farms with three different genetic lines. International Conference on "Animal 
Circoviruses and Associated Diseases" 39. 
 256.  Singh,E.L. and Thomas,F.C., 1987. Embryo transfer as a means of controlling the 
transmission of viral infections. IX. The in vitro exposure of zona pellucida-intact 
porcine embryos to swine vesicular disease virus. Theriogenology 27, 443-449. 
 257.  Singleton,W.L., 2001. State of the art in artificial insemination of pigs in the United 
States. Theriogenology 56, 1305-1310. 
 258.  Smith,W.J., Thomson,J.R., Done,S., 1993. Dermatitis Nephropathy Syndrome of 
Pigs. Veterinary Record 132, 47-47. 
 259.  Sofia,M., Billinis,C., Psychas,V., Birtsas,P., Sofianidis,G., Leontides,L., Knowles,N., 
Spyrou,V., 2008. Detection and Genetic Characterization of Porcine Circovirus 2 
Isolates from the First Cases of Postweaning Multisystemic and Wasting Syndrome in 
Wild Boars in Greece. Journal of Wildlife Diseases 44, 864-870. 
 260.  Sorden,S.D., 2000. Update on porcine circovirus and postweaning multisystemic 
wasting syndrome (PMWS). Swine Health and Production. 8, 133-136. 
 261.  Sorden,S.D., Harms,P.A., Nawagitgul,P., Cavanaugh,D., Paul,P.S., 1999. 
Development of a polyclonal-antibody-based immunohistochemical method for the 
detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue. 
J.Vet.Diagn.Invest 11, 528-530. 
 262.  Steiner,E., Balmelli,C., Herrmann,B., Summerfield,A., McCullough,K., 2008. 
Porcine circovirus type 2 displays pluripotency in cell targeting. Virology 378, 311-
322. 
 263.  Steinfeldt,T., Finsterbusch,T., Mankertz,A., 2001. Rep and Rep' protein of porcine 
circovirus type 1 bind to the origin of replication in vitro. Virology 291, 152-160. 
 264.  Stevenson,G.W., Kiupel,M., Mittal,S.K., Choi,J., Latimer,K.S., Kanitz,C.L., 2001. 
Tissue distribution and genetic typing of porcine circoviruses in pigs with naturally 
occurring congenital tremors. J.Vet.Diagn.Invest 13, 57-62. 
226 
 
 
 265.  Sun,M., Liu,X., Cao,S., He,Q., Zhou,R., Ye,J., Li,Y., Chen,H., 2007. Inhibition of 
porcine circovirus type 1 and type 2 production in PK-15 cells by small interfering 
RNAs targeting the Rep gene. Vet Microbiol. 123, 203-209. 
 266.  Szeredi,L. and Szentirmai,C., 2008. Proliferative and necrotising pneumonia and 
severe vascular lesions in pigs naturally infected with porcine circovirus type 2. Acta 
Vet Hung 56, 101-109. 
 267.  Thibault,S., Drolet,R., Germain,M.C., D'Allaire,S., Larochelle,R., Magar,R., 1998. 
Cutaneous and systemic necrotizing vasculitis in swine. Vet.Pathol. 35, 108-116. 
 268.  Thomas,P.J., Opriessnig,T., Juhan,N.M., Meng,X.J., Halbur,P.G., 2007. Planned 
exposure to porcine circovirus type 2 by serum injection is not effective at preventing 
porcine circovirus associated disease. J.Swine Hlth Prod.15, 330-338. 
 269.  Thomson,J.R., Higgins,R.J., Smith,W.J., Done,S.H., 2002. Porcine dermatitis and 
nephropathy syndrome. clinical and pathological features of cases in the United 
Kingdom (1993-1998). J.Vet.Med.A Physiol Pathol.Clin.Med. 49, 430-437. 
 270.  Thomson,J.R., MacIntyre,N., Henderson,L.E.A., Meikle,C.S., 2001. Detection of 
Pasteurella multocida in pigs with porcine dermatitis and nephropathy syndrome. 
Veterinary Record 149, 412-417. 
 271.  Timmusk,S., Wallgren,P., Brunborg,I.M., Wikstrom,F.H., Allan,G., Meehan,B., 
McMenamy,M., McNeilly,F., Fuxler,L., Belak,K., Podersoo,D., Saar,T., Berg,M., 
Fossum,C., 2008. Phylogenetic analysis of porcine circovirus type 2 (PCV2) pre- and 
post-epizootic postweaning multisystemic wasting syndrome (PMWS). Virus Genes 
36, 509-520. 
 272.  Tischer,I., Gelderblom,H., Vettermann,W., Koch,M.A., 1982. A very small porcine 
virus with circular single-stranded DNA. Nature 295, 64-66. 
 273.  Tischer,I., Mields,W., Wolff,D., Vagt,M., Griem,W., 1986. Studies on epidemiology 
and pathogenicity of porcine circovirus. Arch.Virol. 91, 271-276. 
 274.  Tischer,I., Peters,D., Rasch,R., Pociuli,S., 1987. Replication of porcine circovirus: 
induction by glucosamine and cell cycle dependence. Arch.Virol. 96, 39-57. 
 275.  Tischer,I., Rasch,R., Tochtermann,G., 1974. Characterization of papovavirus-and 
picornavirus-like particles in permanent pig kidney cell lines. 
Zentralbl.Bakteriol.[Orig.A] 226, 153-167. 
 276.  Todd,D., Bendinelli,M., Biagini,P., Hino,S., Mankertz,A., Mishiro,S., Niel,C., 
Okamoto,H., Raidal,S., Ritchie,B.W., Teo,G., 2005. Circoviridae. Eighth report of the 
international committee on taxonomy of viruses, 327-334. 
227 
 
 
 277.  Vila,T., Autret,D., Callen,A., Bridoux,N., Brune,A., Charreyre,C., Hérin,J.B., 
Joisel,F., Larour,G., Lau,L., Longo,S., Lorenzo,J., Shade,A., Smits,H., 2009. 
Management of PCV2 disease (or PCVD) using vaccination with CIRCOVAC: 
Recent European field experiences. Proc.40th American Association of Swine 
Veterinarians 231-237. 
 278.  Vincent,I.E., Carrasco,C.P., Herrmann,B., Meehan,B.M., Allan,G.M., 
Summerfield,A., McCullough,K.C., 2003. Dendritic cells harbor infectious porcine 
circovirus type 2 in the absence of apparent cell modulation or replication of the 
virus. J.Virol. 77, 13288-13300. 
 279.  Waddilove,A.E.J. and Marco,E., 2002. Assessing serotherapeutic control of PMWS 
in the field. Proceedings of the 17th International Pig Veterinary Society Congress 2, 
204. 
 280.  Walker,I.W., Konoby,C.A., Jewhurst,V.A., McNair,I., McNeilly,F., Meehan,B.M., 
Cottrell,T.S., Ellis,J.A., Allan,G.M., 2000. Development and application of a 
competitive enzyme-linked immunosorbent assay for the detection of serum 
antibodies to porcine circovirus type 2. J.Vet.Diagn.Invest 12, 400-405. 
 281.  Wallgren,P., Blomqvist,G., Thorén,P., Elander,J., Wallgren,M., 2008. Incidence of 
PCV2 in semen collected at Swedish boar stations. Proceedings of the 20th 
International Pig Veterinary Society Congress 2, 62. 
 282.  Wallgren,P., Hasslung,F., Bergstrom,G., Linder,A., Belak,K., Hard af,S.C., 
Stampe,M., Molander,B., Bjornberg,K.T., Norregard,E., Ehlorsson,C.J., 
Tornquist,M., Fossum,C., Allan,G.M., Robertsson,J.A., 2004. Postweaning 
multisystemic wasting syndrome--PMWS. The first year with the disease in Sweden. 
Vet.Q. 26, 170-187. 
 283.  Wang,K., Huang,L.H., Kong,J., Zhang,X.W., 2008. Expression of the capsid protein 
of porcine circovirus type 2 in Lactococcus lactis for oral vaccination. Journal of 
Virological Methods 150, 1-6. 
 284.  Wang,X., Jiang,P., Li,Y., Jiang,W., Dong,X., 2007. Protection of pigs against post-
weaning multisystemic wasting syndrome by a recombinant adenovirus expressing 
the capsid protein of porcine circovirus type 2. Vet Microbiol. 121, 215-224. 
 285.  Wang,X., Jiang,W., Jiang,P., Li,Y., Feng,Z., Xu,J., 2006. Construction and 
immunogenicity of recombinant adenovirus expressing the capsid protein of porcine 
circovirus 2 (PCV2) in mice. Vaccine 24, 3374-3380. 
 286.  Weiblen,R., Kreutz,L.C., Canabarro,T.F., Schuch,L.F., Rebelatto,M.C., 1992. 
Isolation of bovine herpesvirus 1 from preputial swabs and semen of bulls with 
balanoposthitis. J Vet Diagn Invest 4, 341-343. 
228 
 
 
 287.  Welch,J., Bienek,C., Gomperts,E., Simmonds,P., 2006. Resistance of porcine 
circovirus and chicken anemia virus to virus inactivation procedures used for blood 
products. Transfusion 46, 1951-1958. 
 288.  Wellenberg,G.J., Stockhofe-Zurwieden,N., De Jong,M.F., Boersma,W.J., 
Elbers,A.R., 2004. Excessive porcine circovirus type 2 antibody titres may trigger the 
development of porcine dermatitis and nephropathy syndrome: a case-control study. 
Vet.Microbiol. 99, 203-214. 
 289.  West,K.H., Bystrom,J.M., Wojnarowicz,C., Shantz,N., Jacobson,M., Allan,G.M., 
Haines,D.M., Clark,E.G., Krakowka,S., McNeilly,F., Konoby,C., Martin,K., 
Ellis,J.A., 1999. Myocarditis and abortion associated with intrauterine infection of 
sows with porcine circovirus 2. J.Vet.Diagn.Invest 11, 530-532. 
 290.  White,M. and Higgins,R.J., 1993. Dermatitis Nephropathy Syndrome of Pigs. 
Veterinary Record 132, 199-199. 
 291.  Yaeger,M.J., Prieve,T., Collins,J., Christopher-Hennings,J., Nelson,E., Benfield,D., 
1993. Evidence for the transmission of porcine reproductive and respiratory 
syndrome (PRRS) virus in boar semen. Swine Health and Production 1, 7-9. 
 292.  Yoon,K.J., Jepsen,R.J., Pogranichniy,R.M., Sorden,S., Stammer,R., Evans,L.E., 
2004. A novel approach to intrauterine viral inoculation of swine using PCV type 2 as 
a model. Theriogenology 61, 1025-1037. 
 293.  Yu,S., Opriessnig,T., Kitikoon,P., Nilubol,D., Halbur,P.G., Thacker,E., 2007a. 
Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune 
cells in early infected pigs. Vet Immunol Immunopathol. 115, 261-272. 
 294.  Yu,S., Vincent,A., Opriessnig,T., Carpenter,S., Kitikoon,P., Halbur,P.G., Thacker,E., 
2007b. Quantification of PCV2 capsid transcript in peripheral blood mononuclear 
cells (PBMCs) in vitro. Vet Microbiol 123, 34-42. 
 295.  Zhou,J.Y., Chen,Q.X., Ye,J.X., Shen,H.G., Chen,T.F., Shang,S.B., 2006. Serological 
investigation and genomic characterization of PCV2 isolates from different 
geographic regions of Zhejiang province in China. Vet.Res.Commun. 30, 205-220. 
 296.  Zizlavsky,M., Czanderlova,L., Gampova,M., Kellnerova,D., Tydlitat,D., Drabek,J., 
2008. Significant role of PCV2 in reproductive disorders of sows. Proceedings of the 
20th International Pig Veterinary Society Congress 2, 110. 
 297.  Zlotowski,P., Correa,A.M.R., Barcellos,D.E.S.N., Cruz,C.E.F., Asanome,W., 
Barry,A.F., Alfieri,A.A., Driemeier,D., 2008. Intestinal lesions in pigs affected with 
postweaning multisystemic wasting syndrome. Pesquisa Veterinaria Brasileira 28, 
313-318. 
  
229 
 
 
ACKNOWLEDGMENTS 
 It is extremely difficult to succeed without the support and guidance of others. This 
journey I embarked on is no different. I first would like to sincerely thank my committee 
members; Drs. Tanja Oppressing, Michael Yaeger, Patrick Halbur, Joseph Haynes, and Kelly 
Lager for their direction, time, and assistance. I would specially like to thank Dr. Tanja 
Opriessnig for mentoring, teaching, and pushing me during this process. “It was not always 
easy, but we did it together and accomplished many great things, thank you.”  
 There are many others who have helped me accomplish this task. I first would like to 
recognize my fellow graduate students, Drs. Abby Patterson and Phil Gauger, in the 
Veterinary Diagnostic Laboratory for listening to my frustrations, aiding in trial work and 
preparation, and numerous other activities. I would also like to acknowledge Dr. Narinder Pal 
for assisting with PCR assays, the numerous veterinary students and the Laboratory Animal 
Resources staff who contributed in caring for the animals and collecting samples. 
 In addition, I would like to thank the Veterinary Diagnostic Laboratory and the 
Veterinary Pathology Department for giving the opportunity to conduct my graduate studies 
and believing in me, and the numerous pathologists in both sections for taking the time to 
bestow their experiences and knowledge. 
   Last, but certainly not least, I would like to thank my wife, Katie, and my parents, 
Richard and Faye Madson, for their love, support, and understanding. I am truly honored and 
blessed to have such a wonderful family. “I am proud to be your husband and your son.”  
    
  
 
